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Improving Zinc Finger Nucleases – 
Strategies for Increasing Gene Editing Activities and Evaluating Off-Target Effects 
 
Abstract 
 
Zinc finger nucleases (ZFNs) induce double-strand DNA breaks at specific recognition 
sites. ZFNs can dramatically increase the efficiency of incorporating desired insertions, 
deletions, or substitutions in living cells. These tools have revolutionized the field of genome 
engineering in several model organisms and cell types including zebrafish, rats, and human 
pluripotent stem cells. There have been numerous advances in ZFN engineering and 
characterization strategies, some of which are detailed in this work. 
The central theme of this dissertation is improving the activity and specificity of 
engineered zinc finger nucleases with the ultimate goal of increasing the safety and efficacy of 
these tools for human therapy. As a first step, I undertook a large-scale effort to demonstrate that 
the modular assembly method of ZFN synthesis has a significantly higher failure rate than 
previously reported in the literature. This strongly suggested that engineering of ZFNs should 
better account for context-dependent effects among zinc fingers. 
The second advance reported in this dissertation is a method for biasing repair of zinc 
finger protein-induced DNA breaks toward homology-driven rather than error-prone repair in the 
presence of a donor template. Catalytically inactivating one monomer of a ZFN dimer results in a 
zinc finger nickase (ZFNickase) whose cleavage preference is directed at only one DNA strand.  
In human cell reporter assays, these ZFNickases exhibit a higher likelihood of repair by 
iv 
 
homology-driven processes, albeit with reduced absolute rates of correction. With further 
optimization, zinc finger nickases could provide a safer alternative to ZFNs in the context of 
gene correction therapies.  
Third, realizing there was no robust method for determining off-target cleavage sites of 
ZFNs in a genome-wide manner, I validated a collaborator’s novel in vitro selection system in 
human cells by identifying eight new potential off-target cleavage sites for a ZFN pair currently 
being used in clinical trials. Although it is unlikely these low-frequency mutations would be 
deleterious to patients, these results demonstrated that ZFNs induced more off-target effects than 
had been appreciated by previous work in the field. Collectively, the findings of this dissertation 
have contributed to more robust strategies for designing and evaluating ZFNs. 
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Chapter One 
 
Introduction 
Parts of this chapter were reprinted with permission from Springer/Kluwer Academic Publishers 
and originally appeared in "Chapter 5: Engineered Zinc Finger Nucleases for Targeted Genome 
Editing." Cherie L. Ramirez & J. Keith Joung. Site directed insertion of transgenes. Editors: 
Sylvaine Renault & Philippe Duchateau. 2012. 
 
Since its proposal in the 1970s, the idea of modifying genomic DNA to cure diseases 
caused by genetic mutations has remained a challenging goal (Wigler et al., 1979). Despite the 
multitude of advances recently made to improve delivery methods and minimize unwanted side-
effects, gene therapy technologies are still moving slowly and  hesitantly toward clinical 
applications (Jensen et al., 2011). Within the last two decades, the field has been galvanized by 
the discovery that introducing double-strand breaks (DSBs) in DNA at specific genomic 
locations can significantly stimulate gene repair machinery (Rouet et al., 1994). Using 
engineered nuclease technologies, natural cellular repair processes have been harnessed to either 
disrupt targeted genes as in a therapy currently in clinical trials as a treatment for HIV/AIDS 
(Holt et al., 2010) or to correct genetic defects to restore health as in a recent study to treat 
hemophilia in a mouse model (Li et al., 2011). In particular, zinc finger nuclease (ZFN) 
technology is emerging as a versatile tool for the realization of these therapeutic strategies as 
well as the advancement of several key areas of basic research, including the rapid generation of 
new transgenic organisms that facilitate the study of human disease (Urnov et al., 2010, Rahman 
et al., 2011). 
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Zinc Fingers: Structure and Function 
 Proteins with zinc finger domains comprise the most abundant class of DNA transcription 
factors in the human genome, with as many as 900 of ~20,000 predicted proteins bearing this 
DNA-binding motif (Miller et al., 1985, Tupler et al., 2001, Urnov, 2002). Study of the Xenopus 
transcription factor TFIIIA led to identification of the consensus sequence for a Cys2-His2 zinc 
finger domain: (F/Y)-X-C-X2-4-C-X-X-X-(F/Y)-X-X-X-X-X-γ-X-X-H-X3-5-H, where X is any 
amino acid and γ is a hydrophobic residue (Miller et al., 1985). Subsequent studies demonstrated 
that sequences in this configuration adopt a ββα fold that coordinates a zinc atom using the 
conserved cysteine and histidine pairs; this structure is particularly well-suited for DNA-binding 
(Parraga et al., 1988, Lee et al., 1989). 
The concept of engineering Cys2-His2 zinc finger (hereafter zinc finger) domains with 
new DNA-binding specificities originated from analyzing the co-crystal structure of DNA-bound 
zinc fingers from the Zif268/Egr1 protein, a transcriptional regulator that determines thymus size 
in mouse (Figure 1.1a) (Pavletich and Pabo, 1991, Bettini et al., 2002). The DNA binding 
domain of Zif268 consists of three tandem zinc fingers that wrap around B-DNA. Primary 
contacts are made between residues -1, +2, +3, and +6 of each zinc finger’s α-helix (or 
“recognition helix”) and the edges of bases in the major groove from the G-rich strand of the 
Zif268 binding site (Figure 1.1a). Each finger binds partially overlapping 3-4 base pair (bp) 
“subsites”: the amino-terminal finger (F1) binds to the 3’-most subsite, the middle finger (F2) 
binds to the middle subsite, and the carboxy-terminal finger (F3) binds to the 5’-most subsite 
within the target site. Interactions both among adjacent zinc finger domains within a multi-finger 
array and between the zinc finger protein and DNA are highly complex, setting the stage for the 
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from its natural DNA-binding domain (Li et al., 1992). The first zinc finger nucleases were 
assembled as chimeras of zinc finger domains for DNA-binding and the FokI cleavage domain 
(Kim et al., 1996, Bitinaite et al., 1998). The FokI cleavage domain functions enzymatically as a 
dimer in the native protein (Kim et al., 1996, Bitinaite et al., 1998). However, it has been 
suggested that  unlike the wild-type FokI enzyme (Pingoud and Silva, 2007), ZFNs engineered as 
dimer pairs may have a small potential for cleavage when only one of the monomers is bound to 
DNA and the other is weakly bound to DNA or in solution (Bitinaite et al., 1998, Catto et al., 
2008, Halford et al., 2011).  Each artificial zinc finger monomer typically recognizes a 9 to 12 bp 
“half-site” separated by 5 to 7 bp of intervening sequence (within which the FokI typically 
cleaves), conferring sufficient specificity in dimer pairs to generate DSBs at sites long enough 
(typically 18 to 24 bp long) to be considered unique in complex genomes (Handel and 
Cathomen, 2011, Rahman et al., 2011). 
  
Zinc Finger Engineering Platforms 
Engineering Single Zinc Finger Domains with Novel DNA-Binding Specificities 
One of the first effective methods for engineering individual single ZFs with novel DNA-
binding specificities was phage-display of combinatorial zinc finger libraries comprised of 
recognition helices with randomized residues at positions expected to make sequence-specific 
DNA contacts. In this selection strategy, the randomized finger was positioned over a desired 3-4 
bp subsite of interest by embedding it within a three-finger array between two fingers that were 
held constant and served as “anchors” that would bind well to a constant sequence. Phage display 
was used successfully to interrogate these libraries and identify individual fingers that bound to a 
wide variety of different 3-4 bp target sites (Choo and Klug, 1994, Jamieson et al., 1994, Rebar 
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Modular Assembly 
One of the first practical and simple methods for the rational design of artificial zinc 
finger arrays was modular assembly (Figure 1.2a) (Bhakta and Segal, 2010). In pioneering work 
by Klug and colleagues, three-finger arrays capable of binding to a sequence in the BCR-ABL 
translocation were engineered (Choo et al., 1994). During the years following that initial success, 
large collections of individual zinc finger domains with in vitro binding activity for particular 
DNA triplets were identified by three research groups: Barbas and colleagues at the Scripps 
Research Institute (Beerli et al., 1998, Segal et al., 2003), Sangamo BioSciences (Liu et al., 
2002), and ToolGen, Inc. (Bae et al., 2003). Along with detailed protocols, these reagents were 
later made publicly available by the Zinc Finger Consortium (Wright et al., 2006). With access to 
the pre-made module archives, polydactyl zinc finger proteins could be assembled by repeating 
simple steps until the desired number of modules—typically three or four, as too few fingers 
have neither sufficient affinity nor specificity and too many fingers can reduce activity (Shimizu 
et al., 2011)—had been added to recognize a particular binding site.  
Although modular assembly is straightforward to practice, the success rate of this method 
was empirically found to be low. A large-scale study by our group estimated that three-finger 
proteins made by modular assembly and tested for DNA binding activity in a bacterial two-
hybrid transcriptional activation assay have on average a 76% failure rate, which was as high as 
100% for sites lacking GNN subsites1 (Ramirez et al., 2008). Another large-scale analysis by 
Kim and colleagues also revealed a similarly low success rate for modularly assembled ZFNs in 
human cells (Kim et al., 2009). The most likely reason for these high failure rates is that modular 
assembly largely ignores the well-documented context-dependent behaviors of zinc fingers that 
can occur within a multi-finger array (Elrod-Erickson et al., 1998, Wolfe et al., 1999, Wolfe et 
                                                 
1 Refer to Chapter 2. 
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al., 2001). This limitation of the method may explain why modularly assembled proteins have in 
some cases been reported to have low affinities and specificities in vitro (Hurt et al., 2003) and 
low activities and high toxicities in cultured human cells (Cornu et al., 2008).  
An alternative argument brought forth by Hughes and colleagues to explain the high 
failure rates reported by Ramirez & Foley et al. is that modular assembly is appropriate for 
engineering zinc finger proteins with specificity to degenerate motifs (a normal property of 
naturally-occurring transcription factors) as assessed by protein-binding microarray assays, but is 
an unrealistic choice for generating proteins with exclusive specificity to a particular 9 bp site 
(Lam et al., 2011). Direct comparisons of proteins generated by modular assembly and context-
dependent assembly methods demonstrate that while proteins made by modular assembly are 
often not functional at their intended targets in bacterial- and human-cell-based assays, context-
dependent methods can more reliably produce proteins capable of interacting with their intended 
targets in living cells (Maeder et al., 2008, Sander et al., 2011b).   
Given these difficulties, some groups have suggested that one way of ensuring a higher 
likelihood of success is to only use modules that consistently perform well when assembled into 
arrays (Kim et al., 2009, Sander et al., 2009, Kim et al., 2010). However, an important 
consequence of using a smaller subset of modules is that the absolute probability of identifying a 
functional protein for a target of interest is reduced, which in turn limits the range of potential 
downstream applications possible (Joung et al., 2010). 
Oligomerized Pool Engineering (OPEN) 
Selection protocols that take into account the context-dependent effects of adjacent 
fingers on overall binding specificity have been successful at identifying multi-finger proteins 
with high activity (Greisman and Pabo, 1997, Hurt et al., 2003, Maeder et al., 2008). Building on 
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the work of Hurt et al., Oligomerized Pool Engineering (OPEN) was developed by the Zinc 
Finger Consortium to simplify highly specialized techniques for interrogating partially 
randomized zinc finger libraries with greater than 108 members into a relatively rapid protocol 
accessible to academic scientists (Figure 1.2b) (Maeder et al., 2009). The key to this method is 
the archive of degenerate zinc finger pools for 66 currently available DNA triplets of a 
theoretical maximum of 192. Each pool contains up to 95 unique solutions that may function in 
many potential contexts. Targetable binding sites within user-defined sequences of interest can 
be identified with the free online tool ZiFiT (Sander et al., 2007, Fu et al., 2009, Sander et al., 
2010a). Although practicing this method requires exquisite attention to the detailed protocol, 16 
of 24 (~67%) zinc finger nuclease pairs were found to be active in zebrafish, plant, or human 
cells, and on average, it is possible to find approximately five potential zinc finger nuclease sites 
per kilobase (kb) of random sequence (Maeder et al., 2008). 
Data derived from the outcomes of 135 successful and failed OPEN selections were used 
to create a machine learning algorithm to assign relative probabilities that a zinc finger nuclease 
pair will function with high accuracy and specificity. These confidence scores have been 
integrated into ZiFiT to facilitate the process of identifying the most promising zinc finger 
nuclease sites from user-specified sequences (Sander et al., 2010b). ZiFDB was developed as an 
online repository for investigator-annotated data on the outcomes of zinc finger engineering 
efforts (Fu et al., 2009). To further aid researchers interested in modifying endogenous loci in 
frequently studied organisms, ZFNGenome was developed as a tool dynamically linked to 
ZiFDB that is used for browsing genomes to visualize any of the 11.6 million potential target 
sites of OPEN-generated zinc finger nucleases (Reyon et al., 2011). 
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Context-Dependent Assembly (CoDA) 
 By analyzing the results of dozens of OPEN selections, the striking observation was 
made that certain F2 (middle) zinc fingers in three-finger arrays appear repeatedly between 
different first and third fingers, suggesting that these zinc fingers may remain functional under 
various contexts (Sander et al., 2011b). Using 18 fixed second-finger units, 319 first-finger units 
and 344 third-finger units were selected by OPEN and assembled into 181 three-finger arrays to 
assess the relative success of the method (Figure 1.2c). The targeting range of CoDA is 
approximately 1 in 500 bp of random sequence with a success rate of >50% (26 of 47 target 
sites) when tested as nucleases in zebrafish, Arabidopsis, and soybean (Curtin et al., 2011, 
Sander et al., 2011b). Independent groups have also used the method to generate active ZFNs 
(Osborn et al., 2011). The ZiFiT software was updated to output sequences encoding CoDA 
proteins if they are found within the investigator’s region of interest.   
Commercial Zinc Finger Engineering 
In addition to the above-mentioned publicly available zinc finger engineering platforms, 
it is also possible to purchase zinc finger proteins through a commercial source, albeit at a 
significant cost and under restrictions posed by legal terms and conditions (Urnov et al., 2005, 
Pearson, 2008, Carbery et al., 2010). While these engineering methods and the reagents 
necessary to practice them are proprietary, some of the details have been disclosed in 
publications; using a previously published strategy originally described by Choo and colleagues 
(Isalan and Choo, 2001, Isalan et al., 2001, Moore et al., 2001, Jamieson et al., 2003), four- and 
six-finger arrays are likely assembled from validated two-finger modules (Doyon et al., 2008, 
Perez et al., 2008), derived from a proprietary archive owned by Sangamo (Figure 1.2d).  
10 
 
Depending on context, two-finger units can be joined together by canonical linkers (TGEKP) or 
by non-canonical “disrupted linkers” (e.g. TGSQKP) (Moore et al., 2001, Perez et al., 2008).  
 
Modified Zinc Finger Nuclease Architectures 
 One problem with using the FokI cleavage domain is that instead of the two different 
monomers of a ZFN pair interacting as a heterodimeric pair as intended, each monomer could 
potentially form homodimers and cut at undesired sites, possibly causing genetic damage. 
Structural analysis and functional characterization of FokI by independent groups yielded two 
sets of heterodimer architectures in which hydrophobic and electrostatic interactions have been 
modified, including the EL:KK (also termed ‘-‘ and ‘+’, respectively) (Miller et al., 2007) and 
DD:RR frameworks (Szczepek et al., 2007); these frameworks are virtually orthologous and 
therefore enable the concurrent introduction of two pairs of ZFNs into cells with minimal 
cytotoxicity (Sollu et al., 2010, Doyon et al., 2011), a capability that is useful for applications 
requiring simultaneous modification of two genomic loci. Unsurprisingly, ZFNs with FokI 
heterodimers have been shown to significantly reduce rates of off-target cleavage (particularly at 
loci with homodimeric half-sites) in human cells relative to the homodimeric FokI framework 
(Gabriel et al., 2011).  
 Although heterodimeric FokI cleavage domains exhibit reduced toxicity, they also 
possess less robust nuclease activity compared to the original homodimeric FokI domain. Novel 
mutations (N496D and H537R, numbered relative to the wild-type FokI sequence) that favor the 
formation of salt bridges to strengthen interactions between the aforementioned heterodimeric 
FokI domains directly address this problem. These mutations not only enhance ZFN activity to 
levels comparable with the activity of homodimeric FokI ZFNs, but also serve to further 
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repaired with the introduction of short insertions or deletions (indels) of extraneous bases by an 
error-prone process known as non-homologous end joining (NHEJ; Figure 1.3 “NHEJ (no 
donor)”) (Hartlerode and Scully, 2009, Orlando et al., 2010). NHEJ is the primary mechanism 
for correction in the event that a repair template for homology-directed repair (HDR) cannot be 
found (van Gent et al., 2001). Even in the absence of selection, gene disruption rates exceeding 
50% can be achieved under optimal conditions (Doyon et al., 2011). Short indels from ZFN-
mediated mutagenesis can be detected by mismatch-sensitive endonuclease assays (Cel-
I/Surveyor or T7 endonuclease I) with a detection limit of about 1% (Oleykowski et al., 1998, 
Kim et al., 2009, Guschin et al., 2010). To identify lower-frequency mutations, DNA sequencing 
is required (Perez et al., 2008, Foley et al., 2009a, Foley et al., 2009b). 
Longer deletions can also be introduced by ZFNs, but these would likely be missed by 
performing standard mutagenesis detection assays or by sequencing short stretches of DNA 
surrounding the intended target site (Morton et al., 2006). In one case, genomic deletions of 
several lengths were introduced using zinc finger nucleases targeted within and near the human 
CCR5 gene; the longest was 15 kb of DNA and attributed to the simultaneous cleavage of 
cognate sites at neighboring genes, CCR5 and CCR2 (Lee et al., 2009). CCR5 is a desirable 
therapeutic target due to the observation that individuals with mutations inactivating this gene 
are not only healthy, but possess a natural resistance to HIV infection (Hutter et al., 2009). 
Translocations can also be induced when ZFN-mediated DSBs are introduced into sites present 
on different chromosomes (Brunet et al., 2009, Simsek et al., 2011). 
Not only can gene disruption be achieved by the NHEJ repair pathway, but this repair 
mechanism can also mediate the insertion of desired donor DNAs with greater than 10% success 
(Figure 1.3 “NHEJ (with donor)”) (Orlando et al., 2010). The authors also report that 
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simultaneous cutting by two zinc finger nuclease pairs in close proximity can result in up to 50% 
donor insertion. 
Stimulation of Homology-Directed Repair 
 
Homologous recombination is a DNA repair pathway in which sequence similarity 
guides DNA repair. Under ordinary circumstances, the spontaneous frequency of homologous 
recombination in mammalian cells is on the order of 1 in 106, a level insufficient for 
therapeutically relevant applications (Vasquez et al., 2001, Paques and Duchateau, 2007). Site-
specific DSBs can stimulate HDR by several orders of magnitude such that 1 in 100 or more 
cells undergo desired DNA repair events (Figure 1.3 “HDR (with donor)) (Rouet et al., 1994, 
Jasin, 1996). It is generally believed that ZFN-induced alterations or insertions should be within 
100 bp of the DSB site for maximal activity due to the relatively short conversion tract length in 
mammals and the observation that the efficiency of gene conversion is inversely related to 
distance (Donoho et al., 1998, Elliott et al., 1998, Hartlerode and Scully, 2009).   
While NHEJ promotes DNA repair throughout a cell’s life, HDR is more active in the S 
and G2 phases of the cell cycle to counteract damage associated with genome replication (Takata 
et al., 1998, Mao et al., 2008, Hartlerode et al., 2011). This observation has been exploited to 
increase the rates of repair for ZFN-induced DSBs by treatment with cytostatic drugs such as 
vinblastine (Urnov et al., 2005) and nocodazole (Olsen et al., 2010), which arrest cultured cells 
in G2/M. Increasing levels of donor in the nucleus can also bias repair toward HDR (Lombardo 
et al., 2007, Gellhaus et al., 2010, Certo et al., 2011). If HDR is the desired outcome, this 
competition between pathways can pose a challenge to achieving high-efficiency error-free 
repair (Hartlerode and Scully, 2009).  
 The delivery method and configuration of the repair template donor can have dramatic 
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effects on rates of correction and fidelity (Figure 1.3 “HDR (with donor)). For instance, plasmid 
DNA with 1.5 kb of homology was used to introduce a silent point mutation in up to 18% of 
IL2Rγ loci in transformed human cells (Urnov et al., 2005). Mutations in the IL2Rγ gene are 
associated with X-linked severe combined immune deficiency (X-SCID, also known as “bubble 
boy” disease); this proof-of-concept could eventually be developed into a therapy to treat 
individuals with this condition. It was later demonstrated that sequences ranging from 12 bp 
epitope tags to 8 kb cassettes harboring multiple transgenes could be knocked-in with 16% and 
6% efficiency, respectively, in the absence of selection (Moehle et al., 2007). Up to 50% 
endogenous gene correction or addition by HDR was achieved in human cells by delivery of 
ZFN and donor via integration-defective lentiviral (IDLV) vectors (Lombardo et al., 2007). 
Adeno-associated viral (AAV) vectors have even been delivered to whole organisms yielding 
partial phenotypic correction of hemophilia in a mouse model (Li et al., 2011). 
Despite surprisingly little shared sequence homology compared to the aforementioned 
donor types, it has also been demonstrated that PCR-derived double-strand linear DNA donors 
with 50 bp homology arms can stimulate transgene addition in 5-10% of chromosomes (Orlando 
et al., 2010). Although initial reports suggested that short single stranded DNA oligonucleotide 
donors could only achieve less than 1% gene conversion (Radecke et al., 2006, Olsen et al., 
2009, Radecke et al., 2010), rates as high as 57% for incorporation of insertions have been 
published for slightly longer single-stranded donors flanked by approximately 40 bp of 
homology on either side of the zinc finger nuclease cut site (Chen et al., 2011). It is not yet clear 
by which mechanism the gene conversion occurs, but there is evidence to suggest that the 
oligonucleotide donors serve as informational templates only that are not incorporated upon 
repair (Radecke et al., 2006, Radecke et al., 2010). In addition, appropriately designed single-
15 
 
stranded donors can be used to mediate deletion of sequences of up to 100 kb (Chen et al., 2011). 
This represents a significant region potentially spanning multiple genes, which may allow for the 
creation of new models of disease. 
Modification of Model Organisms and Cells with Zinc Finger Nucleases 
Zinc finger nucleases have radically simplified and accelerated the generation of novel 
cell lines and model organisms, many of which could not formerly be manipulated genetically 
(Table 1.1). As is often the case, high efficiency rates allow for the identification of founders 
 
Table 1.1: Summary of ZFN-mediated organismic and cell line modifications 
 
Organism References 
Xenopus (Bibikova et al., 2001, Young et al., 2011)  
Drosophila (Bibikova et al., 2002, Bibikova et al., 2003, Beumer et al., 2006, Beumer et al., 2008, Bozas et al., 2009) 
Arabidopsis (Lloyd et al., 2005, Zhang et al., 2010, Sander et al., 2011b) 
Nematode (Morton et al., 2006, Wood et al., 2011) 
Tobacco (Wright et al., 2005, Maeder et al., 2008) 
Zebrafish (Doyon et al., 2008, Meng et al., 2008, Foley et al., 2009b, Sander et al., 2011b) 
Maize (Shukla et al., 2009)  
Rat (Geurts et al., 2009a, Geurts et al., 2009b, Mashimo et al., 2010, Cui et al., 2011, Moreno et al., 2011) 
Mouse (Carbery et al., 2010, Goldberg et al., 2010, Meyer et al., 2010, Cui et al., 2011, Li et al., 2011) 
Pig (Watanabe et al., 2010, Whyte et al., 2011, Yang et al., 2011) 
Sea Urchin (Ochiai et al., 2010) 
Soybean (Sander et al., 2011b) 
Silkworm (Takasu et al., 2010) 
Rabbit (Flisikowska et al., 2011) 
Cell Line  
Chinese hamster ovary (CHO) 
cells (Santiago et al., 2008, Cost et al., 2009, Liu et al., 2010) 
Immortalized or transformed 
human cell lines 
(Porteus and Baltimore, 2003, Alwin et al., 2005, Urnov et al., 2005, 
Moehle et al., 2007, Szczepek et al., 2007, Maeder et al., 2008, 
Radecke et al., 2010) 
Primary human T cells (Urnov et al., 2005, Perez et al., 2008, Wilen et al., 2011) 
Human induced pluripotent stem 
cells (iPSCs) (Hockemeyer et al., 2009, Zou et al., 2009, Zou et al., 2011) 
Human mesenchymal stromal 
cells (Benabdallah et al., 2010) 
Human hematopoietic stem cells 
(HSCs) (Holt et al., 2010) 
 
16 
 
with new genetic mutations by screening a small number of organisms (Foley et al., 2009b). 
For loss-of-function studies, disrupting only one allele is often not enough to suppress activity. 
Fortunately, it has been shown that cell lines with gene disruptions at all alleles can be created at 
high efficiency (Cost et al., 2009, Liu et al., 2010). Despite this success, it is important to note 
that zinc finger nucleases may be less efficient in certain genomic contexts (e.g. regions of 
heterochromatin or DNA methylation), which can vary between cell types (Liu et al., 2001, 
Maeder et al., 2008). As an indirect solution, the introduction of genes into putative “safe 
harbor” loci may be a viable therapeutic strategy (Benabdallah et al., 2010, Zou et al., 2010). 
Safe harbors are loci at which introducing DNA sequence changes is not expected to have 
negative consequences for the host and transgene expression is predicted to be robust. Although 
it has previously been thought that safe harbor loci should be in gene “deserts” to avoid 
disruption of transcription, having the ability to characterize (and in many cases, through 
adequate design considerations, minimize) perturbations in genes neighboring transgene 
integration events may be preferable to altering a poorly understood genetic landscape with 
unknown consequences (Lombardo et al., 2011).  
In proof-of-concept studies at safe harbor loci, zinc finger nuclease-stimulated gene 
integration was achieved in up to 50% of alleles surviving selection in human embryonic stem 
cells (ESCs) and induced pluripotent stem cells (iPSCs) (Hockemeyer et al., 2009, Hockemeyer 
and Jaenisch, 2011). This strategy could one day be used to restore gene function in diseases 
such as hemophilia and cystic fibrosis, for which a particular genetic defect prevents adequate 
levels of the affected protein from being made. Employing autologous cell transplantation, a 
patient’s own cells can be modified and then re-introduced, theoretically preventing immune 
rejection unless a hitherto unfamiliar gene product is generated that is recognized as an antigen. 
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Having the ability to directly modify the patient’s DNA at the sequence level offers numerous 
advantages over competing gene therapy strategies, including the retention of an endogenous 
promoter to regulate expression of the corrected gene. 
 
Cytotoxicity and Off-Target Effects 
Assessing and Attenuating Zinc Finger Nuclease-Mediated Cytotoxicity 
 Having been explicitly designed to cleave DNA, zinc finger nucleases are by nature 
cytotoxic, the degree of which varies for each zinc finger nuclease pair and is determined in part 
by the specificity with which a zinc finger nuclease can bind to its intended unique target at the 
exclusion of alternative sites. Unsurprisingly, it has been demonstrated that obligate zinc finger 
nuclease heterodimers greatly reduce cytotoxicity (Miller et al., 2007, Szczepek et al., 2007, 
Doyon et al., 2011).  
As excess protein concentration exacerbates cytotoxic effects, zinc finger nuclease 
expression should ideally be as low and transient as possible in order to achieve the desired 
modification without otherwise affecting genomic integrity and cellular viability (Beumer et al., 
2006, Pruett-Miller et al., 2008). A variety of delivery options have been explored, including 
plasmids (Porteus and Baltimore, 2003, Holt et al., 2010), mRNAs (Doyon et al., 2008, Meng et 
al., 2008, Zou et al., 2010), and viral vectors—adeno-associated (Porteus et al., 2003), adeno 
(Perez et al., 2008), and integrase-deficient lenti (Cornu and Cathomen, 2007, Lombardo et al., 
2007).  
 A multitude of assays have been used to evaluate cytotoxicity of zinc finger nucleases, 
for readouts including cell death (Alwin et al., 2005), integration of donor plasmid at off-target 
double-strand break sites (Olsen et al., 2010), cell survival (Porteus and Baltimore, 2003, Alwin 
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et al., 2005, Cornu et al., 2008, Maeder et al., 2008, Pruett-Miller et al., 2008, Sollu et al., 2010), 
and organismal developmental defects (Doyon et al., 2008, Meng et al., 2008, Foley et al., 
2009b). Visualizing repair factors recruited to sites of DSBs (e.g. γ-H2AX foci staining) has 
been used to assess cytotoxicity in the past (Miller et al., 2007, Szczepek et al., 2007, Cornu et 
al., 2008). However, these assays only provide a snapshot of double-strand break repair activity 
and lack the sensitivity to determine whether DSBs are occurring at off-target sites over the 
background of intended DSBs and those occurring naturally in dividing cells (Perez et al., 2008, 
Ramalingam et al., 2010). 
Profiling and Validation of Off-Target Cleavage Events 
DNA-binding properties of zinc finger monomers have been evaluated using a variety of 
techniques, including Enzyme-Linked Immunosorbent Assays (ELISA) (Segal et al., 1999, Segal 
et al., 2003), microarrays (Bulyk et al., 2001), Electrophoretic Shift Assays (EMSA) (Hurt et al., 
2003), Systematic Evolution of Ligands by Exponential Enrichment (SELEX) (Wolfe et al., 
1999, Liu and Stormo, 2005, Perez et al., 2008), bacterial two-hybrid transcriptional activation 
assay (Wright et al., 2006), Cyclical Amplification and Selection of Targets (CAST) (Segal et 
al., 2003, Brayer et al., 2008), bacterial one-hybrid profiles (Meng et al., 2007, Gupta et al., 
2011), Bind-n-Seq (Zykovich et al., 2009), fluorescent anisotropy (Sander et al., 2009), 
molecular modeling (Yanover and Bradley, 2011), and purely computational approaches (Sander 
et al., 2010a, Cradick et al., 2011). A subset of these various methods can be used to obtain DNA 
specificity profiles for zinc finger proteins; this information can then be used to computationally 
search for potential off-target sites in genomes of interest.  
The greatest limitation of these computational approaches is that the DNA-binding 
profiles of each ZFN monomer must be used to extrapolate the cleavage specificity of the zinc 
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finger nuclease dimer. Given that dimerization of the FokI nuclease domains may lead to 
cooperative binding of zinc finger nuclease monomers in a dimer (Bitinaite et al., 1998), it has 
been postulated that using the monomeric DNA-binding specificities of zinc finger nucleases 
may not provide sufficient information to identify the full range of potential off-target cleavage 
events (Pattanayak et al., 2011). A novel and recently developed selection scheme for elucidating 
actual cleavage preferences of an active zinc finger nuclease dimer in vitro has enabled the 
identification of new potential zinc finger nuclease off-target sites in human cells.  With this 
approach, eight previously unknown off-target sites for zinc finger nucleases targeted to the 
CCR5 locus were identified in human K562 cells2 (Pattanayak et al., 2011). In addition, an 
important finding of this study was that the position and number of mutations in one half-site can 
affect the probability that a ZFN monomer will be able to bind to the other half-site, suggesting a 
compensation model for cooperative ZFN binding and supporting the theory that monomeric 
binding data is insufficient to infer dimeric ZFN cleavage preferences. 
A complementary approach by which ZFN off-target loci were identified was by 
mapping insertions of integration-defective lentiviruses at DSB sites, which led to the 
identification of eight additional off-target sites for the same CCR5-targeted zinc finger 
nucleases (Gabriel et al., 2011). Both of these methods identified off-target sites in cells that had 
not been predicted computationally from monomeric zinc finger nuclease binding data. 
Interestingly, these methods yielded non-overlapping lists of novel off-target cleavage sites for 
the CCR5 zinc finger nucleases, strongly suggesting that neither approach comprehensively 
identifies off-target sites at the genome-wide level and that there is much work remaining to be 
done in mapping zinc finger nuclease specificity profiles. 
                                                 
2 Refer to Chapter 4. 
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 As the cost of DNA sequencing continues to drop, the possibility of subjecting clonal cell 
populations or small organisms such as nematodes to whole genome sequencing analysis will 
become an increasingly viable option (Rahman et al., 2011, Wood et al., 2011). However, in 
applications for which polyclonal cell populations will be used therapeutically, the need for 
comprehensive off-target characterization will continue to be highly relevant (Cathomen and 
Schambach, 2009). Given that chromosomal translocations are a potential risk with zinc finger 
nuclease treatment, karyotyping should be performed to screen for gross abnormalities (Brunet et 
al., 2009, Cathomen and Schambach, 2009, Hockemeyer et al., 2009, Simsek et al., 2011). Once 
zinc finger nuclease off-target cleavage profiles can be derived with greater accuracy and 
confidence and for less cost, these methods will enable routine identification of zinc finger 
nuclease off-target sites.  An important question for future research will be to develop methods 
for further optimizing the cleavage profiles of zinc finger nucleases so as to minimize 
particularly deleterious off-target effects (Gupta et al., 2011). 
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Introduction to the Thesis 
The collected works presented in this dissertation describe strategies for making 
improvements to zinc finger nuclease engineering efforts on multiple fronts including design 
strategies (Chapter 2), reducing genotoxicity (Chapter 3), and assessing specificity (Chapter 4).  
 
Chapter 2: “Unexpected failure rates for modular assembly of engineered zinc-fingers” 
 Before the results presented in Chapter 2 were made public, success rates for modularly 
assembled zinc finger proteins were reported in the range of 60% (Bae et al., 2003) to 100% 
(Segal et al., 2003) in the most comprehensive large-scale studies available in the published 
literature. Based on experimental failures far surpassing these estimates, we and others pooled 
our collective data on the effectiveness of modular assembly in a variety of in vitro and cell-
based assays and supplemented it with a large-scale survey of 168 zinc-finger arrays designed for 
104 DNA target sites of diverse compositions (Ramirez et al., 2008). We found that the failure 
rate in a bacterial-cell-based reporter assay for zinc finger proteins made by modular assembly 
was on average ~76%, which was much greater than previously thought, and higher still (~94%) 
if one considers the combined probabilities for two arrays used in a ZFN dimer pair.  
Our study raised awareness of the hitherto underappreciated limitations of modular 
assembly not only within the zinc finger engineering community, but also within the community 
of non-specialist investigators who used these reagents as tools for attempting to modify model 
organisms and cells. We also established the standard against which future zinc finger 
engineering efforts would be measured, paving the way for more robust context-dependent 
methods such as OPEN (Maeder et al., 2008) and CoDA (Sander et al., 2011b). 
22 
 
Chapter 3: “Engineered zinc finger nickases induce homology-directed repair with reduced 
mutagenic effects” 
While ZFNs are powerful tools for modifying genomes as reviewed above, there is a 
strong bias for NHEJ-mediated gene repair over HDR in most cellular contexts encountered, 
which may be problematic when the goal of an intervention is gene correction. Realizing that 
nicks are less genotoxic to cells than DSBs and inspired by descriptions of a FokI mutant 
(D450A) that is incapable of cleaving DNA yet continues to promote dimerization (Waugh and 
Sauer, 1993, Bitinaite et al., 1998, Beumer et al., 2006), I hypothesized that ZFNs could make 
nicks instead of cuts in DNA if the D450A mutation were introduced into only one monomer of 
a ZFN pair.  
While it was relatively straightforward to characterize the novel nicking activities of zinc 
finger nickases (ZFNickases) in vitro, demonstrating that they were active in cells and could 
preferentially mediate HDR over NHEJ was a significant challenge due to the relatively 
insensitive (detection limit: ~1%) assays traditionally used for detecting HDR events. Using 
human cell-based reporter assays—in particular the Traffic Light Reporter assay developed by 
Certo and colleagues, which made it possible to simultaneously measure NHEJ and HDR rates 
(Certo et al., 2011)—we were able to demonstrate that ZFNickases do in fact typically stimulate 
HDR more often than NHEJ, although absolute rates of HDR are significantly reduced relative to 
nucleases. We present these findings in Chapter 3 (Ramirez et al., 2012) and offer suggestions 
for increasing the activity of ZFNickases in Chapter 5.        
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Chapter 4: “Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro 
selection” 
 Zinc finger engineering strategies have become sufficiently reliable for creating ZFNs 
targeted to loci of interest that characterizing the full range of ZFN specificity has moved 
decidedly into the forefront of experimental concern in recent years. At the time the work 
described in Chapter 4 was begun, the gold standard for surveying genome-wide off-target ZFN-
cleavage sites was limited to performing monomeric DNA binding assays and using the results to 
computationally extrapolate a list of about a dozen putative loci of interest to deep sequence 
(Perez et al., 2008); the ZFNs analyzed in this report were subjected to this level of scrutiny due 
to their intended use in clinical trials for conferring HIV-resistance to T-cells by mimicking a 
naturally-occurring mutation in the CCR5 gene (NCT01044654, NCT00842634, 
NCT01252641). 
Postulating that even the best available methods were likely missing potentially important 
off-target cleavage sites, we developed various approaches to examine the specificity of ZFNs 
more rigorously. Among these strategies, we validated putative off-target sites for the CCR5 
ZFNs guided by a method developed by Pattanayak and colleagues for assaying the cleavage 
preferences of dimeric zinc finger nucleases in vitro (Pattanayak et al., 2011). We identified 
evidence of NHEJ at eight previously undescribed CCR5 ZFN off-target sites in human K562 
cells, supporting our hypothesis that existing methods were not sufficiently robust and offering a 
feasible alternative that could be built upon for future studies of nuclease specificity.  
The ongoing advancement of zinc finger nuclease and nickase engineering technologies and 
recent successes in modifying model organisms and cells with high efficiency and specificity are 
promising steps toward the realization of gene therapy as a commonplace therapeutic strategy.
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Chapter Two 
 
Unexpected failure rates for modular assembly of engineered zinc fingers 
 
Cherie L. Ramirez*, Jonathan E. Foley*, David A. Wright, Felix Müller-Lerch, Shamim H. 
Rahman, Tatjana I. Cornu, Ronnie J. Winfrey, Jeffry D. Sander, Fengli Fu, Jeffrey A. Townsend, 
Toni Cathomen, Daniel F. Voytas, and J. Keith Joung 
 
 
The thesis author and Jonathan Foley were joint first authors (denoted by “*”) of this 
work, and together constructed the zinc finger arrays that were tested for the described bacterial-
2-hybrid experiments, performed these experiments, and conducted data analysis. The thesis 
author oversaw these efforts and performed Western blots on all bacterial cell lysates. Jonathan 
Foley generated the reporter strains used for the bacterial-2-hybrid activity assays and re-
sequenced all constructs. David A. Wright, Ronnie J. Winfrey, Jeffry D. Sander, Fengli Fu, and 
Jeffrey A. Townsend performed electrophoretic mobility shift assays (EMSA) and plant single-
strand annealing (PSSA) assays. Episomal homologous recombination (HR) assays in human 
cells were performed by Felix Müller-Lerch, Shamim H. Rahman, and Tatjana I. Cornu. Jeffry 
D. Sander provided assistance in DNA and protein sequence data analysis.  
 
Reference: “Unexpected failure rates for modular assembly of engineered zinc fingers.” Ramirez 
CL, Foley JE, Wright DA, Müller-Lerch F, Rahman SH, Cornu TI, Winfrey RJ, Sander JD, Fu F, 
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article has been adapted from its published version for presentation in the dissertation. 
 
26 
 
 
Unexpected failure rates for modular assembly of engineered zinc-fingers 
 
Cherie L. Ramirez1,2,7, Jonathan E. Foley1,7, David A. Wright3, Felix Müller-Lerch4, Shamim H. 
Rahman4, Tatjana I. Cornu4, Ronnie J. Winfrey3, Jeffry D. Sander3,5,Fengli Fu3,5, Jeffrey A. 
Townsend3, Toni Cathomen4, Daniel F. Voytas3, & J. Keith Joung1,2,6 
 
1 Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and 
Integrative Biology, 149 13th Street, Room 7132, Massachusetts General Hospital, Charlestown, 
MA 02129 USA. 
2 Biological and Biomedical Sciences Program, Division of Medical Sciences, Harvard Medical 
School, Boston, MA 02115 USA. 
3 Department of Genetics, Development & Cell Biology, Iowa State University, 1035A Roy J. 
Carver Co-Lab, Ames, Iowa 50011, USA. 
4 Charité Medical School, Institute of Virology (CBF), Hindenburgdamm 27, D-12203 Berlin, 
Germany. 
5 Interdepartmental Graduate Program in Bioinformatics and Computational Biology, 2114 
Molecular Biology Building, Iowa State University, Ames, Iowa 50011, USA. 
6 Department of Pathology, Harvard Medical School, Boston, MA 02115 USA. 
7 These authors contributed equally to this work. 
 
To the Editor: Zinc-finger nucleases (ZFNs) consist of an engineered zinc-finger array 
fused to a nuclease domain. Dimers of ZFNs can create targeted double-strand DNA breaks 
which can stimulate highly efficient gene targeting in many cell types (Supplementary Figure 
2.1a-b) (Porteus and Carroll, 2005).  Here we show that the modular assembly method of 
engineering zinc-finger arrays has an unexpectedly higher failure rate than previously reported. 
Modular assembly advocates linking individual zinc-fingers, each of which typically 
binds to a 3 bp “subsite” (Supplementary Figure 2.2). Two large-scale surveys have suggested 
that modular assembly is highly effective (i.e. 60-100% success rates) for making three-finger 
arrays designed to bind 9 bp target sites (Bae et al., 2003, Segal et al., 2003). The Zinc Finger 
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Consortium recently constructed an archive of 141 previously published finger modules (Liu et 
al., 2002, Bae et al., 2003, Mandell and Barbas, 2006) encoded on a standardized platform 
(Wright et al., 2006). However, our initial experiences using these reagents suggested that 
modular assembly was surprisingly inefficient (Supplementary Discussion and Supplementary 
Table 2.1). 
To perform a larger-scale test, we assembled 168 zinc-finger arrays designed for 104 
diverse target DNA sites (Supplementary Table 2.2 and Chapter 2 Supplementary Methods). 
These domains were tested for DNA-binding using a bacterial two-hybrid (B2H) assay (Wright 
et al., 2006) which accurately identifies arrays that lack activity as ZFNs in human cells 
(Supplementary Figures 2.3 and 2.4 and Chapter 2 Supplementary Discussion). For 79 of the 104 
target sites, we failed to obtain a single three-finger array that scored positively in the B2H assay 
(overall failure rate of ~76%) (Figure 2.1a and Chapter 2 Supplementary Table 2). Strikingly, the 
method was far less effective for target sites composed of two, one, or no GXX subsites (where 
X is any base) compared with those composed of three GXX subsites (Figure 2.1a). In addition, 
since ZFNs function as dimers, failure rates for making a ZFN pair would be expected to be even 
higher (Chapter 2 Supplementary Discussion). Importantly, these values are all likely 
underestimates of actual failure rates because not all finger arrays that are positive in the B2H 
will be active as ZFNs in human cells (Supplementary Figure 2.4). 
One reason for the apparent discrepancy between previously published studies (Bae et al., 
2003, Segal et al., 2003) and this report is that the former primarily used 9 bp sites composed of 
two or three GXX subsites whereas we used sites with more varied GXX subsite composition 
(Figure 2.1b); this difference will critically affect the observed failure rate (Figure 2.1a). Our 
study represents a more meaningful evaluation because target sites containing one or no GXX  
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subsites (underrepresented in previous studies) encompass the majority (>75%) of the 107,011 
potential 9 bp sites that can be targeted with existing modules (Figure 2.1b).  
Our results strongly suggest that potential users of modular assembly should expect that it 
will fail to yield a functional multi-finger array for the majority of potentially targetable sites and 
to emphasize this we have modified content on the Zinc Finger Consortium website 
(http://www.zincfingers.org) (Chapter 2 Supplementary Methods). Highly effective but more 
labor-intensive selection-based methods for engineering zinc-finger arrays have been previously 
described (Chapter 2 Supplementary Discussion) and at present these are the only publicly 
available alternatives for academic researchers interested in using ZFN technology. 
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Chapter 2 Supplementary Materials: 
 
Supplementary Figure 2.1:   ZFNs induce highly efficient gene targeting events 
Supplementary Figure 2.2:   Schematic illustrating the “modular assembly” method of 
engineering multi-finger domains 
Supplementary Figure 2.3:   Schematic of the bacterial two-hybrid (B2H) reporter used to 
assess DNA-binding activities of zinc finger arrays 
Supplementary Figure 2.4:  The B2H assay identifies zinc-finger arrays that fail to show 
significant activity as ZFNs in human cells 
Supplementary Table 2.1:   Small-scale tests of modular assembly using various activity assays   
Supplementary Table 2.2:   Modularly assembled zinc finger arrays, cognate target binding 
sites, and their activities in the B2H assay 
Chapter 2 Supplementary Discussion 
Chapter 2 Supplementary Methods 
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Supplementary Table 2.1: Small-scale tests of modular assembly using various activity 
assays 
Thirty-six three-finger arrays (named “ZFA __” for zinc finger array) were assembled using 
modules based on the Zinc Finger Consortium Modular Assembly Kit 1.0 (Wright et al., 2006), 
and the identities of the three modules used to construct each three-finger array use the 
Consortium numbering scheme (F1, F2, and F3 are the amino-terminal, middle, and carboxy-
terminal fingers, respectively). All target binding sites are written 5’ to 3’ (note that the F3 
module binds to the 5’ most triplet subsite while F1 binds to the 3’ most triplet subsite). The 
number of GXX subsites in each target site is also indicated. For nine of the arrays, the amino 
acid sequence of the zinc finger backbone differs from the modules in the archive. These arrays 
are noted in the far left column by a double asterisk, and their complete amino acid sequences are 
available upon request. Activity of 27 arrays was tested by electrophoretic mobility shift assays 
(EMSA). A plus sign in the far right column indicates that the finger array caused a shift in 
mobility of a double-strand oligonucleotide corresponding to the intended target sequence on 
polyacrylamide gels. In all cases, binding could be competed away with an excess of the target 
oligonucleotide. Western blots were performed for all zinc finger arrays to ensure they were 
expressed. Plant single-strand annealing (PSSA) assays (see Chapter 2 Supplementary Methods) 
were used to assess function of seven arrays, five of which were also tested by EMSA. The 
PSSA assay tests the ability of the zinc finger array to function as a ZFN. A minus sign in the 
table indicates that activity was comparable to negative controls in which plant protoplasts were 
not transformed with the ZFN construct. An episomal recombination (HR) assay was used to 
assess the activity of nine ZFNs in human 293T cells (see Chapter 2 Supplementary Methods). A 
plus sign indicates that ZFN activity in stimulating HR was >40% as compared to the activity of 
a control I-SceI meganuclease on the same target locus. EMSA, electrophoretic mobility shift 
assay; a positive value indicates DNA binding that could be competed away by an excess of an 
oligonucleotide corresponding to the target site. PSSA, plant single-strand annealing assay; a 
positive value indicates reporter gene function that is at least two-fold over background controls. 
HR, episomal recombination assay; a positive value indicates at least 40% activity as compared 
to I-SceI on the same target template. For further information on the activity assays, see Chapter 
2 Supplementary Methods. 
 
**Finger arrays with backbone sequences that differ from the ZF finger archive. 
***Finger arrays previously described (Alwin et al., 2005). 
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Supplementary Table 2.2: Modularly assembled zinc finger arrays, cognate target binding 
sites, and their activities in the B2H assay 
See legend to Supplementary Table 2.1 for descriptive detail pertaining to each of this table’s 
columns. In addition, the original source of the modules used to construct each array (B = Barbas 
group (Mandell and Barbas, 2006), S = Sangamo BioSciences (Liu et al., 2002, Wright et al., 
2006), and T = Toolgen, Inc. (Bae et al., 2003)) is indicated. Because the Zinc Finger 
Consortium Modular Assembly Kit 1.0 includes more than one module for certain subsites 
(Wright et al., 2006), we were able to construct 168 zinc finger arrays that could potentially 
recognize the 104 different target sites. Additional   details regarding the construction of the B2H 
zinc finger expression plasmids and the B2H binding site reporter plasmids are provided in 
Chapter 2 Supplementary Methods. Fold-activation of transcription in the B2H assay was 
determined for each zinc finger array using β-galactosidase assays as previously described 
(Cornu et al., 2008). β-galactosidase assays for each zinc finger array were performed a 
minimum of four times and means and standard errors of the mean are shown. The expression of 
all zinc finger arrays that failed to activate transcription by more than 1.57-fold in the B2H assay 
were verified by Western blot using a monoclonal antibody which detects a FLAG epitope 
present on all arrays (data not shown). 
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Chapter 2 Supplementary Discussion: 
Small-scale surveys suggest a low success rate for modular assembly 
Motivated by a desire to use ZFNs for genome modification, our labs constructed the 36 
zinc finger arrays listed in Supplementary Table 2.1. These arrays are highly biased for GXX 
subsites, and collectively include 22 3-GXX arrays, 8 2-GXX arrays, 2 1-GXX arrays and 4 
arrays without GXX subsites. Using three different assays to test for function (see legend to 
Supplementary Table 2.1), seven arrays were deemed functional. Six of these sites were 
composed of three GXX subsites and one was composed of two GXX subsites. Since six of the 
seven arrays were only tested by EMSA, it is difficult to extrapolate how many of these arrays 
would function in vivo when challenged with the diverse sequence targets present in a genome.  
The B2H assay accurately identifies zinc finger arrays that fail to show ZFN function in human 
cells 
In previously published studies from our groups, we observed a general correlation 
between failure to activate in the B2H assay and failure to show ZFN function in human cells 
(Cornu et al., 2008). To further assess this correlation, we tested the activities of 23 ZFNs using a 
human cell-based episomal homologous recombination (HR) assay (Chapter 2 Supplementary 
Methods). The zinc finger arrays in these 23 ZFNs each activated transcription to different levels 
in the B2H system ranging from 0.85- to 5.07-fold. As shown in Supplementary Figure 2.4, we 
found that zinc finger arrays which activated transcription by 1.57-fold or less in the B2H system 
all failed to show significant activity as ZFNs in human cells (nine out of nine ZFNs tested; pink 
bars in Supplementary Figure 2.4). Conversely, many (although not all) of the zinc finger arrays 
which activated transcription by >1.57-fold in the B2H system showed significant activity as 
ZFNs in the episomal repair assay (light blue bars with red asterisks in Supplementary Figure 
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2.4). We conclude that zinc finger arrays that activate transcription by 1.57-fold or less in the 
B2H system are unlikely to function as ZFNs in human cells and we used this threshold level to 
interpret the results of our experiments. 
Predicted failure rates for identifying zinc finger arrays needed to engineer a ZFN pair  
Analysis of our results shows that modular assembly is far less effective for target sites 
composed of two, one, or no GXX subsites (71%, 88% and 100% failure rates, respectively; 
Figure 2.1a) compared with those that contain three GXX subsites (41% failure rate; Figure 
2.1a). Because ZFNs function as dimers, the failure rates for making a ZFN pair will therefore be 
~65%, ~92%, ~99%, and 100% for ZFN targets composed of pairs of 3-GXX, 2-GXX, 1-GXX, 
and 0-GXX 9 bp “half-sites”, respectively. These failure rates are calculated by multiplying 
estimated success rates for each monomer in the ZFN pair and subtracting this percentage from 
100%. 
Alternative selection-based strategies for engineering multi-finger arrays 
A fundamental flaw with the modular assembly method (and a likely cause of its low 
success rate) is its assumption that zinc finger domains behave as independent modular units. A 
number of studies have shown that zinc fingers can cross over and interact with adjacent fingers 
and neighboring finger binding sites (Elrod-Erickson et al., 1996, Isalan et al., 1997, Isalan et al., 
1998, Wolfe et al., 2001). Various engineering strategies have been described in the literature 
that account for these context-dependent effects on zinc finger DNA-binding. Greisman and 
Pabo first described a sequential optimization strategy in which combinations of fingers that 
work well together are identified using serial selections from randomized libraries (Greisman and 
Pabo, 1997). Isalan, Klug, and Choo described a “bipartite” optimization strategy in which 
“halves” of a three-finger domain are first optimized by randomization and selection and then 
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joined together to create a final protein (Isalan et al., 2001). Finally, Joung and colleagues 
described a domain shuffling approach in which pools of fingers are first identified for each 
subsite in parallel and then shuffled together to create a recombined library for use in a final 
stringent selection (Hurt et al., 2003). A limitation of all of these different approaches is that they 
require specialized expertise in the construction of multiple very large randomized libraries and 
in the interrogation of these libraries using selection methods. 
 
Chapter 2 Supplementary Methods 
Construction of B2H zinc finger expression vectors and reporter strains 
104 B2H reporter strains each harboring a single copy target site-reporter plasmid were 
constructed as previously described (Wright et al., 2006). B2H expression vectors encoding 
different three finger arrays were constructed essentially as previously described1 using the Zinc 
Finger Modular Assembly Kit 1.0 which includes 141 modules made by the Barbas group, 
Sangamo BioSciences, and Toolgen, Inc. (Wright et al., 2006). For each target site, we made 
three-finger arrays using modules from the Barbas, Sangamo, and Toolgen collections but we did 
not mix and match modules across these different sets. We chose not to make “cross-platform” 
arrays because: (1) the Barbas website software does not advocate use of their modules with 
others (Mandell and Barbas, 2006), (2) the Toolgen group discovered that their human zinc 
fingers worked best with one another and not as well with other engineered modules (Bae et al., 
2003), and (3) the Sangamo modules are position-specific and have linkers joining them that 
differ from the canonical TGEKP linker used by the Barbas and Toolgen modules (Liu et al., 
2002). 15 of the arrays we constructed were toxic when expressed in the B2H assay and these 
proteins were not included in our analysis. After setting aside these toxic proteins, we 
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characterized the remaining 168 zinc finger arrays. All expression and reporter plasmids were 
confirmed to be correct by DNA sequencing prior to use in B2H assays. 
B2H assays, verification of protein expression, and re-verification of DNA sequences 
The activities of three-finger arrays were tested in the B2H assay by co-transforming a 
target site reporter strain with a B2H zinc finger array-Gal11P expression vector and a 
compatible plasmid encoding an E. coli RNA polymerase alpha-Gal4 hybrid protein (Wright et 
al., 2006). Fold-activation was calculated as the ratio of the level of β-galactosidase (lacZ) 
reporter activity in the presence and absence of the zinc finger array as previously described 
(Thibodeau et al., 2004). All β-galactosidase measurements were performed at least four 
independent times. The expression of each zinc finger array that failed to activate transcription 
by more than 1.57-fold in the B2H assay was verified by performing Western blot on cell 
extracts from the β-galactosidase assays using a monoclonal antibody against the FLAG epitope 
present on all zinc finger array-Gal11P fusion proteins. For zinc finger arrays that exhibited less 
than 1.57-fold transcriptional activation in the B2H assay, we re-sequenced the zinc finger 
coding sequences and the reporter plasmid binding sites from the same cells used for β-
galactosidase assays to re-confirm the identities of the zinc finger recognition helices and 
binding sites tested in these cells. We performed this additional re-sequencing control on >80% 
of our samples (94 of the 115 zinc finger array/binding site combinations) that were negative in 
the B2H assay and found that all helices and binding sites were correct as expected. 
Plant single-strand annealing (PSSA) assays 
Zinc finger arrays were fused to the FokI nuclease domain and the resulting ZFNs were 
transiently expressed in tobacco protoplasts. Plasmids encoding these ZFNs were co-transformed 
with a target plasmid carrying a non-functional β-glucuronidase (GUS) gene. The GUS gene was 
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rendered non-functional by a direct duplication of part of its coding sequence. Between the direct 
repeats, a recognition site was inserted for the given ZFN being tested. After expression of the 
ZFN and cleavage of the GUS reporter, repair by single strand annealing can restore GUS 
function. This can be measured by standard GUS activity assays. We routinely observe GUS 
activity 25-fold above background when the assay is performed with a ZFN based on the 
transcription factor Zif268. 
Episomal recombination (HR) assay in human cells 
For the episomal HR assay, 293T cells in 24-well plates were transfected by calcium 
phosphate precipitation with 20 ng of the respective target plasmid, 1 μg of the donor plasmid 
(pUC.Zgfp/REx), and 100 ng of a CMV-driven endonuclease expression vector encoding the 
ZFNs, I-SceI (pRK5.LHA-Sce1) or a control vector (pCMV.Luc). Two days after transfection, 
50,000 cells were analyzed by flow cytometry (FACSCalibur, BD Bioscience) to determine the 
percentage of EGFP-positive cells. The number of DsRedExpress (REx)-positive cells was used 
to normalize for transfection efficiency. All experiments were repeated at least three times. ZFN 
activity is indicated as the fraction of EGFP-positive cells relative to the number of EGFP-
positive cells measured in the presence of I-SceI. 
Revisions to the Zinc Finger Consortium website 
We have previously described ZiFiT, a web-based software program that enables users to 
rapidly identify potential zinc finger target sites within genes of interest (Sander et al., 2007). 
ZiFiT identifies target sites for which zinc finger arrays might be made using modular assembly 
and the Zinc Finger Consortium Modular Assembly Kit 1.0 (Wright et al., 2006). Given the 
results of this current study, we have revised the ZiFiT program by adding the following section 
to its instructions: 
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Scoring: To assess the effectiveness of modular assembly, we generated a large 
number of zinc finger arrays and tested their activity using a bacterial cell-based 
two-hybrid (B2H) assay (Ramirez et al., 2008). In the B2H assay, productive 
interaction of a zinc finger array with its cognate binding site activates 
transcription of a linked reporter gene. A total of 168 three finger arrays were 
assembled that recognize 104 different target DNA sites that varied in their GXX, 
AXX, CXX, and TXX subsite composition. Transcriptional activation of >1.57-
fold over negative controls was determined to be indicative of target site 
recognition by a given protein. After measuring the activity of the 168 zinc finger 
arrays, it was found that the subsite composition of binding sites critically 
affected success rates. Modular assembly was far less effective for target sites 
composed of one or no GXX subsites (12% and 0% success rates, respectively) 
compared with those that contain three or two (59% and 29% success rates, 
respectively). Based on these results, we provide users of ZiFiT with an 
approximation of the likelihood that a given three finger protein will recognize its 
target. For example, three finger proteins comprised of three GXX subsites will 
receive a score of 0.59, reflecting the success rate observed in our survey. Most 
users will be interested in the likelihood that two arrays will function together as a 
ZFN. This can be approximated by multiplying the success rate of individual 
arrays. For example, the likelihood of success that a ZFN with all GXX subsites 
will recognize its target is 0.59 X 0.59 = 0.35 or 35%. Because multiple modules 
are often available for given subsites, investigators may increase their likelihood 
of success by making multiple different proteins against a single target. One note 
of caution: the scoring function is a prediction for the activity of a given three 
finger array in the B2H assay; the protein may behave differently when tested for 
activity in a eukaryotic cell. We have also revised the output that ZiFiT currently 
provides to users to include guidance about the likelihood of success for different 
target DNA binding sites. 
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Chapter Three 
 
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects 
 
Cherie L. Ramirez*, Michael T. Certo*, Claudio Mussolino, Mathew J. Goodwin, Thomas J. 
Cradick, Anton P. McCaffrey, Toni Cathomen, Andrew M. Scharenberg, and J. Keith Joung 
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for in vitro protein activity assays and coordinated the efforts of the collaborating authors. 
Mathew Goodwin performed in vitro assays in replicate and assisted with data analysis. With 
regard to human cell experiments, Michael Certo designed and carried out Traffic Light Reporter 
assays and Claudio Mussolino performed GFP reconstitution assays. Thomas Cradick provided 
assistance with determining initial conditions for in vitro protein activity assays.  
 
Reference: “Engineered zinc finger nickases induce homology-directed repair with reduced 
mutagenic effects.” Ramirez CL, Certo MT, Mussolino C, Goodwin MJ, Cradick TJ, McCaffrey 
AP, Cathomen T, Scharenberg AM, Joung JK. Nucleic Acids Research. 2012 Feb 28. Published 
online ahead of print. Reprinted by permission of Oxford University Press. The article has been 
adapted from its published version for presentation in the dissertation. 
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Abstract 
Engineered zinc finger nucleases (ZFNs) induce DNA double-strand breaks at specific 
recognition sequences and can promote efficient introduction of desired insertions, deletions, or 
substitutions at or near the cut site via homology-directed repair (HDR) with a double- and/or 
single-stranded donor DNA template.  However, mutagenic events caused by error-prone non-
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homologous end-joining (NHEJ)-mediated repair are introduced with equal or higher frequency 
at the nuclease cleavage site.  Furthermore, unintended mutations can also result from NHEJ-
mediated repair of off-target nuclease cleavage sites.  Here we describe a simple and general 
method for converting engineered ZFNs into zinc finger nickases (ZFNickases) by inactivating 
the catalytic activity of one monomer in a ZFN dimer.  ZFNickases show robust strand-specific 
nicking activity in vitro.  In addition, we demonstrate that ZFNickases can stimulate HDR at 
their nicking site in human cells, albeit at a lower frequency than by the ZFNs from which they 
were derived. Finally, we find that ZFNickases appear to induce greatly reduced levels of 
mutagenic NHEJ at their target nicking site. ZFNickases thus provide a promising means for 
inducing HDR-mediated gene modifications while reducing unwanted mutagenesis caused by 
error-prone NHEJ. 
 
Introduction 
Zinc finger nucleases (ZFNs) are chimeras of engineered zinc finger domains fused to the 
non-specific nuclease domain of the restriction enzyme FokI (Kim et al., 1996). Dimers of ZFNs 
generate site-specific DNA double-strand breaks (DSBs) with each ZFN monomer cutting one 
DNA strand (Mani et al., 2005). Obligate heterodimeric versions of the FokI nuclease domain 
have been engineered that minimize homodimeric interactions between ZFN monomers within a 
pair (Miller et al., 2007, Szczepek et al., 2007, Sollu et al., 2010, Doyon et al., 2011). 
ZFNs, as well as engineered homing endonucleases and transcription activator-like 
effector nucleases (TALENs), can be used to improve the efficiency of homology-directed repair 
(HDR) in a variety of different organisms and cell types (Arnould et al., 2011, Bogdanove and 
Voytas, 2011, Handel and Cathomen, 2011).  Repair of a nuclease-induced DSB mediated by an 
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exogenous “donor template” can be exploited to introduce sequence alterations or insertions at or 
near the site of the break. Although nuclease-induced HDR is highly efficient, repair of a DSB 
can also occur by the non-homologous end-joining (NHEJ) pathway. NHEJ-mediated repair of 
nuclease-induced DSBs has been shown to be error-prone, leading to insertion or deletion 
mutations (indels) at the site of the break (Bibikova et al., 2002) or the formation of 
chromosomal translocations (Brunet et al., 2009). NHEJ and HDR are believed to be competing 
pathways (Hartlerode and Scully, 2009). Thus, although HDR-mediated alterations can be 
efficiently introduced using engineered nucleases, alleles can also acquire NHEJ-mediated 
mutations (e.g. (Maeder et al., 2008, Zou et al., 2011)). Unwanted alterations at other off-target 
genomic sites can also be introduced by NHEJ-mediated repair; for example, two recent reports 
have shown that ZFNs introduce a greater spectrum of off-target DSBs (and therefore NHEJ-
mediated mutations) than previously appreciated (Gabriel et al., 2011, Pattanayak et al., 2011).  
Given the potential undesirable consequences of introducing DSBs in living cells, we 
hypothesized that it might be possible to induce DNA repair with single strand breaks (SSBs or 
nicks) as a less mutagenic alternative to DSBs. Thousands of SSBs naturally occur per day in 
human cells, generally without deleterious consequences (Holmquist, 1998). The concept of 
harnessing the benign nature of nicks for stimulation of homologous recombination has been 
previously suggested in the context of theoretical models and RAG1-induced recombination 
(Meselson and Radding, 1975, Lee et al., 2004, Weinstock and Jasin, 2006, Holliday, 2007). In 
addition, homing endonucleases have been demonstrated to stimulate HDR when converted to 
nickases (McConnell Smith et al., 2009, van Nierop et al., 2009, Certo et al., 2011, Chan et al., 
2011, Davis and Maizels, 2011, Metzger et al., 2011). However, conferring novel DNA binding 
specificities to this class of enzymes without disrupting catalytic activity has proven to be 
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challenging because the domains for DNA recognition and cleavage are not structurally 
independent (Arnould et al., 2011) as they are for ZFNs and TALENs. 
Here we describe a general method for creating site-specific zinc finger nickases 
(ZFNickases).  To do this, we employed obligate heterodimeric ZFNs (Miller et al., 2007) and 
introduced a mutation that had previously been described to inactivate FokI cleavage activity 
(D450A) (Waugh and Sauer, 1993, Bitinaite et al., 1998, Beumer et al., 2006) into one monomer, 
thereby directing a break to only one strand, as recently shown with the native FokI enzyme 
(Sanders et al., 2009). We demonstrate that ZFNickases can generate DNA single strand breaks 
efficiently in vitro and can also induce targeted HDR in cultured human cells with significantly 
lower rates of associated NHEJ-mediated mutation at the nicking site.  ZFNickases provide an 
important additional tool for performing highly precise genome editing with reduced levels of 
NHEJ-mediated mutagenesis. 
 
Methods 
Qualitative in vitro analysis of ZFN and ZFNickase activities 
For in vitro protein expression experiments, we constructed vectors derived from 
pMLM290 and pMLM292 (Addgene plasmids 21872 and 21873, respectively (Maeder et al., 
2008)). Zinc finger domains in the ZFNs HX735, VF2468, and VF2471 have been described 
previously (Maeder et al., 2008) and were cloned as XbaI/BamHI fragments into pMLM290 and 
pMLM292 vectors modified to contain 3xFLAG instead of 1xFLAG epitopes. Previously 
reported zinc finger domains designed to bind the human CCR5 gene (Lombardo et al., 2007, 
Perez et al., 2008) were assembled from overlapping oligonucleotides generated by DNAWorks 
(Hoover and Lubkowski, 2002) and cloned into the 3xFLAG-pMLM290 and 3xFLAG-
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pMLM292 vectors. The nuclease inactivating D450A mutation (numbered relative to the native 
FokI enzyme) (Bitinaite et al., 1998) was introduced by QuikChange Lightning Site-Directed 
Mutagenesis (Agilent). Protein lysates were prepared following manufacturer’s instructions for 
the T7 TnT Quick Coupled Transcription/Translation System (Promega) using 1 μg plasmid 
template per 50 μl lysate and incubating for 90 minutes at 30°C. 
To generate target sites for in vitro analysis, annealed oligonucleotides with compatible 
overhangs were cloned into the BsaI restriction sites of pBAC-lacZ (using oligonucleotides 
OC152/OC153 for CCR5; Table 3.1) as described previously (Maeder et al., 2009) or the 
BglII/SpeI sites of pCP5 (a gift from Daniel Voytas; using oligonucleotides OC665/OC666 for 
VF2468, OC667/OC668 for VF2471, and OC671/OC672 for HX735; Table 3.1) as described 
previously (Townsend et al., 2009). Primers labeled with 6–carboxyfluorescein (6-FAM) were 
used to amplify DNA fragments for cleavage assays with the Expand High Fidelity PCR System 
(Roche Applied Science). Primers OC213/OC215 were used for pBAC-lacZ-derived targets and 
OC417/OC418 used for pCP5-derived targets (see Table 3.1 for sequences of primers).   
 
Table 3.1: Sequences of oligonucleotides used in this study 
 
Name 5’ to 3’ Sequence 
OC152 ATCTGTCATCCTCATCCTGATAAACTGCAAAAG 
OC153 TAATCTTTTGCAGTTTATCAGGATGAGGATGAC 
OC213 GACGCCCGCCATAAACTG 
OC215 GCACGTTCCTTATATGTAGCTTTCG 
OC417 CGGTGTGAAATACCGCACAG 
OC418 CAGCAGCAGCAGACCATTTTC  
OC665 GATCGAGCAGCGTCTTCGAGAGTGAGGAC 
OC666 CTAGGTCCTCACTCTCGAAGACGCTGCTC 
OC667 GATCCAGCGTCTTCGAGAGTGAGGACGTGT 
OC668 CTAGACACGTCCTCACTCTCGAAGACGCTG 
OC671 GATCGAGACTCCCACGGCCGGGGAAGAGT 
OC672 CTAGACTCTTCCCCGGCCGTGGGAGTCTC 
ams1228 GGTCGAGCAGCGTCTTCGAGAGTGAGGACGTGTA 
ams1229 CTAGTACACGTCCTCACTCTCGAAGACGCTGCTCGACCTGCA 
ams1230 GGGGTCATCCTCATCCTGATAAACTGCAAAAGGA 
ams1231 CTAGTCCTTTTGCAGTTTATCAGGATGAGGATGACCCCTGCA 
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Cleavage reactions were performed under light-protected conditions using opaque black 
tubes in 100 μl volumes with 10 μl protein lysate and 80 ng 6-FAM-labeled cleavage substrate in 
1x NEBuffer 4 (New England Biolabs). Reactions were incubated at 37°C for 1 hour, purified 
using a Minelute PCR Purification kit (Qiagen) according to the manufacturer’s instructions with 
final elution into 20 μl 0.1X buffer EB, and submitted to the DNA Core Facility at Massachusetts 
General Hospital (Cambridge, MA) for denaturing capillary electrophoresis with fluorescent 
detection. Analysis of the resulting data was performed using Peak Scanner Software v1.0 
(Applied Biosystems). 
Chromosomal EGFP repair assay in U2OS cells 
For the generation of the reporter cell lines used in the chromosomal EGFP repair assay, 
the cleavage site for the HX735 ZFNs (Maeder et al., 2008) was cloned between the lacZ ORF 
and the 5’-truncated EGFP (∂GFP) gene in plasmid pLV.LacZ∂GFP (Alwin et al., 2005). The 
donor plasmid used for these experiments harbors a 5’-truncated lacZ (∂lacZ) gene followed by 
the corrected EGFP ORF and also lacks a promoter (pUC. ∂LacZ-GFP) (Cornu et al., 2008). 
To generate ZFNs and ZFNickases for mammalian expression, zinc finger domains were 
cloned into a previously described dual expression plasmid in which the CMV promoter drives 
expression of two ZFN monomers separated by a self-cleaving T2A peptide (Sollu et al., 2010).  
The D450A mutation was introduced into one or both of the FokI subunits in this vector as 
needed by subcloning or using the QuikChange Lightning Site-Directed Mutagenesis (Agilent). 
For the chromosomal EGFP repair assay, U2OS-based reporter cell lines containing the 
LacZ-HX735-∂GFP target locus were generated by lentiviral transduction (LV.CMV.LacZ-
HX735-∂GFP) with a viral dose that rendered <1% of cells resistant to geneticin-sulfate (0.4 
mg/ml), thus preferentially generating reporter cells with a single copy target locus (Alwin et al., 
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2005). Reporter cells, cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% 
fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen), were seeded at a density 
of 50,000 cells/well in 24-well plates. Twenty-four hours later, transfection was performed using 
X-tremeGENE HP DNA Transfection Reagent (Roche Applied Science) following the 
manufacturer’s instructions. Transfection cocktail included 150 ng of ZFN or ZFNickase 
expression plasmids, 600 ng of donor plasmid (pUC.∂LacZ-GFP) and 100 ng of a plasmid 
encoding for mCherry (Mussolino et al., 2011) to identify transfected cells. The extent of gene 
targeting was assessed after 8 days using flow cytometry (FACSCalibur; BD Biosciences) to 
determine the percentage of EGFP-positive cells in the fraction of mCherry-positive cells. 
Experiments were performed at least twice independently in duplicate. 
Traffic Light Reporter assay in HEK293 cells 
Traffic Light Reporter (TLR) experiments were performed as described in Certo et al. 
(Certo et al., 2011). Briefly, oligonucleotides each harboring one or two ZFN or ZFNickase 
target sites (oligonucleotides ams1228/ams1229 for the VF2468 and VF2471 sites and 
oligonucleotides ams1230/ams1231 for the CCR5 site) were cloned into the SbfI and SpeI 
restriction sites of the TLR2.1 plasmid. Note that the VF2468 and VF2471 targets overlap 
significantly so only one TLR reporter encompassing both sites was created. Cell lines were 
generated by transduction of HEK293T cells with limiting amounts of a lentivirus containing a 
target site of interest cloned into the Traffic Light Reporter, followed by selection in 1 μg/ml 
puromycin.  The puromycin-resistant population was then bulk sorted by FACS to isolate a 
polyclonal population of EGFP-negative, mCherry-negative cells. These cells were cultured in 
glutamine-free Dulbecco’s modified Eagle’s medium supplemented with 2 mM L-glutamine, 
10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen). For transfections, 1 
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x 105 reporter cells were plated per 24-well plate and transfected 24 hours later with 0.5 μg of 
ZFN- or ZFNickase-encoding plasmids and 0.5 μg Donor-T2A-BFP plasmid (Addgene plasmid 
31485) using Fugene6 reagent according to the manufacturer’s protocol (Roche Applied 
Science).  Cells were split into a six-well plate 24 hours post-transfection, and analyzed using a 
flow cytometer (LSRII or FACSAria; BD Biosciences) 72 hours post-transfection. Transfection 
efficiency was controlled for by gating on 103 to 104 BFP-positive cells prior to HDR and NHEJ 
analysis. Experiments were performed independently three times.  
 
Results 
In vitro enzymatic activities of ZFNs and ZFNickases 
Based on recent work demonstrating that mutational inactivation of one monomer in a 
FokI dimer can convert this nuclease into a nickase (Sanders et al., 2009), we reasoned that a 
similar strategy might be used to convert a ZFN dimer into a nickase. To test this possibility, we 
used four previously described ZFN pairs targeted to sites in three endogenous human genes; one 
to the HOXB13 gene (HX735), two to the VEGF-A gene (VF2468 and VF2471), and one to the 
CCR5 gene (CCR5) (Lombardo et al., 2007, Maeder et al., 2008, Perez et al., 2008). For each 
ZFN pair, we arbitrarily designated one of the monomers as the “Left monomer” and the other as 
the “Right monomer” (Table 3.2) and generated variants of each monomer harboring a 
previously described mutation (D450A) that inactivates the catalytic activity of the FokI nuclease 
domain (Bitinaite et al., 1998).   
To test whether inactivation of one monomer in a ZFN pair might result in generation of 
a zinc finger nickase (ZFNickase), we developed a qualitative version of an in vitro assay similar 
to one recently described by Halford and colleagues (Sanders et al., 2009) that allowed us to  
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Table 3.2: ZFN/ZFNickase target sites 
 
Target site Full site LEFT half-site (5’to3’) 
RIGHT half-site 
(5’to3’) 
CCR5 gGTCATCCTCATCctgatAAACTGCAAAAGg cCAGTAGGAGTAGgactaTTTGACGTTTTCc gGATGAGGATGACc tAAACTGCAAAAGg 
HX735 gAGACTCCCAcggccGGGGAAGAGt cTCTGAGGGTgccggCCCCTTCTCa gTGGGAGTCTc cGGGGAAGAGt 
VF2468 gAGCAGCGTCttcgaGAGTGAGGAc cTCGTCGCAGaagctCTCACTCCTg aGACGCTGCTc aGAGTGAGGAc 
VF2471 cAGCGTCTTCgagagtGAGGACGTGt gTCGCAGAAGctctcaCTCCTGCACa cGAAGACGCTg tGAGGACGTGt 
 
assess the introduction of breaks into either strand of a double-stranded DNA fragment.  In this 
system, a target site for a ZFN is positioned asymmetrically within a DNA fragment that is 
fluorescently labeled on the 5’ ends of both DNA strands (Figure 3.1).  This DNA is then 
incubated with different combinations of active and inactive Left/Right monomers that have been 
co-expressed in vitro using a coupled transcription/translation system (Cradick et al., 2010). 
Following this incubation, fluorescently labeled DNA strands of various sizes are generated 
depending upon whether the top or bottom strands are cut or not cut (Figure 3.1). These 
fluorescently labeled products can be analyzed under denaturing conditions using capillary 
electrophoresis, which separates DNA molecules based on size and enables visualization of 6-
FAM-labeled DNA strands. 
Using this qualitative in vitro assay, we tested the effects of various combinations of 
active/inactive monomers for the HX735, VF2468, VF2471, and CCR5 ZFNs on their target 
DNA sites.  As expected, with all four active Left/active Right pairs, both strands in the target 
sites were cleaved and with all inactive Left/inactive Right pairs, no cleavage of either strand 
was observed (Figure 3.2a-d, top and bottom panels).  However, when pairs of active/inactive 
monomers were tested, we observed preferential cleavage of only one DNA strand, the strand 
with which the active ZFN monomer is expected to make its primary DNA base contacts (Figure 
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ZFNickases and the donor plasmid reflect the abilities of ZFNs to stimulate HDR at the target 
locus.   
We tested ZFNs and corresponding ZFNickases targeted to the HX735 site for their 
abilities to induce HDR in the EGFP reporter assay. ZFNs targeted to the HX735 locus were able 
to stimulate gene repair, inducing EGFP expression in 0.29% of transfected cells, a statistically 
significant increase relative to the 0.01% of cells that expressed EGFP upon transfection with a 
catalytically inactive ZFN (Figure 3.3b).  Interestingly, expression of corresponding HX735 
ZFNickases designed to nick one strand or the other restored EGFP expression in 0.14% and 
0.05% of cells, although only the former increase in HDR was statistically significant relative to 
the level observed with the catalytically inactive ZFN.  Thus, these results suggest that a 
ZFNickase can induce HDR in this EGFP reporter gene assay albeit at a lower level than that 
observed with its parental ZFN.   
Assessment of HDR and NHEJ induced by ZFNs and ZFNickases in human cells 
To further test the ability of ZFNickases to induce HDR and to simultaneously assess the 
rate of NHEJ-mediated mutagenesis at the same target site, we used the recently described 
“Traffic Light Reporter” (Certo et al., 2011). In this assay, the reporter harbors a nuclease target 
site (or sites) of interest positioned within a defective EGFP coding sequence that is followed by 
a mCherry coding sequence joined out of frame to the EGFP gene via a T2A peptide sequence.  
HDR with an exogenously provided donor template reconstitutes a functional EGFP coding 
sequence, turning cells green, whereas NHEJ-induced indels can create frameshifts that place the 
downstream mCherry protein in-frame, turning cells red (Figure 3.4a). Thus, with these reporter 
cells, the extent of nuclease-induced HDR and NHEJ can be monitored simultaneously for a 
given target site using flow cytometry. 
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We derived polyclonal HEK293T cell lines harboring the Traffic Light Reporter with 
targets for either the VF2468 and VF2471 ZFNs (a single cell line with both overlapping targets 
present, just as they occur in the endogenous locus (Maeder et al., 2008)) or the CCR5 ZFNs. For 
each ZFN pair, we transfected combinations of plasmids encoding active and/or inactive ZFN 
monomers together with a donor template for correcting the EGFP gene.  Flow cytometry was 
then used to determine HDR and NHEJ rates by quantifying the percentages of EGFP-positive 
and mCherry-positive cells, respectively (Figure 3.4b-e). For all three target sites, ZFNs tested 
showed robust activities, inducing high percentages of EGFP-positive cells (indicative of HDR 
events) and even higher percentages of mCherry-positive cells (indicative of NHEJ events) in 
transfected cells (Figure 3.4b, left column).  All but one of the six ZFNickases tested for the 
three target sites induced significantly higher levels of EGFP-positive cells compared with 
negative controls (Figure 3.4b-e).  The percentage of EGFP-positive cells for the VF2468 and 
CCR5 ZFNickases are three- to ten-fold lower than what was observed with their corresponding 
ZFNs (Figure 3.4c and e, compare second and third white-colored columns with the first white-
colored column), suggesting that HDR is induced by ZFNickases but again at a lower rate than is 
observed with the parental ZFNs.  The activities of the VF2471 ZFNickases were detectable but 
quite low despite the high activity of the VF2471 ZFNs (Figure 3.4d). However, for all three 
target sites, the ZFNickases consistently induce lower percentages of mCherry-positive cells 
relative to their matched ZFNs, suggesting that fewer mutagenic NHEJ-mediated events are 
occurring with the nickases compared with the nucleases (Figure 3.4c-e).  In addition, the ratio of 
the percentage of EGFP-positive cells to the percentage of mCherry-positive cells is higher for 5 
of the 6 ZFNickases compared with the parental ZFN (Figure 3.4f-h).  We also found, in 
accordance with previous studies conducted with homing endonucleases and nickases, that 
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Figure 3.4: Assessment of ZFNickase-mediated HDR and NHEJ using a human cell-based 
Traffic Light Reporter assay  
(a) Schematic of the “Traffic Light Reporter.”  HDR-mediated correction of the EGFP gene with 
a co-transfected donor template results in EGFP-positive cells.  Mutagenic NHEJ events at the 
nuclease target site results in mCherry-positive cells.  
(b) Representative flow cytometry plots showing percentages of EGFP-positive and mCherry-
positive cells following transfection of Traffic Light Reporter cell lines with plasmid encoding 
the indicated ZFNs and ZFNickases and the donor template. In the experiments shown, cells 
have been gated for BFP expression (encoded by the plasmid harboring the donor template) to 
normalize for transfection efficiencies.  
(c-e) Bar graphs showing mean percentages of EGFP-positive and mCherry-positive cells for 
experiments performed with the VF2468, VF2471, and CCR5 ZFNs and ZFNickases. Results 
were derived from 3 independent experiments with SEM shown. Statistically significant 
differences in HDR and mutagenic NHEJ rates relative to donor-only control (-/-) are indicated 
by * (P<0.05) or ** (P<0.01). (f-h) Ratios of percentage of EGFP-positive cells to percentage of 
mCherry-positive cells for the VF2468, VF2471, and CCR5 ZFNs and ZFNickases using the 
data from (c-e). Data used to create Figure 3.4c-h is available in Table 3.3. 
  
 Figure 3.4 (continued): 
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 Table 3.3
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Figure 3.5: Effect of donor template concentration on ZFNickases (illustrated with the 
CCR5 site) as assessed by gating on different mean fluorescence intensities (MFI) of the 
BFP-linked donor template.  
(a) Cell populations were gated to analyze cells with low, medium, and high BFP MFIs for each 
combination of active and/or inactive CCR5 monomers. A set of representative plots is shown. 
(b) As indicators of mutagenic NHEJ and HDR rates, respectively, the percent of mCherry 
positive (y-axis) and EGFP-positive (x-axis) cells are noted for each cell population analyzed in 
(a).  
(c) Bar graphs show mean percentages of EGFP-positive and mCherry-positive cells, with results 
derived from 3 independent experiments. Error bars indicate SEM.  
(d) Ratios of percentage of EGFP-positive cells to percentage of mCherry-positive cells for the 
CCR5 ZFNs and ZFNickases using the data from (c). 
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ZFN pair can generate a ZFNickase. This result parallels recent work from Halford and 
colleagues in which they used a similar approach to convert the wild-type FokI restriction 
enzyme into a nickase. Our qualitative in vitro data demonstrate that each ZFNickase 
preferentially cuts one DNA strand at a position either identical or within 1 nt of the cut positions 
of its matched ZFN. Furthermore, the data show that each ZFN monomer cuts the DNA strand to 
which it makes most of its DNA base contacts, providing direct experimental support for the 
model of binding and cleavage illustrated in Figure 3.1.  
Testing in two different human cell-based reporter systems revealed that ZFNickases can 
induce HDR-mediated repair, albeit at lower levels than matched ZFNs from which they were 
derived.  Of the eight ZFNickases we tested (two pairs each derived from ZFNs targeted to four 
different target sites; data presented in Figures 3.3 and 3.4), six induced statistically significant 
levels of HDR.  The levels of HDR we observed with the ZFNickases ranged widely, from 
between two-fold to over 100-fold lower than those observed with the corresponding ZFNs from 
which they were derived. However, for at least some of the ZFNickases we tested (e.g. HX735 -
/+, VF2468 -/+ and +/-, and CCR5 -/+ and +/-), the levels of HDR induced were of sufficiently 
high frequency (0.1% or higher) to be useful for research applications and some potential 
therapeutic strategies.  Our observations that ZFNickases can induce HDR events and that HDR 
efficiency is positively correlated with the concentration of donor present in cells are consistent 
with the findings of others using homing endonucleases engineered to induce nicks (McConnell 
Smith et al., 2009, van Nierop et al., 2009, Certo et al., 2011, Chan et al., 2011, Davis and 
Maizels, 2011, Metzger et al., 2011).  However, to our knowledge, our findings are the first to 
report that nickases derived from ZFNs can be used to induce HDR events.     
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Although absolute rates of HDR were lower for ZFNickases than ZFNs in our human 
cell-based reporter assays, we also observed a consistent reduction in mutagenic NHEJ rates in 
the Traffic Light Reporter assay. This reduction is not entirely surprising given that nicks are 
typically repaired without causing mutations (Holmquist, 1998).  However, we do not know the 
origin of the residual NHEJ-mediated events we observed with some of the ZFNickases we 
tested.  Possible explanations include conversion of a nick into a DSB that may occur with 
replication fork collapse (see below) or weak residual homodimerization of the active ZFNickase 
monomer that may lead to cleavage at the intended target site.  Use of improved second-
generation FokI heterodimer variants (Doyon et al., 2011) may reduce activity due to the latter 
mechanism (we used first-generation FokI heterodimer variants (Miller et al., 2007) for this 
study). 
Importantly, for five of the six ZFNickases we tested in the Traffic Light Reporter assay, 
the ratio of HDR to NHEJ events was increased compared with the three matched ZFNs from 
which they were derived.  These results demonstrate that ZFNickases can induce HDR events 
with relatively lower rates of NHEJ-mediated mutations created at the nick site.  We do not 
currently know the mechanism of the ZFNickase-mediated HDR or the improved HDR:NHEJ 
ratios we observe.  One possibility for the improved HDR:NHEJ ratios is that a nick in the path 
of a DNA replication fork may be converted to a DSB leading to fork collapse, repair of which 
would be expected to lead to repair by either NHEJ or HDR. A potential hypothesis for why we 
observe a preferential shift from NHEJ to HDR with ZFNickases may be the more frequent 
repair of nick-induced replication fork collapse by HDR (Saleh-Gohari et al., 2005), in part due 
to the availability of repair factors for homologous recombination during DNA replication in S-
phase (Hartlerode et al., 2011).  Interestingly, for every target site we tested in our human cell-
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based assays, one ZFNickase combination consistently outperformed the other with respect to 
absolute HDR rates and, for those assayed using the Traffic Light Reporter assay, improved 
HDR:NHEJ ratios. This reproducible difference does not appear to be correlated with whether 
the nicked strand is transcribed or not, and there were no strand cleavage preferences discernible 
from the in vitro data. It is possible that strand-dependent differences in HDR activity arise due 
to different DNA-binding affinities of zinc finger domains in each monomer and how this may 
affect asymmetric accessibility to the break by cellular repair machinery. Regardless of the 
precise mechanism, our results suggest that testing both potential ZFNickases for a given target 
site is worthwhile to identify the most active nickase possible. 
Our work demonstrates that ZFNickases with predictable strand nicking activities can be 
easily derived from ZFNs and that these enzymes can be used in cells to induce HDR with 
improved HDR:NHEJ ratios.  It will be of interest in future experiments to test whether 
ZFNickase-induced HDR rates can be further increased by using improved FokI heterodimer 
frameworks and hyperactive FokI variants (Guo et al., 2010, Doyon et al., 2011).  Our 
observation of reduced mutagenic NHEJ events at the target nicking site suggest that ZFNickases 
will also likely induce fewer mutations at potential off-target sites elsewhere in the genome, a 
prediction that can easily be tested for ZFNs with known off-target sites (Gabriel et al., 2011, 
Pattanayak et al., 2011).  In addition, site-specific nickases may generally be of interest for the 
study of biological phenomena such as replication fork dynamics.  Our results suggest 
ZFNickases may provide a means to induce HDR with reduced mutagenesis caused by NHEJ 
and that additional optimization of this platform should be an important goal for future 
investigation.  
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Chapter Four 
 
 Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection 
 
Vikram Pattanayak, Cherie L. Ramirez, J. Keith Joung, and David R. Liu  
 
 
Vikram Pattanayak developed the selection methodology described in this chapter, 
performed the selection experiments, and carried out analysis for the selections and human cell 
deep sequencing data. The thesis author designed the strategy for examining putative off-target 
sites determined from in vitro selection results, optimized vectors and conditions for CCR5-224 
and VF2468 ZFN expression in K562 cells, and performed deep sequencing experiments in 
K562 cells to interrogate potential off-target loci.  
 
Reference: “Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro 
selection.” Pattanayak V, Ramirez CL, Joung JK, Liu DR. Nature Methods. 2011 Aug 7; 
8(9):765-70. Reprinted by permission from Macmillan Publishers Ltd: Nature Methods, 
copyright 2011. The article has been adapted from its published version for presentation in the 
dissertation. 
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Abstract 
Engineered zinc-finger nucleases (ZFNs) are promising tools for genome manipulation, 
and determining off-target cleavage sites of these enzymes is of great interest. We developed an 
in vitro selection method that interrogates 10
11 
DNA sequences for cleavage by active, dimeric 
ZFNs. The method revealed hundreds of thousands of DNA sequences, some present in the 
human genome, that can be cleaved in vitro by two ZFNs: CCR5-224 and VF2468, which target 
the endogenous human CCR5 and VEGFA genes, respectively. Analysis of identified sites in one 
cultured human cell line revealed CCR5-224–induced changes at nine off-target loci, though this 
remains to be tested in other relevant cell types. Similarly, we observed 31 off-target sites 
cleaved by VF2468 in cultured human cells. Our findings establish an energy compensation 
model of ZFN specificity in which excess binding energy contributes to off-target ZFN cleavage 
and suggest strategies for the improvement of future ZFN design. 
 
 
 
 
74 
 
Introduction 
 
Zinc-finger nucleases (ZFNs) are enzymes engineered to recognize and cleave desired 
target DNA sequences.  A ZFN monomer consists of a zinc-finger DNA-binding domain fused 
with a non-specific FokI restriction endonuclease cleavage domain (Kim et al., 1996).  As the 
FokI nuclease domain must dimerize and bridge two DNA half-sites to cleave DNA (Vanamee et 
al., 2001), ZFNs are designed to recognize two unique sequences flanking a spacer sequence of 
variable length and to cleave only when bound as a dimer. ZFNs have been used for genome 
engineering in many organisms including mammals (Urnov et al., 2005, Maeder et al., 2008, 
Perez et al., 2008, Santiago et al., 2008, Hockemeyer et al., 2009, Zou et al., 2009, Cui et al., 
2011) by stimulating either non-homologous end joining or homologous recombination. In 
addition to providing powerful research tools, ZFNs also have potential as gene therapy agents.  
Clinical trials have recently started with two ZFNs: one as part of an anti-HIV therapeutic 
approach (CCR5-224 clinical trials NCT00842634, NCT01044654 and NCT01252641) and the 
other to modify cells used as anticancer therapeutics (NCT01082926). 
DNA cleavage specificity is a crucial feature of ZFNs.  The imperfect specificity of some 
designed zinc-fingers domains has been linked to cellular toxicity (Cornu et al., 2008) and 
therefore determining the specificities of ZFNs is of significant interest.  ELISA assays (Segal et 
al., 1999), microarrays (Bulyk et al., 2001), a bacterial one-hybrid system (Meng et al., 2007), 
SELEX (Segal et al., 2003, Liu and Stormo, 2005), and Rosetta-based computational 
predictions(Yanover and Bradley, 2011) have all been used to characterize the DNA-binding 
specificity of monomeric zinc-finger domains in isolation.  As a result, information about the 
specificity of zinc-finger nucleases to date has been based on the unproven assumptions that (i) 
dimeric zinc-finger nucleases cleave DNA with the same sequence specificity with which 
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isolated monomeric zinc-finger domains bind DNA; and (ii) the binding of one zinc-finger 
domain does not influence the binding of the other zinc-finger domain in a given ZFN.  The 
DNA-binding specificities of monomeric zinc-finger domains have been used to predict potential 
off-target cleavage sites of dimeric ZFNs in genomes (Perez et al., 2008, Gupta et al., 2011, 
Soldner et al., 2011), but to our knowledge no study to date has reported a method for 
determining the broad DNA cleavage specificity of active, dimeric ZFNs.   
 Here we present an in vitro selection method to broadly examine the DNA cleavage 
specificity of active ZFNs. We coupled our selection with high-throughput DNA sequencing to 
evaluate two obligate heterodimeric ZFNs, CCR5-224 (Perez et al., 2008, Holt et al., 2010) 
currently in clinical trials, and VF2468 (Maeder et al., 2008) which targets the human VEGFA 
promoter, for their abilities to cleave each of 1011 potential target sites. We identified 37 sites and 
2,652 sites in the human genome that can be cleaved in vitro by the ZFNs CCR5-224 and 
VF2468, respectively, and hundreds of thousands of in vitro–cleavable sites for both ZFNs that 
are not present in the human genome. We examined 34 sites or 90 sites for evidence of ZFN-
induced mutagenesis in cultured human K562 cells expressing the CCR5-224 or VF2468 
respectively. Ten of the CCR5-224 sites and 32 of the VF2468 sites we tested had DNA 
sequence changes consistent with ZFN-mediated cleavage in human cells, although we anticipate 
that cleavage is likely to be dependent on cell type and ZFN concentration. One CCR5-224 off-
target site lies in the promoter of the malignancy-associated BTBD10 gene. 
Our results, which could not have been obtained by determining binding specificities of 
monomeric zinc-finger domains alone, indicate that excess DNA-binding energy results in 
increased off-target ZFN cleavage activity and suggest that ZFN specificity can be enhanced by 
designing ZFNs with decreased binding affinity, by lowering ZFN expression and by choosing 
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target sites that differ by at least three base pairs from their closest sequence relatives in the 
genome.  
 
Results 
In Vitro Selection for ZFN-Mediated DNA Cleavage 
Libraries of potential cleavage sites were prepared as double-stranded DNA using 
synthetic primers and PCR.  Each partially randomized position in the primer was synthesized by 
incorporating a mixture containing 79% wild-type phosphoramidite and 21% of an equimolar 
mixture of all three other phosphoramidites.  Library sequences therefore differed from canonical 
ZFN cleavage sites by 21% on average, distributed binomially.  We used a blunt ligation strategy 
to create a 1012-member minicircle library.  Using rolling-circle amplification with phi29 DNA 
polymerase, >1011 members of this library were both amplified and concatenated into high 
molecular weight (>12 kb) DNA molecules.   
 The CCR5-224 or VF2468 DNA cleavage site library was incubated at a total cleavage 
site concentration of 14 nM with two-fold dilutions ranging from 0.5 nM to 4 nM of crude in 
vitro-translated CCR5-224 or VF2468, respectively (Figure 4.1).  Following digestion, the 
resulting DNA molecules (Figure 4.2) were subjected to in vitro selection for DNA cleavage and 
analyzed by paired-end high-throughput DNA sequencing.  Briefly, three selection steps (Figure 
4.3) enable the separation of sequences that are cleaved from those that are not.  First, only sites 
that have been cleaved contain 5’ phosphates, which are required for the ligation of adapters 
required for sequencing.  Second, after PCR, a gel purification step enriches the smaller, cleaved 
library members.  Finally, a computational step after sequencing counts only sequences that have 
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Figure 4.2: Library cleavage with ZFNs 
Cleavage of 1 g of concatemeric libraries of CCR5-224 (a) or VF2468 (b) target sites are 
shown with varying amounts CCR5-224 or VF2468, respectively.  The lane labeled “+ lysate” 
refers to pre-selection concatemeric library incubated with the volume of in vitro 
transcription/translation mixture contained in the samples containing 4 nM CCR5-224 or 4 nM 
of VF2468.  The lane labeled “+PvuI” is a digest of the pre-selection library at PvuI sites 
introduced adjacent to library members.  The laddering on the gels result from cleavage of pre-
selection DNA concatamers at more than one site.  There is a dose-dependent increase in the 
amount of the bottom band, which corresponds to cleavage at two adjacent library sites in the 
same pre-selection DNA molecule.  This bottom band of DNA was enriched by PCR and gel 
purification before sequencing. 
 
 
Off-target cleavage is dependent on ZFN concentration 
As expected, each enzyme cleaved only a subset of library members. The preselection 
libraries for CCR5-224 and VF2468 had means of 4.56 and 3.45 mutations per complete target 
site (two half-sites), respectively, whereas ‘postselection’ libraries exposed to the highest 
concentrations of ZFN (4 nM CCR5-224 and 4 nM VF2468) during the in vitro selection had 
means of 2.79 and 1.53 mutations per target site, respectively (Figure 4.4). We note that this 
selection strategy will most likely not recover all cleaved sequences owing to limitations in 
sequencing throughput.  
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Figure 4.5: Cleavage efficiency of individual sequences is related to selection stringency 
In vitro DNA digests were performed on sequences identified in selections of varying 
stringencies (marked with ‘X’s).  2 nM CCR5-224 (a) or 1 nM VF2468 (b) was incubated with 8 
nM of linear substrate containing the sequence shown.  The 1 kb linear substrate contained a 
single cleavage site with the spacer sequence found in the genomic target of CCR5-224 
(“CTGAT”) or VF2468 (“TCGAA”) and the indicated (+) and (-) half-sites.  Mutant base pairs 
are represented with lowercase letters.  CCR5-224 sites and VF2468 sites that were identified in 
the highest stringency selections (0.5 nM ZFN) are cleaved most efficiently, while sites that were 
identified only in the lowest stringency selections (4 nM ZFN) are cleaved least efficiently. 
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(+) site (5’->3’) (-) site (5’->3’) 4 nM 2 nM 1 nM 0.5 nM 
wt GAT GAG GAT GAC AAA CTG CAA AAG X X X X 
5-4 GAT GAG Ggg cga AAA CTG CAA AAG X X X X 
5-3 GAT GAG Gca cga AAA CTG CAA AAG X X X 
5-2 GcT GAG GAT aAC AAA aTG gAA cAG X X 
5-1 GAT aca GAT GAC AAA CTG gAA AAa X 
a 
b 
(+) site (5’->3’) (-) site (5’->3’) 4 nM 2 nM 1 nM 0.5 nM 
wt GAG TGA GGA GAC GCT GCT X X X X 
4-4 GAG TGA aac  GAC Gt T GCT X X X X 
4-3 GAG TGA Gt c  GAC Gt T aCT X X X 
4-2 Gt G TGA aaA GAC Gt T GCT X X 
4-1 GAG TGA GGA GAC Gaa aCc  X 
uncut 
cut 
cut 
uncut 
cut 
cut 
83 
 
 The DNA-cleavage specificity profile of the dimeric CCR5-224 ZFN (Figure 4.6a, Figure 
4.7a,b) was notably different from DNA-binding specificity profiles of the CCR5-224 monomers 
previously determined by SELEX (Perez et al., 2008).  For example, some positions, such as the 
fifth position recognized in the (+) site, canonically containing an adenine (denoted (+)A5) and 
(+)T9, exhibited tolerance for off-target base pairs in our cleavage selection that had not been 
predicted by the SELEX study. VF2468, which had not been previously characterized with 
respect to either DNA-binding or DNA-cleavage specificity, revealed two positions, (−)C5 and 
(+)A9, that exhibited limited sequence preference, suggesting that they were poorly recognized 
by the ZFNs (Figure 4.6b, Figure 4.7c,d). We note that 2 nM CCR5-224 and 1 nM VF2468 
cleave with similar efficiencies in vitro (Figure 4.1d), and therefore we show these data together 
in Figure 4.6. 
Compensation between half-sites affects DNA recognition 
Our results revealed that ZFN substrates with mutations in one half-site are more likely to 
have additional mutations in nearby positions in the same half-site compared to the preselection 
library and are less likely to have additional mutations in the other half-site. Although this effect 
was greatest when the most strongly specified base pairs were mutated (Figure 4.8), we observed 
this compensatory phenomenon for all specified half-site positions for both the CCR5 and 
VEGFA-targeting ZFNs (Figure 4.9 and 4.10). For a minority of nucleotides in cleaved sites, 
such as VF2468 target site positions (+)G1, (–)G1, (–)A2 and (–)C3, mutation led to decreased 
tolerance of mutations in base pairs in the other half-site and also a slight decrease, rather than an 
increase, in mutational tolerance in the same half-site. When two of these mutations, (+)G1 and 
(–)G1, were included at the same time, mutational tolerance at all other positions decreased 
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Figure 4.7: Concentration-dependent sequence profiles for CCR5-224 and VF2468 ZFNs 
The heat maps show specificity scores for the cleavage of 14 nM of total DNA library with 
varying amounts of (a) CCR5-224 or (b) VF2468.  The target DNA sequence is shown below 
each half-site. Black boxes indicate target base pairs.  Specificity scores were calculated by 
dividing the change in frequency of each base pair at each position in the post-selection DNA 
pool compared to the pre-selection pool by the maximal possible change in frequency of each 
base pair at each position.  Blue boxes indicate specificity for a base pair at a given position, 
white boxes indicate no specificity, and red boxes indicate specificity against a base pair at a 
given position.  The darkest blue shown in the legend corresponds to absolute preference for a 
given base pair (specificity score = 1.0), while the darkest red corresponds to an absolute 
preference against a given base pair (specificity score = -1.0). 
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Figure 4.8: Stringency at the (+) half-site increases when CCR5-224 cleaves sites with 
mutations at highly specified base pairs in the (-) half-site 
The heat maps show specificity scores for sequences identified in the in vitro selection with 2 
nM CCR5-224.  For (-)A3 and (-)G6, indicated by filled black boxes, both pre-selection library 
sequences and post-selection sequences were filtered to exclude any sequences that contained an 
A at position 3 in the (-) half-site or G at position 6 in the (-) half-site, respectively, before 
specificity scores were calculated.  For sites with either (-) half-site mutation, there is an increase 
in specificity at the (+) half-site.  Black boxes indicate target base pairs. Specificity scores were 
calculated by dividing the change in frequency of each base pair at each position in the post-
selection DNA pool compared to the pre-selection pool by the maximal possible change in 
frequency of each base pair at each position.  Blue boxes indicate specificity for a base pair at a 
given position, white boxes indicate no specificity, and red boxes indicate specificity against a 
base pair at a given position.  The darkest blue shown in the legend corresponds to absolute 
preference for a given base pair (specificity score = 1.0), while the darkest red corresponds to an 
absolute preference against a given base pair (specificity score = -1.0). 
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Figure 4.9: Data processing steps used to create mutation compensation difference maps 
The steps to create each line of the difference map in Figure 3 are shown for the example of a 
mutation at position (-)A3. (a) Heat maps of the type described in Supplementary Figure S7 are 
condensed into one line to show only the specificity scores for intended target site nucleotides (in 
black outlined boxes in Supplementary Figure S7). (b) The condensed heat maps are then 
compared to a condensed heat map corresponding to the unfiltered baseline profile from Figure 
2, to create a condensed difference heat map that shows the relative effect of mutation at the 
position specified by the white box with black outline on the specificity score profile. Blue boxes 
indicate an increase in sequence stringency at positions in cleaved sites that contain mutations at 
the position indicated by the white box, while red boxes indicate a decrease in sequence 
stringency and white boxes, no change in sequence stringency. The (+) half-site difference map 
is reversed to match the orientation of the (+) half-site as it is found in the genome rather than as 
it is recognized by the zinc finger domain of the ZFN.  
 Figure 4.9 (continued): 
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Figure 4.10: Evidence for a compensation model of ZFN target site recognition 
Specificity scores calculated from the set of all sites identified in selections containing (a) 2 nM 
CCR5-224 or (b) 1 nM VF2468 selections were subtracted from specificity scores calculated 
from the set of sites containing mutations in the positions specified by black boxes.  Shades of 
blue indicate increased specificity score (more stringency) when the boxed position is mutated 
and shades of red indicate decreased specificity score (less stringency).  Sites are listed in their 
genomic orientation; the (+) half-site of CCR5-224 and the (+) half-site of VF2468 are therefore 
listed as reverse complements of the sequences found in Figure 4.  Positions near off-target base 
pairs are generally recognized with decreased stringency, while positions in non-mutated half-
sites are generally recognized with increased stringency. 
 
This compensation model for ZFN site recognition applies not only to non-ideal half-sites 
but also to spacers with non-ideal lengths. In general, the ZFNs cleaved at characteristic 
locations in the spacers (Figure 4.12), and preferentially cleaved 5 bp and 6 bp spacers over 4 bp 
and 7 bp spacers (Figure 4.13 and 4.14). However, cleaved sites with 5 bp or 6 bp spacers had 
greater sequence tolerance at the flanking half-sites than sites with 4 bp or 7 bp spacers (Figure 
4.15). Therefore, spacer imperfections, similar to half-site mutations, lead to more stringent in 
vitro recognition of other regions of the DNA substrate. 
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Figure 4.11:  Stringency at both half-sites increases when VF2468 cleaves sites with 
mutations at the first base pair of both half-sites 
The heat maps show specificity scores for sequences identified in the in vitro selection with 4 
nM VF2468.  For (+)G1, (-)G1, and (+)G1/(-)G1, indicated by filled black boxes, both pre-
selection library sequences and post-selection sequences were filtered to exclude any sequences 
that contained an G at position 1 in the (+) half-site and/or G at position 1 in the (-) half-site, 
before specificity scores were calculated.  For sites with either mutation, there is decrease in 
mutational tolerance at the opposite half-site and a very slight decrease in mutational tolerance at 
the same half-site.  Sites with both mutations show a strong increase in stringency at both half-
sites.  Black boxes indicate on-target base pairs. Specificity scores were calculated by dividing 
the change in frequency of each base pair at each position in the post-selection DNA pool 
compared to the pre-selection pool by the maximal possible change in frequency of each base 
pair at each position.  Blue boxes indicate specificity for a base pair at a given position, white 
boxes indicate no specificity, and red boxes indicate specificity against a base pair at a given 
position.  The darkest blue shown in the legend corresponds to absolute preference for a given 
base pair (specificity score = 1.0), while the darkest red corresponds to an absolute preference 
against a given base pair (specificity score = -1.0).  
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Figure 4.12: ZFN cleavage occurs at characteristic locations in the DNA target site 
The plots show the locations of cleavage sites identified in the in vitro selections with (a) 4 nM 
CCR5-224 or (b) 4 nM VF2468. Figure 4.16 shows results for 4 nM VF2468. The cleavage site 
locations show similar patterns for both ZFNs except in the case of five-base pair spacers with 
four-base overhangs. The titles refer to the spacer length/overhang length combination that is 
plotted (a site with a six base-pair spacer and a four base overhang is referred to as “6/4”). The 
black bars indicate the relative number of sequences cleaved for each combination of spacer 
length and overhang length. ‘P’ refers to nucleotides in the (+) target half-site, ‘M’ refers to 
nucleotides in the (-) target half-site, and ‘N’ refers to nucleotides in the spacer. There were no 
“7/7” sequences from the 4 nM VF2468 selection. Only sequences with overhangs of at least 4 
bases were tabulated. 
  
 Figure 4.12 (continued): 
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Figure 4.13: CCR5-224 preferentially cleaves five- and six-base pair spacers and cleaves 
five-base pair spacers to leave five-nucleotide overhangs 
The heat maps show the percentage of all sequences surviving each of the four CCR5-224 in 
vitro selections (a-d) that have the spacer and overhang lengths shown. 
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Figure 4.14: VF2468 preferentially cleaves five- and six-base pair spacers, cleaves five-base 
pair spacers to leave five-nucleotide overhangs, and cleaves six-base pair spacers to leave 
four-nucleotide overhangs 
The heat maps show the percentage of all sequences surviving each of the four VF2468 in vitro 
selections (a-d) that have the spacer and overhang lengths shown. 
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Figure 4.15: ZFNs show spacer length-dependent sequence preferences 
Both CCR5-224 (a-c) and VF2468 (d-f) show increased specificity for half-sites flanking four- 
and seven-base pair spacers than for half-sites flanking five- and six-base pair spacers. For both 
ZFNs, one half-site has a greater change in mutational tolerance than the other, and the change in 
mutational tolerance is concentration dependent. 
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Table 4.5: There are many more similar genomic sequences to the VF2468 site than to the 
CCR5-224 site 
The human genome was computationally searched for sites up to nine mutations away from the 
canonical CCR5-224 target site and up to six mutations away from the canonical VF2468 target 
site.  The number of occurrences of sites containing five or six base pair spacers in the genome, 
including repeated sequences, is listed in the table. 
 
CCR5-224  VF2468 
# of mutations 
# of sites in 
genome  # of mutations 
# of sites in 
genome 
0 1  0 1 
1 0  1 3 
2 1  2 245 
3 6  3 3,201 
4 99  4 35,995 
5 964  5 316,213 
6 9,671  6 2,025,878 
7 65,449    
8 372,801    
9 1,854,317    
 
Identified sites are cleaved by ZFNs in human cells 
We tested whether CCR5-224 could cleave at sites identified by our selections in human 
cells by expressing CCR5-224 in K562 cells and examining 34 potential target sites in the human 
genome for evidence of ZFN-induced mutations using PCR and high-throughput DNA 
sequencing. We defined sites with evidence of ZFN-mediated cleavage as those with insertion or 
deletion mutations (indels) characteristic of non-homologous end-joining repair (Table 4.6) that 
were significantly enriched (P < 0.05) in cells expressing active CCR5-224 compared to control 
cells containing an empty vector. We obtained ~100,000 sequences for each site analyzed, which 
enabled us to detect that sites were modified at frequencies of at least ~1 in 10,000. Our analysis 
identified ten such sites: the intended target sequence in CCR5, a previously identified sequence 
in CCR2 and eight other off-target sequences (Tables 4.3 and 4.6), one of which was in the 
promoter of the BTBD10 gene. The eight newly identified off-target sites were modified at fre-
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Table 4.6: Sequences of CCR5-224-mediated genomic DNA modifications identified in 
cultured human K562 cells 
Sequences with insertions (blue) and deletions (red) identified after sequencing potential CCR5-
224 off-target sites from cultured K562 cells expressing CCR5-224 are shown.  The numbers of 
occurrences are shown to the right of each sequence.  The unmodified site is listed under the 
gene name or coordinates (build 36), and the spacer sequence is underlined. 
 
 
 
 
 
# of sequences # of sequences
BTBD10 (promoter) chr6:52114315-52114343
ATTTTGCAGTTT GCTTT GATGAGGAAAAC CTTTTTCAGTTT CTTTT GCTGAGCAGGAC
ATTTTGCAGTTT GCTTT GATGAGGAAAAC 63 CTTTTTCAGTTT CTTTT GCTGAGCAGGAC 35
ATTTTGCAGTTT GCTTTGCTTT GATGAGGAAAAC 86
ATTTTGCAGTTT GgTTTGCTTT GATGAGGAAAAC 1
ATTTTGCAGTTT GCTTTGCTTT GgTGAGGAAAAC 1 KCNB2
gTTTTGCAGTTT GCTTTGCTTT GATGAGGAAAAC 1 CATTTGCAGTTT CGGGA GATGAGGAACAT
cTTTTGCAGgTT GCTTTGCTTT GATGAGGAAAAC 1
ATTTTGCAGTTT GCTTTGCTTT GATGtGGAAAAC 1 CATTTGCAGTTT CGGGAGA GATGAGGAACAT 158
ATTTTGCAGTTT GCTTT GATGAGGAAAAC 1 CATTTGCAGTTa CGGGAGA GATGAGGAACAT 1
CATTTGCAGTTT CGGGAGA GATGAGGgACAT 1
CATTTGacGcTT CGGGAGA GgTGAGGgACAT 1
chr17:61624429-61624457 CATTTGCAGTTT CGGGCGGGA GATGAGGAACAT 109
GTTTTGCAGTTC CTTTT GATGAAGATGAC CATTTGCAGTTT CGGGCGGGA GATGcGGAACAT 1
CATTTGCAGTTT CGGGCGGGc GATGAGGAACAT 1
GTTTTGCAGTTC CTTTT GATGAAGATGAC 51 CATTTGCAGTTT CGGGCGGGA GgTGAGGAACAT 1
GTTTTGCAGgTC CTTTT GATGAAGATGAC 1 CgTTTGCAGTTT CGGGCGGGA GATGAGGAACAT 2
CATTTGCtGTTT CGGGCGGGA GATGAGGAACAT 1
CATTTGCAGTTT CGGGCGGGA GATGAGGAcCAT 1
TACR3 CATTTGCAGTTT CGGGCGGGA GgTGAGGAACAT 1
ACTTTACAGTTT ATGCT GATGAAGATGAC CcTTTGCAGTTT CGGGCGGGA GATGAGGAACAT 1
CATTTGCAGTTg CGGGCGGGA GATGAGGAACAT 1
ACTTTACAGTTT ATGCT GATGAAGATGAC 5
ACTTTACAGTTT ATGCT GATGAAGATGAC 169
gCTTTACAGTTT ATGCT GATGAAGATGAC 1 chr8:4865886-4865914
ACTTTACAGTTT ATGCT GATGAAGAatAC 1 GTCTTCCTGATG CTACC AAACTGGAAAAG
ACTTTACAGTTT ATGCT GATGAAGATGtt 1
ACTTTACAGTTT ATGCT GATGAAGATGAC 34 GTCTTCCTGATG CTACC AAACTGGAAAAG 30
ACTTTACgGTTT ATGCT GATGAAGATGAC 1 GTCTTCCTGATG CTACC AAACTtGAAAAG 1
ACTTTACAGTTT ATGCT GATGAAGATGAC 180 GTCTTCaTGATG CTACC AAACTGGAAAAG 1
ACTTTACAGTTT ATGCT GATGAAGATGcC 1
ACTTTACAGTTT ATGCTATGCT GATGAAGATGAC 507
gCTTTACAGTTT ATGCTATGCT GATGAAGATGAC 1 chr9:80584200-80584229
ACTTTACgGTTT ATGCTATGCT GATGAAGATGAC 1 CTTTTGCAGTCT GTAGGT GTTGAGGTTGAC
ACTTTACAGTTT ATGCTATGCT GATGAtGATGAC 1
ACgTTACAGTTT ATGCTATGCT GATGAAGATGAC 1 CTTTTGCAGTCT GTAGGT GTTGAGGTTGAC 125
ACTTTACAGTTT ATGCT GATGAAGATGAC 140 CTTTTGCAGTCT GTAGGT GTTGAGGTTGAC 1
ACTTTACAGTTT ATGCT GATGAAGATGtC 1 CTTTTGCAGTCT GTAGGT GTTGAGGTTGAC 1
WBSCR17
GTTATCCTCAGC AAACTA AAACTGGAACAG
GTTATCCTCAGC AAACTAACTA AAACTGGAACAG 128
GTTATCCTCAGC AAACTA AAACTGGAACAG 118
GTTATCCTCAGC AAACTA AAACTGGgACAG 1
GTTATCCTCAGC AAACTA AAACTGGAcCAG 1
GTTATaCTCAGC AAACTA AAACTGGAACAG 1
GTTATCCTCAGC AAACTA AAACTGGAACAG 116
aTTATCCTCAGC AAACTA AAACTGGAACAG 1
GTTATCCTtAGC AAACTA AAACTGGAACAG 1
GTTATCCTCAGC AAACTA AAACTGGAACAG 118
GaTATCCTCAGC AAACTA AAACTGGAACAG 1
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Table 4.7: Potential VF2468 genomic off-target sites 
DNA for 90 out of 97 potential VF2468 genomic target sites were amplified by PCR from 
cultured K562 cells expressing active VF2468 ZFN or from cells containing empty expression 
vector. Bolded red sites have significantly enriched indel percentages in the active nuclease 
sample compared to cells not expressing nuclease.  The sequences of the sites are listed as 5’ (+) 
half-site/spacer/(-) half-site 3’, therefore the (+) half-site is listed in the reverse sense as it is in 
the sequence profiles.  Indels and totals are not shown for sites that were not tested.  P-values 
shown are for the one-sided alternative hypothesis that the indel frequency is greater for active 
ZFN treated cells than for cells not expressing ZFN. 
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quencies of 1:300 to 1:5,300. We also expressed VF2468 in cultured K562 cells and performed 
the same analysis as above for 90 of the most highly cleaved sites identified by in vitro selection. 
Of the 90 VF2468 sites analyzed, 32 had indels consistent with ZFN-mediated targeting in K562 
cells (Table 4.7). We did not obtain site-specific PCR amplification products for three CCR5-224 
sites and seven VF2468 sites, and therefore could not analyze the occurrence of non-homologous 
end-joining at those loci. Taken together, these observations indicate that off-target sequences 
identified through the in vitro selection method include DNA sequences that can be cleaved by 
ZFNs in human cells. 
 
Discussion 
Using the method presented here we identified hundreds of thousands of sequences that 
can be cleaved by two active, dimeric ZFNs, including many that are present and can be cut in 
the genome of human cells. 
One newly identified cleavage site for CCR5-224 is in the promoter of BTBD10. When 
downregulated, BTBD10 has been associated with malignancy (Chen et al., 2004) and with 
pancreatic beta cell apoptosis (Wang et al., 2011).  When upregulated, BTBD10 has been shown 
to enhance neuronal cell growth (Nawa et al., 2008) and pancreatic beta cell proliferation 
through phosphorylation of Akt family proteins (Nawa et al., 2008, Wang et al., 2011). This 
potentially important off-target cleavage site, as well as seven others we observed in cells, had 
not been identified in a recent study6 that used in vitro monomer-binding data to predict 
potential CCR5-224 substrates. Although our selection results increased the number of known 
CCR5-224 off-target sites, the number of sequence reads obtained per selection in our study 
(approximately one million) is likely insufficient to cover all cleaved sequences in the 
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postselection libraries. It is therefore possible that additional off-target cleavage sites for CCR5-
224 and VF2468 could be identified in the human genome as sequencing capabilities improve. It 
is also possible that the datasets generated by this method could be used to develop 
computational models to predict additional ZFN cleavage sites in vitro and in cells. 
We have previously shown that ZFNs that can cleave at sites in one cell line may not 
necessarily function in a different cell line4 most likely because of local differences in chromatin 
structure. Therefore, it is likely that a different subset of the in vitro–cleavable off-target sites 
would be modified by CCR5-224 or VF2468 when expressed in different cell lines. Likewise, 
cell-line choice may influence purely cellular studies of endonuclease specificity, such as a 
recent study of homing endonuclease off-target cleavage that relied on adeno-associated virus 
integration into homing endonuclease–created double-strand breaks in cells (Petek et al., 2010). 
Whereas our in vitro method does not account for some features of cellular DNA, it provides 
general, cell type–independent information about endonuclease specificity and off-target sites 
that can inform subsequent studies performed in cell types of interest. 
Although both ZFNs we analyzed had been engineered to a unique sequence in the 
human genome, both cleave several off-target sites in cells. This finding is particularly surprising 
for the four-finger CCR5-224 pair given that its theoretical specificity is 4,096-fold better than 
that of the three-finger VF2468 pair (CCR5-224 should recognize a 24 bp site that is 6 bp longer 
than the 18 bp VF2468 site). Examination of the CCR5-224 and VF2468 cleavage profiles and 
mutational tolerances of sequences with three or fewer mutations suggests different strategies 
may be required to engineer variants of these ZFNs with reduced off-target cleavage activities. 
The four-finger CCR5-224 showed a more diffuse range of positions with relaxed specificity and 
a higher tolerance of mutant sequences with three or fewer mutations than the three-finger 
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VF2468 ZFN. For VF2468, re-optimization of only a subset of fingers may enable a substantial 
reduction in undesired cleavage events. For CCR5-224, in contrast, a more extensive re-
optimization of many or all fingers may be required to eliminate off-target cleavage events. 
Analysis of more three-finger and four-finger ZFNs will be required to determine whether these 
patterns of off-target cleavage activities are a general property of these respective frameworks. 
Not all four- and three-finger ZFNs will necessarily be as specific as the two ZFNs tested in this 
study. Both CCR5-224 and VF2468 had been engineered using methods designed to optimize the 
binding activity of the ZFNs. Previous work has shown that for both three-finger and four-finger 
ZFNs, the specific methodology used to engineer the ZFN pair can have a tremendous impact on 
the quality and specificity of nucleases (Hurt et al., 2003, Urnov et al., 2005, Meng et al., 2007, 
Ramirez et al., 2008). Therefore, it will be interesting and important to use a method such as the 
one described here to determine and compare the specificities of additional three-finger and four-
finger ZFNs generated using various strategies. 
Our findings have important implications for the design and application of ZFNs with 
increased specificity. Half or more of all potential substrates with one or two site mutations could 
be cleaved by ZFNs, suggesting that binding affinity between ZFN and DNA substrate is 
sufficiently high for cleavage to occur even with suboptimal molecular interactions at mutant 
positions. We also observed that ZFNs presented with sites that have mutations in one half-site 
exhibited higher mutational tolerance at other positions in the mutated half-site and lower 
tolerance at positions in the other half-site. These results suggest that to meet a minimum affinity 
threshold for cleavage, a shortage of binding energy from a half-site containing an off-target base 
pair must be energetically compensated by excess zinc finger: DNA binding energy in the other 
half-site, which demands increased sequence recognition stringency at the non-mutated half-site  
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preferences in cells (Bibikova et al., 2001, Handel et al., 2009), but our results suggest that the 
dimeric FokI cleavage domain can influence ZFN target-site recognition. Consistent with this 
model, differences in the frequency of off-target events in zebrafish of two ZFNs with identical 
zinc-finger domains but different FokI domain variants have been reported (Gupta et al., 2011). 
Collectively, our findings suggest that (i) ZFN specificity can be increased by avoiding 
the design of ZFNs with excess DNA binding energy; (ii) off-target cleavage can be minimized 
by designing ZFNs to target sites that do not have similar sites in the genome within three 
mutations; and (iii) ZFNs should be used at the lowest concentrations necessary to cleave the 
target sequence to the desired extent. Although in this study we focused on ZFNs, our method 
should be applicable to all sequence-specific endonucleases that cleave DNA in vitro, including 
engineered homing endonucleases and engineered transcription activator–like effector nucleases. 
This approach can provide important information when choosing target sites in genomes for 
sequence-specific endonucleases and when engineering these enzymes, especially for therapeutic 
applications. 
 
Methods 
Oligonucleotides and sequences 
 All oligonucleotides were purchased from Integrated DNA Technologies or Invitrogen 
and are listed in Table 4.8.  Primers with degenerate positions were synthesized by Integrated 
DNA Technologies using hand-mixed phosphoramidites containing 79% of the indicated base 
and 7% of each of the other standard DNA bases. 
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Library construction 
 Libraries of target sites were incorporated into double-stranded DNA by PCR with Taq 
DNA Polymerase (NEB) on a pUC19 starting template with primers “N5-PvuI” and “CCR5-224-
N4,” “CCR5-224-N5,” “CCR5-224-N6,” “CCR5-224-N7,” “VF2468-N4,” “VF2468-N5,” 
“VF2468-N6,” or “VF2468-N7,” yielding an approximately 545 bp product with a PvuI 
restriction site adjacent to the library sequence, and purified with the Qiagen PCR Purification 
Kit. Library-encoding oligonucleotides were of the form 5’ backbone-PvuI site-NNNNNN-
partially randomized half-site–N4-7–partially randomized half site-N-backbone 3’.  The purified 
oligonucleotide mixture (approximately 10 µg) was blunted and phosphorylated with a mixture 
of 50 units of T4 Polynucleotide Kinase and 15 units of T4 DNA polymerase (NEBNext End 
Repair Enzyme Mix, NEB) in 1x NEBNext End Repair Reaction Buffer (50 mM Tris-HCl, 10 
mM MgCl2, 10 mM dithiothreitol, 1 mM ATP, 0.4 mM dATP, 0.4 mM dCTP, 0.4 mM dGTP, 
0.4 mM dTTP, pH 7.5) for 1.5 hours at room temperature.  The blunt-ended and phosphorylated 
DNA was purified with the Qiagen PCR Purification Kit according to the manufacturer’s 
protocol, diluted to 10 ng/µL in NEB T4 DNA Ligase Buffer (50 mM Tris-HCl, 10 mM MgCl2, 
10 mM dithiothreitol, 1 mM ATP, pH 7.5) and circularized by ligation with 200 units of T4 
DNA ligase (NEB) for 15.5 hours at room temperature.  Circular monomers were gel purified on 
1% TAE-Agarose gels.  70 ng of circular monomer was used as a substrate for rolling-circle 
amplification at 30 °C for 20 hours in a 100 µL reaction using the Illustra TempliPhi 100 
Amplification Kit (GE Healthcare).  Reactions were stopped by incubation at 65 °C for 10 
minutes.  Target site libraries were quantified with the Quant-iT PicoGreen dsDNA Reagent 
(Invitrogen).  Libraries with N4, N5, N6, and N7 spacer sequences between partially randomized 
half-sites were pooled in equimolar concentrations for both CCR5-224 and VF2468. 
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Table 4.8: Oligonucleotides used in this study 
Oligonucleotides “[ZFN] [#] fwd/rev” were ordered from Invitrogen.  All other oligonucleotides 
were ordered from Integrated DNA Technologies.  ‘N’ refers to machine mixed incorporation of 
‘A’,’C’,’G’, or ‘T.’  An asterisk indicates that the preceding nucleotide was incorporated as a 
mixture containing 79 mol % of that nucleotide and 7 mol % each of the other canonical 
nucleotides.  “/5Phos/” denotes a 5’ phosphate group installed during synthesis. 
 
Oligonucleotide name Oligonucleotide Sequence (5’->3’) 
N5-PvuI NNNNNCGATCGTTGGGAACCGGA 
CCR5-224-N4 NG*T*C*A*T*C*C*T*C*A*T*C*NNNNA*A*A*C*T*G*C*A*A*A*A*G*NCAGTGGAACGAA 
CCR5-224-N5 NG*T*C*A*T*C*C*T*C*A*T*C*NNNNNA*A*A*C*T*G*C*A*A*A*A*G*NCAGTGGAACGAAAACTCACG 
CCR5-224-N6 NG*T*C*A*T*C*C*T*C*A*T*C*NNNNNNA*A*A*C*T*G*C*A*A*A*A*G*NCAGTGGAACGAAAACTCACG 
CCR5-224-N7 NG*T*C*A*T*C*C*T*C*A*T*C*NNNNNNNA*A*A*C*T*G*C*A*A*A*A*G*NCAGTGGAACGAAAACTCACG 
VF2468-N4 NA*G*C*A*G*C*G*T*C*NNNNG*A*G*T*G*A*G*G*A*NCAGTGGAACGAAAACTCACG 
VF2468-N5 NA*G*C*A*G*C*G*T*C*NNNNNG*A*G*T*G*A*G*G*A*NCAGTGGAACGAAAACTCACG 
VF2468-N6 NA*G*C*A*G*C*G*T*C*NNNNNNG*A*G*T*G*A*G*G*A*NCAGTGGAACGAAAACTCACG 
VF2468-N7 NA*G*C*A*G*C*G*T*C*NNNNNNNG*A*G*T*G*A*G*G*A*NCAGTGGAACGAAAACTCACG 
test fwd GCGACACGGAAATGTTGAATACTCAT 
test rev CAGCGAGTCAGTGAGCGA 
adapter1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTT 
adapter1(AAT) ACACTCTTTCCCTACACGACGCTCTTCCGATCTAATT 
adapter1(ATA) ACACTCTTTCCCTACACGACGCTCTTCCGATCTATAT 
adapter1(TAA) ACACTCTTTCCCTACACGACGCTCTTCCGATCTTAAT 
adapter1(CAC) ACACTCTTTCCCTACACGACGCTCTTCCGATCTCACT 
adapter2 /5Phos/AGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
adapter2(AAT) /5Phos/ATTAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
adapter2(ATA) /5Phos/TATAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
adapter2(TAA) /5Phos/TTAAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
adapter2(CAC) /5Phos/GTGAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
PE1 CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATC 
PE2 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
CCR5-224 1 fwd ATACATCGGAGCCCTGCCAA CCR5-224 1 rev GGAAAAACAGGTCAGAGATGGC 
CCR5-224 2 fwd TCCTGCCTCCGCTCTACTCG CCR5-224 2 rev ACCCCAAAGGTGACCGTCCT 
CCR5-224 3 fwd TCCCACGTTTTCCCCTTGAC CCR5-224 3 rev GTCCCTCACGACGACCGACT 
CCR5-224 4 fwd GCACTGCCCCAGAAATATTGGT
T
CCR5-224 4 rev TGGTTTGTTGGGGGATCAGG 
CCR5-224 5 fwd ATGCCACCCCTGCCAGATAA CCR5-224 5 rev GCCTACCTCAATGCAGGCAAA 
CCR5-224 6 fwd TCTGCTTCTGCCCTTCTGGA CCR5-224 6 rev GGAGGATCGCCAAGACCTGA 
CCR5-224 7 fwd CCCCAGTGCTTAACATAGTTCT
TGG
CCR5-224 7 rev ACTCCCAGACAAACCCCGCT 
CCR5-224 8 fwd GGCACCAGAACTTACTCACTGC
C
CCR5-224 8 rev TGTGAAGGCCCAAAACCCTG 
CCR5-224 9 fwd GTTTTGGGGGTCATGGCAAA CCR5-224 9 rev TGGGCAGCCCTAGGTCCTTT 
CCR5-224 10 fwd TTTCCCTGGTGATGCACTCCT CCR5-224 10 rev TGATGAGTAACTTGGGCGAAAA 
CCR5-224 11 fwd TTGGGGGAATGAGATTGGGA CCR5-224 11 rev GGAAAATCCAGCAAGGTGAAA 
CCR5-224 13 fwd CCTTCCCATGGTCACAGAGG CCR5-224 13 rev CAACTCTCTAACAGCAAAGTGGCA 
CCR5-224 14 fwd TCCTCCCGTTGAGGAAGCAC CCR5-224 14 rev GCCTCAAAAGCATAAACAGCA 
CCR5-224 15 fwd CAGACCGCTGCTGCTGAGAC CCR5-224 15 rev AGGGCGGACTCATTGCTTTG 
CCR5-224 16 fwd TGGGTTCCTCGGGTTCTCTG CCR5-224 16 rev GAAACCAGAAGTTCACAACAATGCTT 
CCR5-224 17 fwd AGGCATAAGCCACTGCACCC CCR5-224 17 rev TGGCAATGCCTAATCAGACCA 
CCR5-224 18 fwd GAGGATATTTTATTGCTGGCTC
TTGC
CCR5-224 18 rev GAGTTTGGGGAAAAGCCACTT 
CCR5-224 20 fwd GCTGAGGCCCACCTTTCCTT CCR5-224 20 rev TGCTCTGCCAACTGTGAGGG 
CCR5-224 21 fwd TGTTTTGGGTGCATGTGGGT CCR5-224 21 rev TCCAGGGAGTGAGGTGAAGACA 
CCR5-224 22 fwd CTGGGTCAGCTGGGCCATAC CCR5-224 22 rev TCACATCTCCGCCTCACGAT 
CCR5-224 23 fwd CCAGCCTTGGAAAAATGGACA CCR5-224 23 rev CTGACACAGTGGCCAGCAGC 
CCR5-224 24 fwd CATGGATGTAATGGGTTGTATC
TGC
CCR5-224 24 rev GAGGGCAGAAGGGGGTGAGT 
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Table 4.8 (continued): 
 
CCR5-224 25 fwd AGGATGCATTGTCCCCCAGA CCR5-224 25 rev TGGAGTGACATGTATGAAGCCA 
CCR5-224 26 fwd CGTTGGCTTGCAGAAGGGAC CCR5-224 26 rev TGAACCCCGGATTTTTCAACC 
CCR5-224 27 fwd TGACCCAACTAAGTCTGTGACCC CCR5-224 27 rev TTGGGAAAGCTTTGATGCTGG 
CCR5-224 28 fwd TGGGTTGTGTTTTTGACTGACAGA CCR5-224 28 rev CCCTAGGGGTCACTGGAGCA 
CCR5-224 29 fwd CACCCCCATGCAGGAAAATG CCR5-224 29 rev TTGGCTGCTGGCATTTGGTA 
CCR5-224 30 fwd GGCCATTGGTTCTGGAGGAA CCR5-224 30 rev TCCGTTGCTTCATCCTTCCAA 
CCR5-224 31 fwd AGTCAGCAATGCCCCAGAGC CCR5-224 31 rev TGGAGAGGGTTTACTTTCCCAGA 
CCR5-224 32 fwd CCTGGGAGGGTGACTAGTTGGA CCR5-224 32 rev GCTCAGGGCCTGGCTTACAG 
CCR5-224 33 fwd TGGCAATTAGGATGTGCCAG CCR5-224 33 rev TCCACTCACAAATTTACCTTTCCAC 
CCR5-224 34 fwd TGCCCCACATCTTCACCAGA CCR5-224 34 rev CCGCATAAAGGAGGTGTCGG 
CCR5-224 36 fwd GTTGCATCTGCGGTCTTCCA CCR5-224 36 rev GGAGAGTCTTCCGCCTGTGTT 
CCR5-224 37 fwd TAGTGGCCCCAACATGCAAA CCR5-224 37 rev GCACATATCATGCACTGTGACTGTAA 
VF2468 1 fwd CCTTTCCAAAGCCCATTCCC VF2468 1 rev CAACCCCACACGCACACAC 
VF2468 2 fwd TTCACTGCCTTCAGGCCTCC VF2468 2 rev AATGGCCAGAAAATTCCCAAA 
VF2468 3 fwd CACAGGGACCCAGGACTGCT VF2468 3 rev TGACTGGAACCGTGCAGCAT 
VF2468 4 fwd GCACCAGGCTTCTCTGCCAT VF2468 4 rev TCGGGGGTCCATGGTATTTG 
VF2468 5 fwd CCAAGGCGAGGACATTGAGG VF2468 5 rev CCCCAAGTCAGACCCTGCAT 
VF2468 7 fwd ACCATAGTCCAGCGGGGTCA VF2468 7 rev TTCTCCCCAAGGAAGGCTGA 
VF2468 8 fwd AGAAAGGGTGGTCGGGGAAG VF2468 8 rev GCCACCATGCCCAGTCTACA 
VF2468 9 fwd TTCCCATGGGGTCTCAGCTC VF2468 9 rev ATGGCCTTCCCCAACTGTGA 
VF2468 10 fwd CAGCAAGGATGCCCTTCACC VF2468 10 rev CGTTGTGATTGAGGAGACGAGG 
VF2468 11 fwd GGCTTGAGCTGGAAGGACCA VF2468 11 rev TGGAGCAACTGAACATCTTGGG 
VF2468 12 fwd AACCGAGTTTGCACCGTCGT VF2468 12 rev CATAACCACCAGGACATCCGC 
VF2468 13 fwd TATCCTCCCCTTTCCCCTGA VF2468 13 rev TGTTGCCAGAAGTATCAGGTCCC 
VF2468 15 fwd AGAACCCGGAATCCCTTTGC VF2468 15 rev GCAGAGAAGGCAGCAGCACA 
VF2468 16 fwd GGTCTCTGCCATGCCCAACT VF2468 16 rev TGGAGGAAGCAGGAAAGGCAT 
VF2468 18 fwd CCCCTTGGGATCCTTGTCCT VF2468 18 rev TCAACAGGCAGCTACAGGGC 
VF2468 19 fwd CTAGGCCTGTGGGCTGAGGA VF2468 19 rev CAAATGTTGGGGTGTGGGTG 
VF2468 20 fwd TACCTGAAACCCCTGGCCCT VF2468 20 rev CAAGCTGGATGTGGATGCAGAG 
VF2468 21 fwd CGGGGGCCTGACATTAGTGA VF2468 21 rev GCCTGAAGATGCATTTGCCC 
VF2468 22 fwd TGCATTGGCTCAAGAATTGGG VF2468 22 rev TCACACAGTGGTAATGGACAGGAA 
VF2468 23 fwd GCGCTCCCTGTGTTCAGTACC VF2468 23 rev GCGCAAGTTCCCCTTTCTGA 
VF2468 24 fwd TGTTTGGGTTATGGGGGCAG VF2468 24 rev TCCAGCATCTGCTCCTGGTG 
VF2468 25 fwd AAGGAGACTTCTCAGGCCCCA VF2468 25 rev TGAAGGGAAGCCACAGCTCC 
VF2468 26 fwd CTTGGGGGCAGACAGCATCT VF2468 26 rev GCCATGGGATGGCAGTTAGG 
VF2468 27 fwd TGGCCTCAAGCAATCCTCCT VF2468 27 rev TTCCATGGCAGTGAAGGGTG 
VF2468 28 fwd CCAAAGAGCCTGGAGGAGCA VF2468 28 rev CAGAGGGTGTGGTGGTGTCG 
VF2468 29 fwd CCAGCCTGTGAAGCTGGAAGTAA VF2468 29 rev CCAGTGGGCTGAGTGGATGA 
VF2468 30 fwd CATCTGAATGCCCATGCTGC VF2468 30 rev CCGCCACACCCATTCCTC 
VF2468 31 fwd CCTCAAAGAAACGGCTGCTGA VF2468 31 rev GCCGCTCGAAAAGAGGGAAT 
VF2468 32 fwd CGGGCTCTCCTCCTCAAAGA VF2468 32 rev GGCCCCTTGAAAAGAGGGAA 
VF2468 33 fwd GGAATCGCATGACCTGAGGC VF2468 33 rev CGGGCTCTCCTCCTCAAAGA 
VF2468 34 fwd CCCGCCAGACACATTCCTCT VF2468 34 rev CATCTGAATGCCCATGCTGC 
VF2468 35 fwd CCGCACCTTTTTCCTATGTGGT VF2468 35 rev TCAGATGTGCTAGGACACAGATGAC 
VF2468 36 fwd GGTACATGGGCCGCACTTTC VF2468 36 rev GGACAGCTGGGAATTGGTGG 
VF2468 37 fwd TTACACCTGCTGGCAGGCAA VF2468 37 rev GCTGGTGTGAGCAAGAGGCA 
VF2468 38 fwd TGGCCAAGCCTGCCTAACTC VF2468 38 rev TGATCAGTTAGCCCTGGGGG 
VF2468 39 fwd CCCCTTCTGCTCCTGCTTCA VF2468 39 rev CCTTCCTTGCAGCTCAAACCC 
VF2468 40 fwd TGATTTTCAGCGTGGAGGGC VF2468 40 rev ACGGCAAAGCCAGAGCAAAG 
VF2468 41 fwd AAGCTGGCAGCCACTCTTCA VF2468 41 rev TCTCAGGGCTTCTGTGTGCG 
VF2468 42 fwd TCGATTCTCCATACACCATCAAT VF2468 42 rev GCAACCAACTCCCAACAGGG 
VF2468 43 fwd AGGTCCTGGCATTGTCTGGG VF2468 43 rev TGGTTGCCTGTTTCACACCC 
VF2468 45 fwd CTGGGAGGCAGCCAGTCAAG VF2468 45 rev GCCCTGTAAGCTGAAGCTGGA 
VF2468 46 fwd CAGGTGTGCATTTTGTTGCCA VF2468 46 rev GCCTGCCAGGTATTTCCTGTGT 
VF2468 47 fwd TGGCCCTGGTCATGTGAAAA VF2468 47 rev AACTGCAAGTGGCCTCCCAG 
VF2468 48 fwd TTGATAAGGGCGGTGCCACT VF2468 48 rev TAGAGGGAGGTGCTTGCCCA 
VF2468 49 fwd CATCCCCTTGACCAACAGGC VF2468 49 rev GCTTGGGCACTGATCCTGCT 
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Table 4.8 (continued): 
 
VF2468 50 fwd ACTGCCAATGGACCCTCTCG VF2468 50 rev GAGTTGCCCAGGTCAGCCAT 
VF2468 51 fwd GGGGAGCTAGAATGGTGGGC VF2468 51 rev CAAGGTACACAGCTGCCCAGG 
VF2468 52 fwd CCCATGCTGGTCCTGCTGTT VF2468 52 rev GGAGGCTCAGCGGAGAGGAT 
VF2468 53 fwd GGGGTCACCAGGGAAGGTTT VF2468 53 rev AGTTGCGGGGAGGTGCTACA 
VF2468 54 fwd TGCCCAGAGACCTTCCAAGC VF2468 54 rev TGGCCAAGGCCTCTCTAAGC 
VF2468 56 fwd GCCAATGTGCAATCGAGACG VF2468 56 rev TGCATGCCTCTGACTGATGCT 
VF2468 57 fwd TGACTTGAACTGGGTCCCCC VF2468 57 rev CTGGGGCTACAGCCCTCCTT 
VF2468 58 fwd CCCAATCCAGACACCACACG VF2468 58 rev TGCAGATTTTAGGGGTTGCCA 
VF2468 59 fwd GGTGAGGAAGGATGGGGGTT VF2468 59 rev GTAGGCTCTGCCACGCCAGT 
VF2468 60 fwd TGCCCATGTTGTTGCTCCAC VF2468 60 rev GACAAGTTAGACCATCCTAGCCCTCA 
VF2468 61 fwd TCACAGCTCCCCTTTCTCGG VF2468 61 rev TGTGCCTCCACTGACGCATT 
VF2468 62 fwd CCTAGGCACAGTGGGGGATG VF2468 62 rev GGGCTGACACACTGAGGGCT 
VF2468 63 fwd CCATGAGCACAATTGCCAAAA VF2468 63 rev TGAGTTATTTCGAAAGAGGAAACAGT
G
VF2468 64 fwd CTGCCAAGAACAGGAGGGGA VF2468 64 rev AGCCCATCTACCATCCAGCG 
VF2468 66 fwd ATCGGGGCAGGGCTAGAGTC VF2468 66 rev CCCCTGGCATTCCCTACACA 
VF2468 67 fwd GCCGTTAGTGCATTTGCCTG VF2468 67 rev TCCCTTTCAACCCCTGTAGTGC 
VF2468 68 fwd GTTCCTCCCAGAGTGGGGCT VF2468 68 rev ACTGAGGGAGGCAGCACTGG 
VF2468 69 fwd AGGCCTGGCGGTAACCTTG VF2468 69 rev AAGCTCCAGCCCTGTACCCC 
VF2468 70 fwd GGGATCCTACAGGATGGGACAA VF2468 70 rev CAGCCCAGGACAAGGGTAGC 
VF2468 71 fwd GCCACCAAATGTCCACTGGTT VF2468 71 rev TTCCCCAAGCAGTCCAGCTC 
VF2468 72 fwd GCACCAGCCTCTTCGATGGT VF2468 72 rev CCTTTGGCAGACTGTGGCCT 
VF2468 73 fwd AATGGGGCAAAAGGCAAGAAA VF2468 73 rev CAGACCTCGTGGTGCATGTG 
VF2468 74 fwd TGGCGAGATAGGCTCTGCTACA VF2468 74 rev TGGACAGGGAATTACTCAGACCAG 
VF2468 75 fwd TGTGGGCATGAGACCACAGG VF2468 75 rev TTTGACTCCCCCGCATTGTT 
VF2468 76 fwd TCCTATTTTCAGATGCACTCGAACC VF2468 76 rev GTGCTCACTGAAGCCCACCA 
VF2468 77 fwd GGACCTTCTTGCCCTCATGATTC VF2468 77 rev GGGAACTGTGCCTTTGCGTC 
VF2468 78 fwd CCTTGCAAAGGCTTGCCTAAA VF2468 78 rev GGCAGGCACCTGTAGTCCCA 
VF2468 79 fwd TGGCTTGCAGAGGAGGTGAG VF2468 79 rev CAGGGAAGGGTGTTGGCTTG 
VF2468 80 fwd GCTTCAGCACATCAGTGGCG VF2468 80 rev TTCGCCCAGCTCATCAACAA 
VF2468 81 fwd GGTGAGGCCACTGTAAGCCAA VF2468 81 rev TGGGCTGCCATGACAAACAG 
VF2468 83 fwd GAGTTGAGCTGTCAGCGGGG VF2468 83 rev GAAGCCAACTGCCTTGTGAGC 
VF2468 84 fwd TGTTTTCTGCAGTTTTGCAGGG VF2468 84 rev GGCTCAGGGAGTTTGAGCCA 
VF2468 85 fwd GCTCTGGCACCAGGCACACT VF2468 85 rev GGGAGAGAACCATGAATTTCCCA 
VF2468 86 fwd GCCAAACCCTTTCCAGGGAG VF2468 86 rev CCCACCCTATGCACAGAGCC 
VF2468 87 fwd CCTCAGCCAGTTGGAATCGG VF2468 87 rev CAACGGTTTAGTTTAGTTCCGGTTT 
VF2468 88 fwd TGGGTGGTGAAAATGGGGTT VF2468 88 rev GGTGGGGTATGCACTGGTCA 
VF2468 89 fwd GGAATGTGTGGAACTCAATTTCTTT VF2468 89 rev TTGCTTGCAGGGTGTGGAAA 
VF2468 90 fwd CCACAAGGGTCATCTGGGGA VF2468 90 rev CGGAGGCATCATCCACTGAG 
VF2468 91 fwd CCTGGAGTGGTTTGGCTTCG VF2468 91 rev TGGAGCCCTGGAGTTCTTGG 
VF2468 92 fwd GGCTCCTGGGGTCATTTTCC VF2468 92 rev TGTGCTCCATCCTCCTCCCT 
VF2468 93 fwd GTGTGTTTCCGCACACCCTG VF2468 93 rev GCTCTTGGCTTCCCAACCCT 
VF2468 94 fwd CCATCGCCGTGTCTGAGTGT VF2468 94 rev CAGCAGGAACATCATCCCCC 
VF2468 95 fwd AGGCAATGGCACCAAAATGG VF2468 95 rev GCAGCCTTCACCATACCTGTGA 
VF2468 96 fwd TTTTGACTTTGAGAACCCCCTGA VF2468 96 rev CCTTGTCCTTTCTCAGTTAGACACA 
VF2468 97 fwd GCTGAGTGCAAAGCTCAGGGA VF2468 97 rev GGCAACACAGCAAGACCCCT 
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Zinc-finger nuclease expression and characterization 
3xFLAG-tagged zinc finger proteins for CCR5-224 and VF2468 were expressed as 
fusions to FokI obligate heterodimers (Miller et al., 2007) in mammalian expression vectors 
(Maeder et al., 2008) derived from pMLM290 and pMLM292.  Complete vector sequences are 
available upon request.  2 µg of ZFN-encoding vector was transcribed and translated in vitro 
using the TnT Quick Coupled rabbit reticulocyte system (Promega).  Zinc chloride (Sigma-
Aldrich) was added at 500 µM and the transcription/translation reaction was performed for 2 
hours at 30 °C.  Glycerol was added to a 50% final concentration. Western blots were used to 
visualize protein using the anti-FLAG M2 monoclonal antibody (Sigma-Aldrich).  ZFN 
concentrations were determined by Western blot and comparison with a standard curve of N-
terminal FLAG-tagged bacterial alkaline phosphatase (Sigma-Aldrich). 
 Test substrates for CCR5-224 and VF2468 were constructed by cloning into the 
HindIII/XbaI sites of pUC19.  PCR with primers “test fwd” and “test rev” and Taq DNA 
polymerase yielded a linear 1 kb DNA that could be cleaved by the appropriate ZFN into two 
fragments of sizes ~300 bp and ~700 bp.  Activity profiles for the zinc-finger nucleases were 
obtained by digestion of the 1 µg linear 1 kb DNA with varying amounts of ZFN in 1x NEBuffer 
4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 mM 
dithiothreitol, pH 7.9) for 4 hours at 37 °C.  100 µg of RNase A (Qiagen) was added to the 
reaction for 10 minutes at room temperature to remove RNA from the in vitro 
transcription/translation mixture that could interfere with purification and gel analysis.  
Reactions were purified with the Qiagen PCR Purification Kit and analyzed on 1% TAE-agarose 
gels. 
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In vitro selection 
ZFNs of varying concentrations, an amount of TnT reaction mixture without any protein-
encoding DNA template equivalent to the greatest amount of ZFN used (“lysate”), or 50 units 
PvuI (NEB) were incubated with 1 µg of rolling-circle amplified library for 4 hours at 37 °C in 
1x NEBuffer 4 (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 
mM dithiothreitol, pH 7.9). 100 µg of RNase A (Qiagen) was added to the reaction for 10 
minutes at room temperature to remove RNA from the in vitro transcription/translation mixture 
that could interfere with purification and gel analysis.  Reactions were purified with the Qiagen 
PCR Purification Kit.  1/10 of the reaction mixture was visualized by gel electrophoresis on a 1% 
TAE-agarose gel and staining with SYBR Gold Nucleic Acid Gel Stain (Invitrogen). 
 The purified DNA was blunted with 5 units DNA Polymerase I, Large (Klenow) 
Fragment (NEB) in 1x NEBuffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM 
dithiothreitol, pH 7.9) with 500 µM dNTP mix (Bio-Rad) for 30 minutes at room temperature.  
The reaction mixture was purified with the Qiagen PCR Purification Kit and incubated with 5 
units of Klenow Fragment (3’ exo–) (NEB) for 30 minutes at 37 °C in 1x NEBuffer 2 (50 mM 
NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol, pH 7.9) with 240 µM dATP 
(Promega) in a 50 µL final volume.  10 mM Tris-HCl, pH 8.5 was added to a volume of 90 µL 
and the reaction was incubated for 20 minutes at 75 °C to inactivate the enzyme before cooling 
to 12 °C.  300 fmol of “adapter1/2”, barcoded according to enzyme concentration, or 6 pmol of 
“adapter1/2” for the PvuI digest, were added to the reaction mixture, along with 10 ul 10x NEB 
T4 DNA Ligase Reaction Buffer (500 mM Tris-HCl, 100 mM MgCl2, 100 mM dithiothreitol, 10 
mM ATP).  Adapters were ligated onto the blunt DNA ends with 400 units of T4 DNA ligase at 
room temperature for 17.5 hours and ligated DNA was purified away from unligated adapters 
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with Illustra Microspin S-400 HR sephacryl columns (GE Healthcare).  DNA with ligated 
adapters were amplified by PCR with 2 units of Phusion Hot Start II DNA Polymerase (NEB) 
and 10 pmol each of primers “PE1” and “PE2” in 1x Phusion GC Buffer supplemented with 3% 
DMSO and 1.7 mM MgCl2.  PCR conditions were 98 °C for 3 min, followed by cycles of 98 °C 
for 15 s, 60 °C for 15 s, and 72 °C for 15 s, and a final 5 min extension at 72 °C.  The PCR was 
run for enough cycles (typically 20-30) to see a visible product on gel.  The reactions were 
pooled in equimolar amounts and purified with the Qiagen PCR Purification Kit.  The purified 
DNA was gel purified on a 1% TAE-agarose gel, and submitted to the Harvard Medical School 
Biopolymers Facility for Illumina 36-base paired-end sequencing. 
Data Analysis 
Illumina sequencing reads were analyzed using programs written in C++.  Algorithms are 
described in “Algorithms for Data Analysis” (below), and the source code is available on 
request.  Sequences containing the same barcode on both paired sequences and no positions with 
a quality score of ‘B’ were binned by barcode.  Half-site sequence, overhang and spacer 
sequences, and adjacent randomized positions were determined by positional relationship to 
constant sequences and searching for sequences similar to the designed CCR5-224 and VF2468 
recognition sequences.  These sequences were subjected to a computational selection step for 
complementary, filled-in overhang ends of at least 4 base pairs, corresponding to rolling-circle 
concatemers that had been cleaved at two adjacent and identical sites.  Specificity scores were 
calculated with the formulae: 
 
positive specificity score = (frequency of base pair at position[post-selection]-frequency of base 
pair at position[pre-selection])/(1-frequency of base pair at position[pre-selection]) 
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negative specificity score = (frequency of base pair at position[post-selection]-frequency of base 
pair at position[pre-selection])/(frequency of base pair at position[pre-selection]) 
 
Positive specificity scores reflect base pairs that appear with greater frequency in the post-
selection library than in the starting library at a given position; negative specificity scores reflect 
base pairs that are less frequent in the post-selection library than in the starting library at a given 
position.  A score of +1 indicates an absolute preference, a score of -1 indicates an absolute 
intolerance, and a score of 0 indicates no preference. 
Assay of genome modification at cleavage sites in human cells 
CCR5-224 ZFNs were cloned into a CMV-driven mammalian expression vector in which 
both ZFN monomers were translated from the same mRNA transcript in stoichiometric quantities 
using a self-cleaving T2A peptide sequence similar to a previously described vector (Doyon et 
al., 2008).  This vector also expresses enhanced green fluorescent protein (eGFP) from a PGK 
promoter downstream of the ZFN expression cassette.  An empty vector expressing only eGFP 
was used as a negative control.  
To deliver ZFN expression plasmids into cells, 15 µg of either active CCR5-224 ZFN 
DNA or empty vector DNA were used to Nucleofect 2x106 K562 cells in duplicate reactions 
following the manufacturer’s instructions for Cell Line Nucleofector Kit V (Lonza).  GFP-
positive cells were isolated by FACS 24 hours post-transfection, expanded, and harvested five 
days post-transfection with the QIAamp DNA Blood Mini Kit (Qiagen). 
PCR for 37 potential CCR5-224 substrates and 97 potential VF2468 substrates was 
performed with Phusion DNA Polymerase (NEB) and primers “[ZFN] [#] fwd” and “[ZFN] [#] 
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rev” (Tables 4.8) in 1x Phusion HF Buffer supplemented with 3% DMSO. Primers were 
designed using Primer3 (Rozen and Skaletsky, 2000). The amplified DNA was purified with the 
Qiagen PCR Purification Kit, eluted with 10 mM Tris-HCl, pH 8.5, and quantified by 1K Chip 
on a LabChip GX instrument (Caliper Life Sciences) and combined into separate equimolar 
pools for the catalytically active and empty vector control samples. PCR products were not 
obtained for 3 CCR5 sites and 7 VF2468 sites, which excluded these samples from further 
analysis. Multiplexed Illumina library preparation was performed according to the 
manufacturer’s specifications, except that AMPure XP beads (Agencourt) were used for 
purification following adapter ligation and PCR enrichment steps. Illumina indices 11 
(“GGCTAC”) and 12 (“CTTGTA”) were used for ZFN-treated libraries while indices 4 
(“TGACCA”) and 6 (“GCCAAT”) were used for the empty vector controls.  Library 
concentrations were quantified by KAPA Library Quantification Kit for Illumina Genome 
Analyzer Platform (Kapa Biosystems).  Equal amounts of the barcoded libraries derived from 
active- and empty vector- treated cells were diluted to 10 nM and subjected to single read 
sequencing on an Illumina HiSeq 2000 at the FAS Center for Systems Biology Core facility 
(Cambridge, MA). 
Statistical analysis 
In Tables 4.3 and 4.7, p-values were calculated for a one-sided test of the difference in 
the proportions of sequences with insertions or deletions from the active CCR5-224 sample and 
the empty vector control samples. The t-statistic was calculated as t = (p_hat1 - p_hat2) / 
sqrt((p_hat1  (1 - p_hat1) / n1)  (p_hat2  (1 - p_hat2) / n2)),where p_hat1 and n1 are the 
proportion and total number, respectively, of sequences from the active sample and p_hat2 and n2 
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are the proportion and total number, respectively, of sequences from the empty vector control 
sample. 
Plots 
All heat maps were generated in the R software package with the following command: 
image([variable], zlim = c(-1,1), col = 
colorRampPalette(c("red","white","blue"),space="Lab")(2500) 
 
Algorithms for Data Analysis 
Quality score filtering and sequence binning 
1) search each position of both pairs of sequencing read for quality score, reject if any 
position has quality score = ‘B’  
2) output to separate files all sequence reads where the first sequence in the pair start with 
barcodes ("AAT", "ATA", "TAA", "CAC","TCG") and count the number of sequences 
corresponding to each barcode 
Filtering by ZFN (“AAT”,“ATA”,“TAA”,“CAC”) 
For each binned file, 
1) accept only sequence pairs where both sequences in the pair start with the same barcode 
2) identify orientation of sequence read by searching for constant regions 
- orientation 1 is identified by the constant region "CGATCGTTGG" 
- orientation 2 is identified by the constant region  "CAGTGGAACG" 
3) search sequences from position 4 (after the barcode) up to the first position in the 
constant region for the subsequence that has the fewest mutations compared to the CCR5-
224 and VF2468 half-site that corresponds to the identified constant region 
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- search sequences with orientation 1 for "GATGAGGATGAC" (CCR5-224(+)) and 
"GACGCTGCT" (VF2468(-)) 
- search sequences with orientation 2 for "AAACTGCAAAAG" (CCR5-224(-)) and 
"GAGTGAGGA" (VF2468(+)) 
4) bin sequences as CCR5-224 or VF2468 by testing for the fewest mutations across both 
half-sites 
5) the positions of the half-sites and constant sequences are used to determine the 
overhang/spacer sequences, the flanking nucleotide sequences, and the tag sequences 
- the subsequence between the half-site of orientation 1 and the constant region is 
the tag sequence 
o if there is no tag sequence, the tag sequence is denoted by ‘X’ 
- the overhang sequence is determined by searching for the longest reverse-
complementary subsequences between the subsequences of orientation 1 and 
orientation 2 that start after the barcodes 
- the spacer sequence is determined by concatenating the reverse complement of 
the subsequence in orientation 1 that is between the overhang and the half-site  (if 
any), the overhang, and the subsequence in orientation 2 that is between the 
overhang and the half-site 
o if there is overlap between the overhang and half-site, only the non-
overlapping subsequence present in the overhang is counted as part of the 
spacer 
6) to remove duplicate sequences, sort each sequence pair into a tree 
- each level of the tree corresponds to a position in the sequence 
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- each node at each level corresponds to a particular base (A, C, G, T, or X = not(A, 
C, G, or T)) and points to the base of the next position (A,C,G,T,X) 
- the sequence pairs are encoded in the nodes and a subsequence consisting of the 
concatenation of the spacer sequence, flanking nucleotide sequence, and tag 
sequence is sorted in the tree 
- at the terminal nodes of the tree, each newly entered sequence is compared to all 
other sequences in the node to avoid duplication 
7) the contents of the tree are recursively outputted into separate files based on barcode and 
ZFN 
Library filtering (“TCG”) 
1) accept only sequence pairs where both sequences in the pair start with the same barcode 
2) analyze the sequence pair that does not contain the sequence 
"TCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGAC" (the other pair contains 
the library sequence) 
3) search sequences for ZFN half-sites and bin by the ZFN site that has fewer mutations 
- search for "GTCATCCTCATC" and "AAACTGCAAAAG" (CCR5-224) and 
"AGCAGCGTC" and "GAGTGAGGA" (VF2468) 
4) identify the spacer, flanking nucleotide, and nucleotide tag sequences based on the 
locations of the half-sites 
5) use the tree algorithm in step 6 under “Filtering by ZFN” to eliminate duplicate 
sequences 
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Sequence profiles 
1) analyze only sequences that contain no ‘N’ positions and have spacer lengths between 4 
and 7 
2) tabulate the total number of mutations, the spacer length, the overhang length, the 
nucleotide frequencies for the (+) and (-) half-sites, the nucleotide frequencies for spacers 
that are 4 bp, 5 bp, 6 bp, and 7 bp long, and the nucleotide frequencies for the flanking 
nucleotide and the tag sequence 
3) repeat steps 1 and 2 for library sequences 
4) calculate specificity scores at each position using positive specificity score = (frequency 
of base pair at position[post-selection]-frequency of base pair at position[pre-
selection])/(1-frequency of base pair at position[pre-selection]) negative specificity score 
= (frequency of base pair at position[post-selection]-frequency of base pair at 
position[pre-selection])/(frequency of base pair at position[pre-selection]) 
Genomic matches 
1) the human genome sequence was searched with 24 and 25 base windows (CCR5-224) 
and 18 and 19 base windows (VF2468) for all sites within nine mutations (CCR5-224) or 
six mutations (VF2468) of the canonical target site with all spacer sequences of five or 
six bases being accepted 
2) each post-selection sequence was compared to the set of genomic sequences within nine 
and six mutations of CCR5-224 and VF2468, respectively 
Enrichment factors for sequences with 0, 1, 2, or 3 mutations 
1) for each sequence, divide the frequency of occurrence in the post-selection library by the 
frequency of occurrence in the pre-selection library 
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Filtered sequence profiles 
1) use the algorithm described above in “Sequence profiles”, except in addition, only 
analyze sequences with off-target bases at given positions for both pre- and post-selection 
data 
Compensation difference map 
1) use “Filtered sequence profiles” algorithm for mutation at every position in both half-
sites 
2) calculate: (specificity score) = filtered specificity score – non-filtered specificity score 
NHEJ search 
1) identify the site by searching for exact flanking sequences 
2) count the number of inserted or deleted bases by comparing the length of the calculated 
site to the length of the expected site and by searching for similarity to the unmodified 
target site (sequences with 5 or fewer mutations compared to the intended site were 
counted as unmodified) 
3) inspect all sites other than CCR5, CCR2, and VEGF-A promoter by hand to identify true 
insertions or deletions 
  
125 
 
 
 
Chapter Five 
 
 
Discussion and Conclusions 
 
 
 The landscape of the genome engineering field has been altered rapidly in the last few 
years. Interest both from protein engineers and investigators eager to modify model organisms 
and cells has converged not only to expand the repertoire of tools available for these efforts, but 
also to open the floodgates for elegant demonstrations of the efficiency with which virtually any 
genetic alteration—once thought impossible—can be carried out in record time. 
  The thesis author presents the findings of this dissertation in the context of their impact 
to the field and offers perspectives on future directions for study. 
 
Modular Assembly—The Next Generation 
 The publication presented in Chapter 2 was met mostly with appreciation from members 
of the scientific community who had experienced previously unexplained frustration with 
making functional zinc finger proteins by modular assembly (Ramirez et al., 2008). As has been 
reiterated elsewhere (Joung et al., 2010), this is not to say that it is not possible to generate an 
active ZFN pair by modular assembly; nevertheless, given other options available for 
engineering ZFNs, this method offers at best a low probability of success even with GNN-rich 
target sites, severely limiting the targeting range and thus the broad applicability of this 
approach. Interestingly, despite some resistance to accept the validity of our findings from 
certain groups, their studies claiming to refute our conclusions in fact offer further support upon 
closer inspection: in another large-scale study of modular assembly, Kim and colleagues reported 
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that ~93% (294 of 315) of ZFN pairs failed to show activity in a human cell-based reporter 
assay, which is comparable to the ~94% ZFN failure rate predicted by Ramirez & Foley et al. 
(Ramirez et al., 2008, Kim et al., 2009, Joung et al., 2010, Kim et al., 2010).  
A subset of the proteins described in Ramirez & Foley et al. were examined further by 
Hughes and colleagues (Lam et al., 2011). It was determined that these modularly assembled 
proteins resemble natural transcription factors in that they exhibit degenerate binding preferences 
in protein-binding microarray assays, sometimes without showing strong specificity for their 
intended 9 base pair target. Although this reasoning may help to explain why these proteins 
failed, it is clear from direct comparisons between modularly assembled proteins and those 
derived from context-dependent selection methods that the limited specificity and high failure 
rates of modularly assembled proteins in living cells are not a general property of all engineered 
zinc finger nucleases (Maeder et al., 2008, Sander et al., 2011b). 
 Substantial zinc finger engineering advances accessible to the scientific community have 
been made available in the intervening time since the publication of Ramirez & Foley et al., 
including Oligomerized Pool Engineering (OPEN) (Maeder et al., 2008) and Context-Dependent 
Assembly (CoDA) (Sander et al., 2011b). Described in more detail in Chapter 1, OPEN is a 
simplified context-dependent selection strategy for engineering three-finger arrays with a high 
success rate (~67%) as ZFNs in zebrafish, plant, and human cells (Maeder et al., 2008, Maeder et 
al., 2009).  
A derivative of OPEN, Context-Dependent Assembly (CoDA) is a simpler method from 
a technical standpoint than modular assembly, yet it accounts for context-dependence of zinc 
fingers in a multi-finger array and has a much higher success rate (Sander et al., 2011b). Using 
data from dozens of OPEN selections, a subset of 18 “middle” fingers from selected three-finger 
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zinc finger arrays were found to appear in multiple protein contexts. ZFNs made by CoDA 
exhibit gene disruption rates of >50% reported by our group in zebrafish and plants (Sander et 
al., 2011b) and others in human cells (Osborn et al., 2011). The targeting range of this method is 
about 1 in 500 bp of random DNA sequence. The ease with which CoDA can be practiced and its 
higher success rate in direct comparisons with modularly assembled proteins (Sander et al., 
2011b) support its recommendation over modular assembly for rapidly generating functional 
ZFNs (Segal, 2011). 
 These and other advances in ZFN nuclease engineering technologies provided a 
conceptual and experimental foundation for an even faster genesis of targeted nucleases 
amenable to a modular assembly-like design approach—Transcription Activator-Like Effector 
Nucleases (TALENs), fusions of TALE DNA-binding domains and the FokI nuclease domain 
that also function as dimers (Cermak et al., 2011, Huang et al., 2011, Miller et al., 2011, Sander 
et al., 2011a). Derived from highly repetitive proteins originally isolated from Xanthomonas, 
TALENs have emerged as strong competitors to ZFNs, due to both simplicity of design as well 
as generally having high activity in living cells (Clark et al., 2011). The sequence recognition 
elements of TALENs are small (33-35 amino acid) repeat domains that each confer binding 
specificity to one base of DNA, which is determined by the composition of hypervariable 
residues at positions 12 and 13, collectively known as repeat variable diresidues (RVDs) (Boch 
et al., 2009, Moscou and Bogdanove, 2009). TALE proteins with various numbers of repeat 
domains can be assembled rapidly (Cermak et al., 2011, Sander et al., 2011c) and have been 
shown to bind DNA effectively, with naturally occurring TALEs having about 18 repeats (Boch 
et al., 2009, Miller et al., 2011). 
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Although TALENs do generally have high success rates, the suggestion has been made in 
the literature that they may not always work, begging the question of what other parameters 
might affect activity. One possibility recently revealed by structural models is that TAL binding 
may be affected by DNA methylation (Deng et al., 2012, Mak et al., 2012). Functional studies 
support the notion that epigenetic modifications may affect TALEN binding in a cellular context 
(Bultmann et al., 2012). It has also been hypothesized that ZFNs may be similarly influenced by 
regions of heterochromatin and DNA methylation (Liu et al., 2001, Maeder et al., 2008); it will 
be interesting to see whether it is possible to design around these targeting limitations if needed 
using either platform. Yet another possibility is that the seemingly uniform TAL repeat domains 
have some subtle context-dependence or that certain module configurations can affect the 
strength of DNA binding affinity for the protein as a whole.   
Additional questions remain in determining whether TALENs might entirely replace 
ZFNs for future applications, including whether TALENs would elicit an immune response if 
delivered systemically to higher organisms. Having been derived from a bacterial source and 
being much larger proteins than ZFNs, immune rejection may be more of a risk with TALENs 
than with ZFNs, which bear zinc finger motifs similar to those commonly found in transcription 
factors. Fortunately, many therapeutic strategies rely upon ex vivo treatment of cells and their 
subsequent reintroduction into the patient, so it is possible the transient expression of nucleases 
may not be a significant concern in these instances.  
Another point to consider is how specifically TALENs recognize their intended binding 
sites at the exclusion of other sites. Particularly considering their long binding sites, extensive 
studies have not yet been performed on the number of mismatches that can be tolerated per 
monomer, assuming there might be a general trend that can be discerned. Initial efforts to 
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characterize the specificity of TALENs have been attempted (Hockemeyer et al., 2011, Miller et 
al., 2011, Wood et al., 2011), yet little is known about the degenerate sequence preferences of 
TALEN dimers; as was determined for ZFNs, current methods based on monomer binding 
assays may not be able to accurately predict the full range of potential off-target sites for TALEN 
pairs (Pattanayak et al., 2011). The dimeric nuclease selection described in Chapter 4 could 
conceivably be adapted for analysis of TALENs and may provide insights on the effects of 
cooperative binding that cannot be discerned from monomer binding data (Pattanayak et al., 
2011).  
Despite these open questions, it does seem in the short-term as though TALENs are a 
solid first-line option for generating targeted mutations in model organisms and cell lines due in 
large part to the simplicity with which novel proteins can be synthesized, the great amount of 
design flexibility their extensive targeting range provides, and the generally high success rates of 
these nucleases. 
 
 
Engineering Genomes with Nickases 
 Engineered ZFNickases have been shown in most cases to promote higher rates of HDR 
relative to NHEJ in human cell reporter assays, but absolute rates of HDR are 2- to >100-fold 
lower than with nucleases (Ramirez et al., 2012). Soon after the publication of this work, 
evidence that ZFN-derived nicking enzymes can mediate gene correction at endogenous loci was 
reported (Kim et al., 2012, Wang et al., 2012). Despite their lower HDR rates relative to 
nucleases, the lower genotoxicity of ZFNickases is a promising indicator that they ought to be 
further optimized for therapeutic, basic research, or biotechnology applications. Other 
approaches including S/G2 cell cycle arrest with vinblastine (Urnov et al., 2005, Maeder et al., 
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2008) and nocodazole (Olsen et al., 2010) have been shown to dramatically increase gene 
targeting efficiencies up to ~50% in cell culture models, in some cases driving HDR rates to 
exceed NHEJ rates; however, the trade-off for this benefit is even higher NHEJ rates relative to 
ZFN-treated cells not under arrest and much higher cell death. An important consideration is that 
treating humans with cytostatic drugs may limit the feasibility of a therapeutic strategy if there 
are significant side-effects associated with treatment. If this is the case, then nickases may be a 
more benign option to consider for downstream gene correction applications. Through the use of 
cytostatic drugs, nickases, or other approaches, it is critical to raise absolute HDR rates to 
therapeutically relevant levels while maintaining an acceptably low risk-to-benefit ratio for the 
patient. 
 There are several approaches that could be used to improve nickase activity. The most 
apparent is to use the newly-described optimized heterodimer ELD:KKR domains, which have 
been shown to increase cleavage activity and reduce the probability of homodimerization (Doyon 
et al., 2011). In addition, hyperactive FokI mutants compatible with this framework could be 
tested to attain more robust gene targeting rates (Guo et al., 2010). There is evidence to suggest 
that simultaneous nicks on both the repair target and donor may lead to significantly higher 
levels of gene conversion, so it is possible that increasing the nicking activity of ZFNickases may 
provide a non-linear improvements in rates of repair (Goncalves et al., 2011). An alternative 
approach to higher HDR rates would be to treat cells with drugs that inhibit nick repair (e.g. 
PARP-1 inhibitors), which could potentially allow for repair through other mechanisms, 
including HDR of the single-strand break or repair of a double strand break derived from a nick 
in the path of a replication fork (Bouchard et al., 2003). As HDR is most active in dividing cells 
during the S and G2 phases of the cell cycle to counteract damage associated with DNA 
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replication, converting nicks to double-strand breaks during this period could potentially 
leverage favorable cellular conditions toward the desired repair pathway (Takata et al., 1998, 
Mao et al., 2008, Hartlerode et al., 2011). There are currently PARP-1 inhibitors in clinical trials, 
so it is conceivable they could be used in combination with nickases for a future therapeutic 
strategy if they were found to be effective in preliminary experiments (Sessa, 2011). 
It remains to be seen whether TAL nickases can be produced by the same method as 
ZFNickases. The relatively confined and reproducible cleavage patterns of ZFNs (which 
consistently leave 4-5 bp overhangs) is substantially different from the varied cleavage patterns 
of TALENs and the wide range of spacers between TALEN half-sites that can be tolerated. It has 
been demonstrated that certain TALEN architectures have more rigid spacing requirements than 
others, so it may be wisest to start with the former to avoid the risk of inadvertently cutting both 
strands despite only having one active subunit for cleavage (Miller et al., 2011). If it is not 
possible to create reliable TALEN-derived nickases, then this may be a unique engineering 
advantage that ZFNs have over TALENs. 
 
Defining ZFN Specificity: A Work in Progress 
  A study with a complementary approach to examining off-target cleavage sites of ZFNs 
also appeared in print (Gabriel et al., 2011) at the same time as our manuscript presented in 
Chapter 3 was published (Pattanayak et al., 2011). In contrast to our method, in which an in vitro 
selection was used to identify potential off-target sites in ZFN-treated cells, the strategy of 
Gabriel & Lombardo et al. relied upon the integration of a GFP-encoding integration-deficient 
lentiviral vector at double-strand break sites in living cells; these breaks would include cleavage 
at the intended CCR5 locus, off-target break sites, or other loci subject to ZFN-independent 
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double-strand breaks, likely as a natural consequence of normal cellular processes such as 
replication fork collapse during cell division. 
It is striking that our study and the von Kalle study identified non-overlapping novel off-
target sites for the CCR5 224 ZFNs being used in clinical trials (Cheng et al., 2011). One 
possible explanation is that the sensitivity levels for both assays are different. In the lentiviral 
integration method, at least two independent integration events within 500 bp are required to flag 
a locus as a potential ZFN target. As most of the double-strand breaks are likely to occur at the 
CCR5 or CCR2 loci or at non-specific locations in the genome that can vary with each cell 
division cycle, this leaves proportionally only a small fraction of the dataset’s capacity to 
identify infrequent off-target cleavage events, probably biasing signal detection toward more 
frequently represented sites. This is the probable explanation for why the in vitro selection 
system successfully identified off-target sites below the detection limit of the lentiviral assay.  
On the other hand, two drawbacks of the in vitro selection method are that all of the 
sequence space of the library cannot be sampled and only sites in the human genome directly 
derived from the selection were chosen for validation in human cells. For a subsequent iteration 
of this method, it would likely be fruitful to use the results of the in vitro selection to 
computationally predict additional off-target sites, as in its current state, the selection approach 
misses several key off-target sites that were frequent enough to appear in the lentiviral 
integration assay. Another way to improve on the in vitro selection method would be to construct 
a library from genomic DNA of the cell type of interest rather than use a combinatorial library of 
degenerate oligonucleotides. This would greatly reduce the theoretical library size and 
potentially allow for much more sensitive detection of off-target sites. 
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Moving forward, it is likely that combinations of approaches will be required to 
determine ZFN off-target cleavage specificity as extensively as possible. Without any significant 
adaptation, the lentiviral integration method may be better suited for determining off-target 
specificity of TALENs, as their long binding sites would even further limit the sampling of 
sufficient sequence space in the in vitro selection method. Alternatively, with deep sequencing 
prices continuing to drop and data yield continuing to grow, there may come a day when 
sequencing genomes of clonal cell populations may be a less tedious and costly than performing 
indirect methods to predict off-target sites. However, for approaches in which populations of 
patient cells need to be modified (and in which very low frequency but potentially deleterious 
off-target events may occur), approaches including those described herein may be necessary well 
into the future. 
 
Closing Thoughts 
 We have demonstrated in this dissertation that modular assembly has significant 
limitations for generating functional ZFNs for genome engineering applications; the principle of 
this approach may be better suited for TALENs, whose modular recognition domains may lack 
substantial context-dependence.  
Our method for generating zinc finger nickases provides a new tool for stimulating gene 
conversion preferentially over gene disruption, although additional work must be done to 
increase absolute gene conversion rates; it is not clear yet whether it is possible to generate TAL-
derived nickases using a similar strategy.  
We have also developed and validated a strategy for identifying ZFN off-target sites in 
human cells based on an in vitro selection assay. If the combinatorial library for this selection 
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can be adapted to be made from genomic DNA instead of degenerate oligonucleotides, it may be 
possible to sample the cleavage specificities of TALEN dimers in great detail using this method. 
Taken together, these approaches represent our efforts to build on the rich legacy of zinc 
finger technology development strategies to move the genome engineering field ever toward the 
most straightforward, effective, and safe methods for modifying genomes of model organisms 
and human patients. 
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Abstract 
Eukaryotic transcription factors (TFs) perform a variety of complex and combinatorial 
functions within transcriptional networks. Here we present a synthetic framework for 
systematically constructing eukaryotic transcription functions by building from artificial zinc 
fingers, modular DNA-binding domains found within many eukaryotic TFs. Utilizing this 
platform, we construct a library of orthogonal synthetic transcription factor (sTF)-promoter pairs, 
and use these to wire synthetic transcriptional circuits in yeast. We design and interrogate 
complex functions, such as tunable output strength and transcriptional cooperativity, by 
rationally engineering a small, decomposed set of key component properties, e.g., DNA 
specificity, affinity, promoter design, protein-protein interactions. We show that subtle 
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perturbations to these properties can transform an individual sTF between distinct roles 
(activator, cooperative factor, inhibitory factor) within a transcriptional complex, thus drastically 
altering the signal processing behavior of multi-input systems. This platform provides new 
genetic components for synthetic biology, and enables bottom-up approaches to understanding 
the design principles of eukaryotic transcriptional complexes and networks.  
 
Introduction 
The genetic program of a living cell is governed by the faithful execution of a number of 
fundamental molecular functions by transcription factors (TFs). These include wiring specific 
connections to promoter regulatory elements, modulating the transcriptional output of a gene, 
tuning molecular noise, recruiting coactivator/repressor complexes and basal transcriptional 
machinery, cooperating with other TFs to regulate a gene, integrating an array of environmental 
signals, and even physically manipulating the geometrical configuration of chromosomes 
(Ptashne, 1986, Ptashne, 1988, Pedraza and van Oudenaarden, 2005, Rosenfeld et al., 2005, 
Hahn and Young, 2011). A tremendous amount of progress has been made toward understanding 
eukaryotic transcriptional regulation. Yet, there is still much to be learned about how eukaryotic 
TFs accomplish their fundamental tasks to bring about higher-order transcriptional behaviors 
(Hahn and Young, 2011). A synthetic approach, whereby minimal and insulated components and 
circuitry can be constructed to recapitulate eukaryotic transcription functions, would be valuable 
for studying how transcriptional regulatory complexes are assembled and how TFs are wired into 
networks. 
A framework for eukaryotic transcription regulation would also be broadly valuable to 
synthetic biology efforts, which seek to uncover the design principles of gene regulatory 
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networks and program novel biological functions for a range of biotechnological and industrial 
applications  (Elowitz and Leibler, 2000, Gardner et al., 2000, Hasty et al., 2002, Kramer et al., 
2004b, Levskaya et al., 2005, Andrianantoandro et al., 2006, Ajo-Franklin et al., 2007, Bashor et 
al., 2008, Stricker et al., 2008, Win and Smolke, 2008, Mukherji and van Oudenaarden, 2009, 
Tigges et al., 2009, Bashor et al., 2010, Khalil and Collins, 2010, Lim, 2010, Tamsir et al., 
2011). Transcriptional circuitry has been a major focus of the field dating back to its origins, and 
has been used to implement a variety of genetic behaviors, including memory, oscillations, logic 
operations, filtering, and noise propagation (Becskei and Serrano, 2000, Elowitz and Leibler, 
2000, Gardner et al., 2000, Guet et al., 2002, Yokobayashi et al., 2002, Pedraza and van 
Oudenaarden, 2005, Rosenfeld et al., 2005). In these and virtually all other synthetic studies, 
small motifs and circuits have been constructed with a few, classical prokaryotic TFs; these “off-
the-shelf parts” represent the extent of well-understood, reliable, and accessible transcriptional 
components. To date, the synthetic construction of transcriptional networks in eukaryotes has 
relied heavily upon these same, few bacterial TF-promoter pairs (Lu et al., 2009, Weber and 
Fussenegger, 2009).  
This approach of porting bacterial transcriptional components has certain advantages. 
Bacterial TFs perform relatively simple transcriptional tasks (as compared with eukaryotic TFs), 
and therefore assembling and programming with them can be straightforward. Yet, for this 
reason and because they regulate transcription in fundamentally different ways than their 
eukaryotic counterparts, they are a poor starting point for engineering the complex 
transcriptional functions enumerated above. Furthermore, bacterial transcriptional components 
are severely limiting with respect to extensibility – they have been designed to bind a specific 
target and have integrated and coupled properties. This requires re-engineering schemes, such as 
139 
 
directed evolution, to generate an expanded set of components, connectivity, and behaviors. As a 
result, the use of bacterial transcriptional components is unlikely to scale to the more 
sophisticated circuitry needed for engineering higher-order behaviors.  
 We present an alternative approach to synthetic transcriptional components, control, and 
circuitry in eukaryotes. We model our framework on the functional subcomponents that enable 
eukaryotic TFs to bind DNA, activate/repress transcriptional machinery, bind other factors, etc. 
By deconstructing into these molecular subcomponents, we aim to create a modular decomposed 
design of a TF. Our design is based on zinc finger domains. TFs of virtually all eukaryotic taxa 
utilize Cys2-His2 zinc finger (ZF) domains to solve the combinatorial problem of DNA 
recognition and discrimination (Pabo et al., 2001). ZFs are small (~30 amino acid) domains that 
bind to approximately three bps of DNA (Pavletich and Pabo, 1991, Elrod-Erickson et al., 1998), 
and operate in tandem or in combination to dictate DNA specificity. Recent advances in ZF 
engineering have made it possible to purposefully re-engineer ZF DNA-binding specificities to 
recognize a wide variety of sequences and to covalently link them together into artificial, multi-
finger arrays capable of recognizing longer DNA sequences (Pabo et al., 2001, Beerli and 
Barbas, 2002, Jamieson et al., 2003, Maeder et al., 2008, Maeder et al., 2009, Sander et al., 
2011b). Notably, with Oligomerized Pool ENgineering (OPEN) (Maeder et al., 2008, Maeder et 
al., 2009) and other “context-dependent” engineering methods (Sander et al., 2011b), customized 
multi-finger arrays have been successfully generated with the predominant purpose of designing 
ZF nucleases (ZFNs) for targeted gene and genome modification (Maeder et al., 2008, Foley et 
al., 2009b, Townsend et al., 2009, Zou et al., 2009, Sebastiano et al., 2011).   
The sequence-specific recognition of DNA elements by TFs is central to the initiation 
and regulation of transcription. The protein-DNA interaction specificity is therefore the core 
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component property that we wish to control as the basis for engineering synthetic transcriptional 
elements and circuitry. As ZFs represent modular domains underlying the structure-function of 
many eukaryotic TFs and versatile scaffolds for rational engineering, we sought to use artificial 
ZF domains as basic building blocks for eukaryotic synthetic transcription factors (sTFs) and 
gene circuitry. This allows us to generate libraries of interaction partners (artificial ZF proteins 
and target binding sites), and subsequently engineer components to meet functional criteria, such 
as activity within circuits and orthogonality from other synthetic components and native host 
machinery. Using this extensible platform, we construct a library of specific and orthogonal sTF-
promoter pairs, and demonstrate that these pairs can be used to wire synthetic transcriptional 
cascades in Saccharomyces cerevisiae.  
Constructing from artificial ZF domains enables a fully decomposed design of a sTF, in 
which the molecular component properties are accessible, modular, and tunable (Figure A1.1). 
We find that a few, key component properties made accessible by this decomposed design, e.g., 
DNA specificity, DNA affinity, promoter-operator design, protein interactions, can be rationally 
and independently adjusted to engineer complex transcriptional functions and behaviors (Figure 
A1.1). For example, we demonstrate the tuning of transcriptional output through the perturbation 
of multiple properties, notably generating weakly-activating sTFs by lowering the non-specific 
DNA affinity of a ZF. We engineer cooperative transcriptional systems by multimerizing the 
weakly-activating monomers using a modular protein-protein interaction. Finally, we construct a 
simple two-input promoter that recruits two individual sTFs to synthetically explore 
transcriptional signal integration. By systematically altering the architecture of the complex, 
through subtle changes to the sTF component properties, we can assign entirely different 
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transcriptional roles to an individual sTF and thus dramatically alter the signal processing output 
of the system.  
 
Results 
Wiring Specific and Orthogonal Transcriptional Connections with a Library of Synthetic TF-
Promoter Pairs 
Transcriptional networks, natural and synthetic, are wired together with sequence-
specific protein-DNA interactions. We sought to program DNA-binding specificity, via artificial 
ZF proteins, in order to wire specific and orthogonal transcriptional connections in the eukaryote, 
S. cerevisiae. To do so, we first devised a platform by which ZF-based sTFs could be readily 
constructed and customized. The platform consists of a cassette, into which artificial three-finger 
arrays with engineered specificities are inserted to generate sTF species. The sTF cassette is 
paired with a synthetic promoter bearing ZF binding sequences that act as operators for the sTFs 
(Figure A1.2a).  
Transcriptional activation is one of the most common mechanisms for the control of gene 
regulation and appears to be a universally conserved process in all eukaryotes, from fungi to 
metazoans (Fischer et al., 1988, Ma et al., 1988, Ma and Ptashne, 1988, Webster et al., 1988). 
We utilized the principle of activation by recruitment (Ma and Ptashne, 1988, Ptashne, 1988, 
Ptashne and Gann, 1997) to test our sTFs as minimal transcriptional activators. In our design, the 
engineered ZF array recapitulates the TF function of binding to a specific DNA site, in this case, 
to its cognate 9 bp operator in a synthetic promoter. The ZF protein is fused to a VP16 minimal 
activation domain (AD), which autonomously facilitates recruitment of the RNA polymerase II 
machinery for mRNA initiation (Ptashne, 1988). This scheme provides a decoupled, modular 
 Figure A
(a) Circu
expressed
by a cass
VP16 mi
induction
with ZF b
fluoresce
(b) sTF a
synthetic
values fo
1.2: Artific
it design for
 from an A
ette, into wh
nimal activa
, sTFs opera
inding sequ
nt protein (y
ctivator circ
 promoters i
r three expe
ial ZFs can
 synthetic tr
Tc-inducible
ich artificia
tion domain
te on cogna
ences direct
EGFP)).  
uits built fro
n a dose-dep
riments ± st
 be used to 
anscriptiona
 GAL1 prom
l ZF arrays 
 (AD) and a
te synthetic
ly upstream
m artificial 
endent fash
andard devia
143 
construct s
l cascade. S
oter (pGAL
are inserted 
 nuclear loc
 promoters: 
 of the TAT
ZF arrays a
ion (ZF 37-
tion.  
ynthetic tra
ynthetic tran
1). sTF min
to generate 
alization seq
minimal CY
A box (repo
ctivate trans
12 shown he
nscriptiona
scription fa
imal activat
fusions to a 
uence (NLS
C1 promote
rter: yeast-e
cription from
re). Points 
l activators
ctors (sTFs)
ors are enco
herpes simp
). Upon 
r engineered
nhanced gre
 cognate 
represent me
 
 
 are 
ded 
lex 
 
en 
an 
144 
 
approach to transcriptional activation, whereby TFs and the initiation machinery can be 
synthetically recruited in combinatorial ways. From these components, we constructed a 
synthetic transcriptional cascade and used it as a test bed for rationally customizing the 
properties of our transcriptional components to program in vivo behaviors; we chromosomally 
integrated the circuit into S. cerevisiae (Figure A1.2a). Within the circuit, sTF activators are first 
transcribed from a previously described TetR-controlled GAL1 promoter (Murphy et al., 2007, 
Ellis et al., 2009), which is induced by anhydrotetracycline (ATc). Addition of ATc activates 
flux through the circuit to produce sTF activators, which in turn activate downstream 
transcription from cognate synthetic promoters to produce yEGFP expression (Figure A1.2b; 
Supplementary Figure A1.1). The resulting gene regulatory transfer function, which combines 
the effects of the TetR expression system and the operation of sTFs on their synthetic promoters, 
exhibits monotonic, dose-dependent production of yEGFP (Figure A1.2b). These results suggest 
that desired synthetic transcriptional connections can be made based on the specificity of 
engineered ZF proteins to their target sites.  
With the OPEN selection system, we furthermore have the ability to rapidly alter the ZF-
DNA interaction specificity to create a large library of interaction partners (i.e., engineered ZF 
proteins and corresponding target sites). We used artificial ZF arrays constructed by OPEN to 
generate a library of sTF-promoter pairs. In particular, we identified 19 three-finger arrays with 
binding specificities predicted to be orthogonal to one another (we predominately chose OPEN 
ZF arrays that had been engineered to bind sequences in orthologous genes found in plants, 
insects, and metazoans) (Figure A1.3a). The artificial arrays and cognate binding sequences were 
inserted into our framework, and the resulting library of sTF-promoter pairs were tested for 
activation by triggering our synthetic circuits. We found that the sTFs activated yEGFP 
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expression from cognate promoters by factors of 1.3–6.6 (compared to uninduced cells) (Figure 
A1.3b), showing that we could indeed make sequence-specific transcriptional connections with 
artificially designed ZF arrays. Notably, yEGFP expression levels in uninduced cells were 
mostly found to be similar to the basal expression levels of cells harboring only synthetic 
promoters (Supplementary Figure A1.2). Thus, in general, a signal was produced only when we 
induced expression of an sTF in the presence of a cognate promoter. 
 We next investigated whether the transcriptional connections made within our library of 
sTFs were indeed specific only to their cognate synthetic promoters. We selected a subset of 6 
sTFs from our library that exhibited robust activation (> 2.5-fold) (Figure A1.3b, red stars), and 
crossed them with each of the other non-cognate promoters. Upon triggering the circuit, we 
observed no cross-activation in the subset of tested sTFs (Figure A1.3c) with one notable 
exception: the effect of sTF43-8 on Promoter21-16. Examination of the sequence just downstream 
of the ZF operator for Promoter21-16 revealed the fortuitous creation of a sequence possessing 
significant similarity to the binding sequence of 43-8 (at 8 out of 9 bp) (Figure A1.3a, blue 
boxes). Thus, we attribute the observed cross-activation to the presence of this binding sequence 
within the non-cognate promoter. Overall, these results show that synthetic transcriptional 
connections can be designed to be orthogonal to one another by using the OPEN method to 
engineer the DNA-binding specificities of ZF arrays.  
 In the design of synthetic elements and gene circuitry, a further ‘orthogonality’ criterion 
is the degree to which the synthetic system interacts with pathways and machinery native to the 
cellular host. Ideally, insulated networks would interact with host pathways only at desired nodes 
and otherwise function independently. Using our synthetic yeast platform, we investigated one 
potential and rapid method for assessing sTF-host interactions. Specifically, we measured the
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Figure A1.3: Wiring a library of specific and orthogonal transcriptional connections with 
engineered ZF arrays 
(a) sTF-promoter pair library sequences. Amino acid residues of the recognition helices for the 
19 OPEN-engineered three-finger arrays, and corresponding DNA binding sequences (ZF 
binding sequences were inserted between EcoRI and BamHI sites within synthetic promoters). 
(b) sTFs activate transcription from cognate synthetic promoters. “Fold activation” values were 
calculated as the ratio of fluorescence values from induced cells (500 ng/mL ATc) to those from 
uninduced cell. Red stars denote the subset of 6 sTF-promoter pairs chosen to test for 
orthogonality.  
(c) sTFs constructed from OPEN-engineered ZFs are orthogonal to one another. sTF43-8 activated 
non-cognate Promoter21-16 due to the fortuitous creation of a sequence that is significantly similar 
to the binding sequence of 43-8, when the downstream BamHI restriction site is considered (a, 
blue boxes).  
(d) Fitness cost of sTF expression on host cell growth at 30 h after circuit induction (“No ZF” = 
strain integrated with synthetic promoter and sTF cassette lacking a ZF array). Error bars 
represent standard deviation of three experiments. 
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growth of cells with and without the induction of sTFs, under the assumption that unwanted 
interactions with the host genome would impose a fitness cost on the cells. We observed no 
adverse or modest effects on growth in the great majority of sTFs from our library (Figure 
A1.3d, Supplementary Figure A1.3). Our scheme may thus represent a starting point for 
designing and screening sTFs with optimal functionality and orthogonality within a desired host.  
These results show that engineered ZF arrays are effective building blocks for minimal 
sTF activators, and that DNA interaction specificity is a component property that can be 
programmed to mediate the construction of specific and orthogonal, synthetic transcriptional 
connections in yeast. Moreover, largely through this ability to engineer DNA specificity for 
many interaction partners, our platform is able to make meaningful predictions about 
orthogonality (among synthetic components and with host machinery), which remains a major 
unaddressed issue in synthetic biology. 
Tuning Transcriptional Output 
 ZFs are well-studied structural motifs with crystallographic information providing 
blueprints for harnessing their structure-function relationship to program more complex 
transcriptional behaviors. We investigated how we could rationally engineer various component 
properties pertaining to the ZF-DNA interaction to tune transcriptional outputs in our synthetic 
eukaryotic system. For these studies, we focused on the sTF pair 42-10 and 43-8 (sTF42-10 and 
sTF43-8) because they activate transcription robustly to similar levels but show orthogonal 
activities to one another. In addition, these two activators show some distinct properties, e.g., 42-
10 seemed to impose a fitness cost on the yeast host, while 43-8 did not (Figure A1.3d).  
To tune up the level of transcriptional activation, we focused on alterations to the 
promoter architecture. We multimerized ZF binding sequences to create promoters with repeat 
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operators that would correspondingly recruit greater numbers of sTF interactions and thus ADs. 
With promoters harboring one, two, and eight tandem operators, we observed a corresponding 
increase in the transcriptional output of the system, confirming that we could tune up the level of 
activation (Figure A1.4a). Importantly, no cross-activation was observed between these sTFs and 
any of the tandem synthetic promoters (Supplementary Figure A1.4).  
 Eukaryotic promoters are known to integrate multiple inputs by binding to distinct TFs. 
In fact, transcriptional networks may even act as logic gates through such regulation schemes. 
Our synthetic promoters can similarly be designed to recruit distinct sTFs through architectures 
that include distinct operators. We constructed a two-input promoter with operators specific for 
sTF43-8 and sTF42-10. We then directed the expression of sTF43-8 and sTF42-10 under the 
independent and respective control of TetR- and LacI-controlled GAL1 promoters, which could 
in turn be induced by the chemical inputs, ATc and isopropyl-β-D-1-thiogalactopyranoside 
(IPTG). Upon induction of either or both of the sTF species, we observed transcriptional 
activation over the uninduced case (Figure A1.4b), confirming that our promoter design can 
indeed integrate distinct transcriptional signals in Boolean OR-like fashion.  
 Promoter architecture can be designed to alter the number of sTFs recruited and thus tune 
transcriptional output strength. An alternative approach is to regulate the ZF-DNA interaction 
through structure-guided mutation of the ZF backbone to alter non-specific DNA affinity. Along 
these lines, we targeted four arginine residues outside of the DNA recognition helices that are 
known, based on structural studies, to mediate non-specific interactions of a three-finger array 
with the DNA phosphate backbone (Pavletich and Pabo, 1991, Elrod-Erickson et al., 1996). The 
first arginine residue (position 2) is located upstream of the first β-strand of the amino-terminal 
finger, while the remaining three (positions 11, 39, 67) are found within the β-sheets of each of  
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(B2H) system (Wright et al., 2006, Maeder et al., 2008). Single residue alanine substitution 
mutations yielded modest effects, whereas sets of mutations revealed a step-wise decrease in 
DNA-binding activity (Supplementary Figure A1.5). We next incorporated the phosphate 
backbone mutations into sTF42-10, and tested the transcriptional activity of the resulting variants 
in our synthetic eukaryotic system. We found that transcriptional output could be analogously 
tuned down as the number of mutations was increased from zero (sTF42-10) to three (sTF42-10-3x) 
to four (sTF42-10-4x), in effect creating weaker-activating sTF variants from the lower-affinity 
variants (Figure A1.4d). We additionally investigated the effects the weaker-activating sTFs 
have on the yeast host. In the fitness growth assay, we found that the phosphate backbone 
mutations were able to systematically rescue the growth inhibition observed with sTF42-10 (Figure 
A1.4d; Supplementary Figure A1.3). We presume that this effect occurs because the mutant ZF 
proteins are less able to mediate off-target DNA interactions that may be at the root of the fitness 
cost.   
Taken together, these results demonstrate that the rational engineering of ZF binding sites 
in the promoter architecture and the ZF-DNA binding interaction — two component properties 
of our synthetic system — provide effective strategies for tuning transcriptional output.   
Engineering Cooperative Transcriptional Systems From Weakly-Interacting Components 
The assembly of TFs into multimeric complexes is a mechanism for achieving 
cooperativity and shaping input-output responses to regulate transcription. Inspired by natural 
cooperative systems, we next sought to assemble sTFs into multimeric complexes that could 
achieve synergistic transcriptional behaviors (Ptashne and Gann, 2002). To do so, we harnessed 
PDZ interaction domains from metazoan cells. These domains are naturally responsible for 
organizing intracellular signaling complexes, so we explored whether they could be utilized to 
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assemble and organize our synthetic factors in transcriptional applications. Because these 
domains are modular, they provide an additional tunable component property to our framework 
and allow for generalizable designs for multimerization. Furthermore, canonical PDZ domains 
are extremely rare in non-metazoans (Harris and Lim, 2001), and are therefore unlikely to 
interact with endogenous yeast machinery.  
The weakly-activating sTFs represent ideal components with which to demonstrate 
multimerization and the synthetic construction of transcriptional cooperativity. These sTFs were 
built from ZF mutants with lower non-specific DNA binding activity. We therefore investigated 
whether their assembly could stabilize a protein-DNA complex to better initiate transcription, 
presumably by slowing the off-rate of each component from the bound promoter. The well-
studied PDZ domain from the mammalian protein 1-syntrophin (Craven and Bredt, 1998, 
Harris et al., 2001) was fused to the C-terminus of 43-8-4x, and its cognate peptide ligand 
(GSGS-VKESLV), to which it binds with low micromolar affinity, was fused to the C-terminus 
of 42-10-4x. For these studies, only sTF43-8-4x carried an AD, making it a single locus for the 
recruitment of transcription initiation machinery. We did not attach an AD to the dimeric partner 
(sTF42-10-4x) in order to test whether this additional (non-activating) factor could stabilize the 
complex through dimerization and thus aid in the cooperative activation of transcription by 
sTF43-8-4x. In addition, we generated a non-binding partner by fusing a mutated form of the 
cognate ligand (GSGS-VKEAAA) to 42-10-4x. Expression of each ‘monomeric’ sTF was driven 
by independently inducible GAL1 promoters. Upon induction, the sTFs operate on a synthetic 
‘dimeric’ promoter to activate downstream transcription (Figure A1.5).  
We titrated expression of the PDZ-harboring sTF43-8-4x, both in the presence and absence 
of its ligand-carrying partner. In the resulting dose responses, we observed a significant  
 Figure A
activatin
(a) The d
Syntroph
and the r
heterolog
less facto
‘dimeric’
with 20 m
in transcr
to 42-10-
 
synergist
as compa
effect on
binding l
1.5: Transc
g sTF ‘mon
imerization 
in PDZ dom
esulting AD
ous ligand (
r was expre
 promoter to
M IPTG). (
iptional acti
4x.  
ic effect on 
red to when
the transcrip
igand partne
riptional c
omers’ tha
interaction p
ain (dark gr
-carrying sT
light grey) w
ssed from IP
 cooperativ
b) Disruptio
vation. A no
the transcrip
 it was not p
tional outpu
r (Figure A
ooperative 
t are dimer
romotes co
ey) was fus
F ‘monome
as fused to
TG-inducib
ely activate 
n of the dim
n-binding l
tional outpu
resent (Figu
t of the sys
1.5b). These
153 
systems can
ized with a 
operative be
ed to the C-t
r’ was expre
 the C-termi
le pGAL1. T
downstream
erization in
igand varian
t of sTF43-8-
re A1.5a). C
tem in the a
 results sugg
 be enginee
PDZ intera
havior in tra
erminal of Z
ssed from A
nal of 42-10
he factors a
 transcriptio
teraction ab
t (GSGS-VK
4x when the 
ritically, w
nalogous do
est that the
red from w
ction doma
nscriptiona
F affinity m
Tc-inducib
-4x, and the
ssemble at 
n (“IPTG+”
olishes coop
EAAA) w
partner fact
e observed n
se response 
 monomeric
eakly-
in 
l activation.
utant 43-8-
le pGAL1. T
 resulting A
a synthetic 
 = full indu
erative beh
as instead fu
or was prese
o cooperati
with the non
 sTFs, aided
 
 
4x, 
he 
D-
ction 
avior 
sed 
nt, 
ve 
-
 by 
154 
 
engineered protein-protein interactions, cooperate to recruit and stabilize one another at the 
synthetic promoter, thereby increasing the promoter occupancy and the resulting transcriptional 
activity of the complex.  
Engineering Diverse Two-Input Signal Processing Behavior 
With this synthetic framework, we can construct and study cooperative transcriptional 
assemblies. Additionally, we can explore cooperativity and other complex transcriptional 
behaviors within the context of signal integration, as a result of having synthetic control over 
combinatorial inputs and components. We thus harnessed the various control ‘knobs’ of our 
framework to engineer and explore signal processing behavior for synthetic two-input promoters.  
These studies were enabled by the design of ‘dimeric’ promoters harboring distinct 
operators for ZFs 43-8 and 42-10, and the independently-controlled expression of two 
customizable sTF cassettes by the chemical inputs ATc and IPTG (Figure A1.6). Induction of a 
single sTF (PDZ-carrying sTF43-8) by the addition of either the input controlling its expression or 
both inputs resulted in robust and equal levels of transcriptional output from the two-input 
promoter (Figure A1.6a). We utilized this system to engineer a variety of transcriptional input 
combinations. Our previous cooperativity results (Figure A1.5) established an interesting starting 
point for investigating how a pair of transcriptional signals can be integrated. So, we first used 
the dimerizing sTFs, constructed from ZF mutants 43-8-4x and 42-10-4x. The sTF43-8-4x activator 
was directed to the operator closest to the downstream gene’s start codon (proximal position), 
and the AD-less partner monomer to the distal position (Figure A1.6, “Proximal activator” 
architecture). When the distal monomer was engineered to carry the heterologous PDZ ligand, 
we observed cooperative-like amplification in transcriptional output in the presence of both 
inputs (Figure A1.6b). In this case, the distal monomer participates in binding to and stabilizing
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Figure A1.6: Synthetic ZF-based transcription framework can be used to engineer diverse 
two-input behaviors 
(a) The transcriptional operation of a single sTF43-8 (carrying a PDZ domain) at the proximal 
position of a two-input promoter. (b) Cooperative two-input synergy engineered with PDZ-
carrying sTF43-8-4x as the proximal activator and cognate ligand-carrying sTF42-10-4x as the distal 
partner. (c) Cooperative two-input synergy further enhanced by the addition of an AD onto the 
distal partner to create a two-activator system. (d) A ‘null’ two-input system engineered by 
abolishing the dimerization interaction with a PDZ non-binding ligand on the distal partner, thus 
rendering it non-contributory. (e) Inhibitory two-input behavior engineered by reversing the 
activator location (from proximal to distal) and using either PDZ binding or (f) non-binding 
ligands. (g) Inhibition by the proximal monomer can be further increased by increasing the 
proximal ZF affinity to DNA (43-8-4x to 43-8-3x) and decreasing the distal ZF affinity to DNA 
(42-10-3x to 42-10-4x) in both PDZ binding and (h) non-binding cases. (i) By reversing the 
orientation of the operators, sTF43-8-4x is converted from an inhibitor to a cooperative factor to, 
once again, obtain cooperative transcriptional synergy in the two-input behavior. All sTFs were 
expressed from either ATc- or IPTG-inducible pGAL1 (500 ng/mL ATc and/or 20 mM IPTG). 
Horizontal axes correspond to “Mean fluorescence intensity per cell (AU)” and begin at basal 
(promoter-only) fluorescence level.  
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the proximal sTF activator at the promoter to enhance transcription. Interestingly, the two-
component complex achieved transcriptional output levels similar to those of the single WT 
activator (Figure A1.6a), but only through the addition of both inputs and a total DNA operating 
specificity of 18 bp rather than 9 bp. Furthermore, we found that we could boost this effect by 
adding an AD onto the distal monomer, thus engineering a two-activator system and providing 
another source for transcriptional machinery recruitment at the promoter (Figure A1.6c).  
The PDZ-mediated sTF dimerization therefore serves as a key component property for 
enabling this type of synergistic two-input behavior. By simply modifying the ligand to abolish 
the binding interaction (i.e., mutating it to the non-cognate GSGS-VKEAAA), we rendered the 
distal monomer transcriptionally non-contributory in the proximal activator scenario, and 
subsequently engineered a different two-input behavior: one that shows equal output levels in the 
presence of either both inputs or the input directing the proximal activator (Figure A1.6d). In 
other words, we created a two-input system with a ‘null’ effect when both inputs are present. 
 We next sought to reverse the monomer roles by simply switching the placement of the 
AD. We loaded the AD onto ligand-carrying sTF42-10-3x and removed it from PDZ-carrying 
sTF43-8-4x, while directing the two monomers at the same ‘dimeric’ promoter (Figure A1.6, 
“Distal activator” architecture). Strikingly, we did not observe transcriptional output synergy. 
Instead, we observed an inhibition of the output signal in the presence of both inputs (Figure 
A1.6e). Furthermore, the inhibitory behavior was conserved in both PDZ-binding and non-
binding cases (Figure A1.6f). These results suggest that, with this particular combination of 
components in the distal activator scenario, the proximal monomers take on an inhibitory as 
opposed to a cooperative role. If this were the case, then we reasoned that we should be able to 
further strengthen the inhibition by increasing the ZF affinity of the inhibitory monomer (43-8-
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4x) to its operator and decreasing the ZF affinity of the distal activator (42-10-3x). Indeed, when 
we replaced ZF mutants 43-8-4x and 42-10-3x with 43-8-3x and 42-10-4x, respectively, we 
observed a commensurate decrease in transcriptional output in the presence of both inputs down 
to near baseline levels (Figure A1.6g-h). These results further suggest that, through this slight 
change to the complex architecture (proximal activator to distal activator scenarios), the AD-less 
partner monomer has shifted its transcriptional function from cooperative to inhibitory, in effect 
completely transforming the logical behavior of the system.  
Finally, we expected that flipping the orientation of the operators, such that the 42-10 
operator was placed in the proximal position, could ‘rescue’ the cooperative behavior (Figure 
A1.6, ‘Proximal activator (reversed)’ architecture). Indeed, with a reversed dimeric promoter, we 
once again observed a cooperative enhancement in the system’s output in the presence of both 
inputs as compared to that of the single inputs (Figure A1.6i). In effect, this change served to 
transform the transcriptional role of the 43-8-based species from inhibitor to a cooperative factor.  
Taken together, our results demonstrate that sTF monomers can be customized to 
different roles (e.g., activating, cooperative, non-participatory, inhibitory) within a simple two-
input system through the rational perturbation of component properties made accessible by our 
synthetic framework. These distinct roles can differentially shape the signal-processing behavior 
at a promoter. The results also highlight the importance in how a promoter’s geometry couples 
TF recruitment and binding to a downstream transcriptional behavior (Ptashne, 1986).   
 
Discussion 
Synthetic approaches to understand, rewire, and construct higher-order transcriptional 
networks, particularly in eukaryotes, have been severely hindered by a lack of reliable 
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components and a framework for designing and assembling them. We have developed an 
extensible synthetic biology framework for regulating eukaryotic transcription, whereby artificial 
ZF proteins are used as core building blocks from which to construct complex transcription 
functions and circuitry. The use of a context-dependent ZF selection scheme allows us to rapidly 
alter and program the ZF-DNA interaction specificity, and identify orthologous pairs of ZF 
arrays-DNA sites that can be engineered into sTFs for wiring networks within yeast. This work 
brings new forms and levels of connectivity to synthetic transcriptional circuits, beyond that 
which is achievable with the few, classical prokaryotic TF-promoter pairs. Using our 
methodology, one should be able to create a virtually unlimited number of sTF-promoter pairs, 
with which to make transcriptional circuit connections. In this regard, we note that three-finger 
arrays have been engineered for more than 500 different nine bp sites using the OPEN (Maeder 
et al., 2008) and Context-Dependent Assembly (CoDA) (Sander et al., 2011b) methods (J.K. 
Joung and colleagues, unpublished data).  
Engineered Transcription Activator-Like (TAL) effectors have recently emerged as an 
important alternative to customized ZFs for programming DNA specificity. Naturally occurring 
TAL effectors encoded by Xanthamonas bacteria bind to target DNA sequences using arrays of 
highly conserved 33-35 amino acid repeat domains. A single TAL effector repeat binds to one 
nucleotide of DNA with specificity of binding associated with the identities of amino acids at 
two positions known as Repeat Variable Di-residues (RVDs). TAL effector repeats bearing 
different RVDs have been described for specific binding to each of the four possible DNA 
nucleotides, and these repeats can be simply joined together to create arrays capable of binding 
to extended target DNA sequences (Bogdanove and Voytas, 2011). The simplicity and 
modularity of the TAL effector repeats suggests that nearly any DNA sequence should be 
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targetable, and recent work has demonstrated that engineered TAL effector nuclease (TALEN) 
fusions can be robustly generated for a wide variety of different sequences (Reyon et al., 2012). 
Nonetheless, engineered ZFs have several important advantages, including their considerably 
smaller size, their less repetitive coding sequence (potentially important for packaging into viral 
vectors), and a greater understanding of their biochemical properties, structure, and function, 
which is important for creating variations in affinity, specificity, and tunability.   
The use of artificial ZF domains enables a fully decomposed design of a sTF, for which 
the molecular component properties are accessible, modular, and tunable. With these new 
components, we constructed a synthetic transcriptional cascade in yeast and used it as a test bed 
for rationally customizing the component properties to program in vivo behaviors. Specifically, 
we showed that systematic construction of complex transcriptional functions can be achieved by 
the independent control of a set of key component properties. For instance, we tuned the strength 
of transcriptional outputs through modifications of ZF binding sites in the promoter architecture 
as well as through structure-guided modifications to the ZF protein to alter ZF-DNA interactions.  
Our framework additionally provides the ability to engineer and tune transcriptional 
cooperativity. To date, there exists no simple way of building cooperative transcriptional 
systems, even though their importance is well-documented in both natural and synthetic gene 
regulation. As a result, in most synthetic studies, researchers have used TFs with integrated, 
cooperative properties. In contrast, our framework establishes a modular technique for 
constructing cooperative transcriptional activation schemes de novo, through the multimerization 
of weakly-activating ZF-TFs using low-affinity protein interaction domains (i.e., PDZ domains). 
This has important consequences for constructing higher-order complexes that more accurately 
mimic eukaryotic transcriptional regulation schemes, lead to sharper switch-like responses, and 
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modulate cooperativity within circuits. Indeed, multimerization and cooperativity are ubiquitous 
molecular regulation schemes that underlie complex gating and decision-making in cells. For 
example, the yeast GAL1 promoter is able to integrate coactivator proteins in specific temporal 
order by utilizing the cooperativity of certain interactions to gate subsequent recruitment events 
(Bryant and Ptashne, 2003). It is of great interest to understand how activators function 
cooperatively to assemble specific initiation complexes and regulate transcription. Our bottom-
up and modular approach to transcriptional cooperativity could be used to synthetically 
recapitulate such phenomena so as to study these fundamental mechanisms of regulation. This 
type of approach has been used to understand transcriptional synergy in prokaryotes (Joung et 
al., 1993, Joung et al., 1994), and our platform should now enable this strategy to be used to 
model more combinatorially complex eukaryotic promoters. Furthermore, our extensible and 
modular framework for multimeric and cooperative transcriptional systems may allow for the 
implementation of expanded computational operations in eukaryotes, such as logic devices with 
vastly more input possibilities. 
Previous reports have described various frameworks for creating dimeric ZF proteins. In 
all of these studies, elements derived from naturally occurring TFs (Pomerantz et al., 1998, 
Wolfe et al., 2000) or ones selected from combinatorial peptide libraries (Wang and Pabo, 1999, 
Wang et al., 2001) were used to dimerize two-finger units. A disadvantage of this strategy is that 
a dimerized two-finger complex would have a maximum specificity of 12 bp (assuming that each 
of the four fingers in the dimer specifies three bp). Our approach differs by utilizing three-finger 
monomers that have had their binding activities reduced by mutagenesis of non-specific 
phosphate-contacting residues. This strategy creates dimeric proteins that can have specificities 
as high as 18 bps, a sequence long enough to be potentially unique in a mammalian genome. 
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Furthermore, the use of modular protein-protein interaction domains for multimerization is 
advantageous for various reasons. For example, the interaction is orthogonal and tunable, 
allowing us to ‘match’ affinities of all the component interactions making up the sTF complex, 
and it provides extensibility for further expanding the complex architecture and dynamically 
increasing or decreasing the DNA-substrate specificity of the complexes.  
We also showed that complex signal processing functions can arise when control of TF 
cooperativity is combined with the ability to engineer promoters of multimerized ZF binding 
sites. Cellular signal processing is a mechanism by which environmental and other signals are 
integrated to modulate transcription and thus critical cellular processes, such as growth and stress 
responses. We constructed a simple, synthetic two-input transcriptional system that allowed us to 
decompose contributions from the sTF component properties to the system’s processing 
behavior. We showed that, with the same two core TFs and promoter operator sites, a cell could 
process and integrate signals in a variety of ways. For example, subtle changes, such as reversing 
promoter operators and disrupting protein-protein interactions, can have striking effects on the 
output of the system. This led to the construction of not just varied digital logic behavior, but a 
range of analog tunability. In an inhibitory system (Figure A1.6e-h), we arrived at an interesting 
Boolean logic gate that produced a positive signal only in the presence of a single input: A>B (A 
does not imply B). A broad observation from our studies was that specific perturbations to an 
sTF’s component properties (DNA affinity, multimerization with other species, location of 
operator, etc.) could allow it to convert between different transcriptional roles within the 
complex, such as activator, cooperative factor, non-contributory, and inhibitor. This synthetic 
approach could be utilized to explore the diversity of behaviors that can be programmed by even 
just a few transcriptional components; furthermore, our findings provide simple strategies for 
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reprogramming the signal processing behavior of a cell. Similar strategies are undoubtedly 
employed naturally, where there are many examples of individual proteins that can take on either 
activating or repressing roles depending on the cellular and environmental states (Ma and 
Ptashne, 1988, Rubin-Bejerano et al., 1996, Chandarlapaty and Errede, 1998, Maxon and 
Herskowitz, 2001, Kassir et al., 2003).   
Given that TFs containing ZFs play a central role in eukaryotic promoter regulation 
(Pabo et al., 2001), our system represents a promising means for synthetic recapitulation of 
eukaryotic promoter function, and thus will significantly enhance our ability to construct 
synthetic gene networks in mammalian cells, an area of tremendous potential in synthetic 
biology (Weber and Fussenegger, 2009). Indeed, yeast may serve as a well-characterized testbed 
for the design and validation of synthetic gene circuits that can be subsequently ported to higher 
organisms. Synthetic transcriptional regulators based on the sTFs described here can be used to 
create classifier circuits to identify cell state (Nissim and Bar-Ziv, 2010, Xie et al., 2011), 
memory devices to record cellular events, and logic gates for cellular processing (Kramer et al., 
2004a), which can aid in the study and control of stem cell differentiation, therapeutics, and 
complex human diseases. Additionally, ZF-based proteins have been shown to be powerful 
targeting elements of endogenous genomic loci in many mammalian cells, including cancer, 
immune, and stem cells. These proteins include ZF nucleases (Zou et al., 2009), which are being 
tested in therapeutic applications for modifying/disrupting disease-causing alleles and genes, and 
artificial TFs (Blancafort et al., 2005), which can be used to modify the expression of native 
genes for reprogramming purposes. Together with these ZF technologies, our work may lead to 
the construction of integrated gene circuits – artificial circuitry that seamlessly and specifically 
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integrates into endogenous gene networks and/or leads to the modification of endogenous genes 
– for more dynamical and sophisticated genetic control in cell-based therapeutic applications. 
Synthetic biology is helping us to understand how organisms behave and develop through 
the forward engineering of molecular circuitry with well-understood genetic components 
(Elowitz and Lim, 2010). The present work expands the synthetic biology toolkit with new 
genetic components, beyond re-purposed bacterial transcriptional components, to program 
eukaryotic cells. Additionally, it provides a bottom-up framework for exploring the complexity 
of eukaryotic promoters and their combinatorial regulation by TF complexes and circuitry. This 
framework can be a starting point for determining the transcriptional components, modules, and 
circuitry needed to implement the sophisticated behaviors that control the development and 
function of eukaryotic cells.  
 
Methods 
Strains and Media 
S. cerevisiae YPH500 (α, ura3-52, lys2-801, ade2-101, trp1Δ63, his3Δ200, leu2Δ1) 
(Stratagene) was used as the host strain in all yeast experiments, and plasmid chromosomal 
integrations were specifically targeted to the redundant ura-52 locus. Culturing, genetic 
transformation, and verification of transformation were done as previously described (Murphy et 
al., 2007), using either the URA3, TRP1, or LEU2 genes as selectable markers.  
 
Plasmid Construction 
Synthetic promoter plasmids were constructed from integrative plasmid pRS406 
(Stratagene) by cloning ZF binding sequences (BS) directly upstream of the CYC1 minimal 
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promoter (pCYC1) TATA box. The corresponding ZF-activated promoter drives the expression 
of a yeast enhanced green fluorescent protein (yEGFP) (Cormack et al., 1997), which is preceded 
by a Kozak consensus sequence.  
sTF circuit plasmids were constructed from the previously described yeast integrative 
plasmids pTPG1 (TX: TetR-regulated control promoter) and pLOG1 (LX: LacI-regulated control 
promoter) (Ellis et al., 2009). Briefly, these plasmids consist of a GAL1 upstream activation 
signal (UAS) followed by either a TetR- or LacI-regulated wild-type GAL1 promoter, which 
drives the expression of our sTF cassettes; the strong constitutive TEF1 promoter also directs the 
expression of yeast codon-optimized versions of TetR (Tn10.B tetracycline repressor) and the E. 
coli Lac inhibitor (LacI). Constitutive expression of the repressors ensures low basal levels of 
expression of our sTF cassettes from the engineered GAL1 promoter, which can be relieved by 
the respective addition of the chemical inputs, anhydrotetracycline (aTc) and isopropyl-β-D-1-
thiogalactopyranoside (IPTG), to the medium. 
The sTF circuit cassette, which was synthesized (DNA2.0) and cloned as a KpnI/XhoI 
fragment into pTPG1 and pLOG1, enables the molecular customization and expression of 
synthetic ZF-TFs. It consists of an open cloning site (NheI/BglII or XbaI/BamHI) for engineered 
ZF arrays. Upon insertion of a ZF gene, the resulting minimal sTF becomes (N- to C-terminal): 
3xFLAG – nuclear localization sequence (NLS) – VP16 minimal activation domain (AD) (Beerli 
et al., 1998) – ZF array. All ZF genes were codon-optimized, individually synthesized (IDT), and 
cloned as XbaI/BamHI fragments into the cassette. Protein-protein interaction domains, namely, 
syntrophin PDZ domain and peptide ligands, were added as C-terminal fusions to the sTF, 
separated by a short GSGS linker, and cloned from synthesized, codon-optimized gene fragments 
(DNA2.0).  
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All plasmids were constructed and used to transform E. coli to harvest DNA for yeast 
transformations, as previously described (Murphy et al., 2007).  
Determination of ZF Protein Activity by Bacterial-2-Hybrid (B2H) Reporter Assay 
Activity of ZF proteins was quantified using the B2H reporter assay as described 
previously (Wright et al., 2006, Maeder et al., 2009). Briefly, ZF protein monomers were cloned 
as XbaI/BamHI fragments into the B2H expression plasmid (pGP-FF, Addgene plasmid 13480) 
to generate ZF-Gal11P activation domain fusion proteins. Each ZF-Gal11P fusion was 
introduced along with a low-copy alpha-Gal4 hybrid protein into a bacterial reporter strain 
harboring a single-copy reporter (pBAC-lacZ; Addgene plasmid 13422), modified to encode the 
corresponding zinc-finger binding site upstream of a weak promoter controlling lacZ expression 
as previously described (Maeder et al., 2009). The DNA-binding activities of ZF proteins were 
determined by measuring the expression level of β-galactosidase as described previously 
(Thibodeau-Beganny and Joung, 2007). The results were normalized by dividing the number of 
units measured in the presence of the zinc finger monomer by those in its absence, which is 
referred to as the "Fold activation relative to Gal11P" value. 
Induction Experiments 
Single yeast colonies for each strain were picked and used to inoculate 500 μL of SD-Glu 
(synthetic drop-out media containing 2% glucose with selectable amino acid mixtures) in Costar 
96-well assay blocks (V-bottom; 2mL max volume; Fisher Scientific). The cultures were grown 
at 30°C with 900 rpm shaking for 2448 h. A triplicate set of 500-μL YEP-Gal (yeast extract 
peptone media containing 2% galactose) cultures, with and without appropriate inducers (e.g., 
ATc and/or IPTG) (Ellis et al., 2009), were inoculated to an OD600 of ~0.080.1 and grown at 
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30°C with 900 rpm shaking for ~1416 h. Cells were then treated with cycloheximide to inhibit 
protein synthesis, and then assayed for yEGFP expression by flow cytometry.  
Flow Cytometry and Data Analysis 
For all data, we acquired 5,000–10,000 events using a BD LSRFortessa equipped with a 
High Throughput Sampler (BD Biosciences), running samples on a medium flow rate. Events 
were gated by forward and side scatter. The geometric means of the fluorescence distributions 
were calculated. The autofluorescence value of S. cerevisiae YPH500 cells harboring no 
genomic integrations was subtracted from these values to give the fluorescence values reported 
in this study. “Fold activation” values were calculated as the ratio of fluorescence values from 
induced cells to those from uninduced cells. 
Growth Assays 
Growth assays were performed similarly to induction experiments, except that 
experimental cultures were inoculated to an OD600 of ~0.030.05 and grown at 30°C with 900 
rpm shaking for 30 h. OD600 measurements were taken using a SpectraMax M5 fluorescence 
microplate reader (Molecular Devices) using culture volumes of 100 μL. A “No ZF” control – a 
strain engineered with synthetic promoter and sTF cassette lacking a ZF array – was assayed in 
parallel. 
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Appendix 1 Supplementary Materials: 
 
Supplementary Figure A1.1:   Demonstration of yEGFP fluorescence measurements as a 
reliable indicator of steady-state transcriptional circuit output 
Supplementary Figure A1.2:   Flow cytometry data of transcriptional activation by a library of 
synthetic transcription factor (sTF)-promoter pairs 
Supplementary Figure A1.3:   Growth assays for a representative set of sTF circuit strains 
Supplementary Figure A1.4:   sTFs constructed from OPEN ZFs operate orthogonally to one 
another 
Supplementary Figure A1.5:   DNA-binding activities of engineered ZF proteins possessing 
various combinations of non-specific affinity mutations 
Appendix 1 Supplementary Methods 
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Appendix 1 Supplementary Methods: 
Quantitative real-time PCR 
Transcriptional outputs of our circuits were analyzed by quantitative real-time PCR (RT-
PCR). Total RNA was collected from yeast at different induction levels and time points 
(Supplementary Figure A1.1). RNA extraction was performed using RNeasy Mini Kit (Qiagen), 
and DNA contamination was eliminated using TURBO DNA-Free (Ambion) according to the 
manufacturers’ protocols. Concentration of RNA in each sample was estimated using an ND-
1000 NanoDrop spectrophotometer. Template cDNA was synthesized from RNA using the 
Superscript III First Strand Synthesis kit (Invitrogen) and stored at -20°C. RT-PCR reactions 
were prepared using LightCycler 480 SYBR Green I Master Kit (Roche Applied Science) 
according to the manufacturer’s instructions, and RT-PCR was performed using a LightCycler 
480 (Roche). Relative mRNA expression level of yEGFP in a given sample was determined by 
normalization to the transcript level of the reference gene TAF10 (Teste et al., 2009).  
Growth assays 
Longer time-course growth assays were performed for a representative set of sTF circuit 
strains (Supplementary Figure A1.3). Growth assays were performed as described previously 
(see Methods), except that OD600 measurements were taken at 8 h time points for 64 h.  
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